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Abstract 
The interactions of peripheral membrane proteins with both membrane lipids and 
proteins are vital for many cellular processes including membrane trafficking, cellular 
signaling, and cell growth/regulation. Building accurate biophysical models of these 
processes requires quantitative characterization of the behavior of peripheral membrane 
proteins, yet methods to quantify their interactions inside living cells are very limited. 
Because peripheral membrane proteins usually exist both in membrane-bound and 
cytoplasmic forms, the separation of these two populations is a key challenge. This thesis 
aims at addressing this challenge by extending fluorescence fluctuation spectroscopy 
(FFS) to simultaneously measure the oligomeric state of peripheral membrane proteins in 
the cytoplasm and at the plasma membrane. We developed a new method based on z-scan 
FFS that accounts for the fluorescence contributions from cytoplasmic and membrane 
layers by incorporating a fluorescence intensity z-scan through the cell. H-Ras-EGFP 
served as a model system to demonstrate the feasibility of the technique. The 
resolvability and stability of z-scanning was determined as well as the oligomeric state of 
H-Ras-EGFP at the plasma membrane and in the cytoplasm. Further, we successfully 
characterized the binding affinity of a variety of proteins to the plasma membrane by 
quantitative analysis of the z-scan fluorescence intensity profile. This analysis method, 
which we refer to as z-scan fluorescence profile deconvoution, was further used in 
combination with dual-color competition studies to determine the lipid specificity of 
protein binding. Finally, we applied z-scan FFS to provide insight into the early assembly 
steps of the HTLV-1 retrovirus. 
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1.  Introduction 
Proteins are fundamental biomolecules of cellular systems. They provide the cell 
with structure and are central to the execution of every process vital for cell function. 
More specifically, the association of proteins into complexes is a critical aspect of cell 
biology and essential for the execution of specific tasks. Since the cell is divided into 
different compartments, protein complexes are found within each compartment and at the 
interface between compartments. The plasma membrane is a unique interface that 
provides a barrier between the intracellular cytosol and extracellular fluid. It consists of a 
lipid bilayer that incorporates a vast array of membrane proteins. Exchange of cellular 
signals or materials between the cell and its environment often rely on the actions of 
protein complexes to pass through the membrane interface.  
In cellular signaling, the plasma membrane provides a platform for the initiation 
of signal cascades. It functions as a signaling switchboard with membrane proteins 
playing the role of traditional telephone operators. Membrane proteins receive 
information from the extracellular space and relay that information to the cell through 
intracellular signal cascades that ultimately modulate cellular function. Additionally, the 
plasma membrane is important for many vesicle trafficking pathways and plays a role in 
cell motility though interactions with cytoskeletal proteins. Finally, the plasma membrane 
is of particular interest for study, because it is the primary gateway for viral infection and 
is often the site of viral particle assembly.  
The quantification of protein-protein interactions directly inside the living cell is a 
crucial prerequisite to build quantitative models of cellular processes. Fluorescence 
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fluctuation spectroscopy (FFS) is a method that can be used to study such protein-protein 
interactions. Our lab and others have used FFS to characterize the interactions of soluble 
proteins in the nucleus and the cytoplasm of living mammalian cells (1–3). While 
applications of FFS to membrane systems have been reported (4–7), there has been no 
quantitative study critically analyzing the influence of the plasma membrane / cytoplasm 
interface on FFS analysis of protein interactions. In this thesis we investigate this 
situation and demonstrate that the overlap of the excitation light with the membrane and 
the cytoplasm introduces confounding effects that are not captured by traditional FFS 
analysis. Based on this analysis, we developed a new FFS model that accounts for 
cytoplasmic and membrane contributions to the fluorescence signal by performing an 
axial scan of the laser excitation beam through the cell. After developing and testing the 
method we apply it to quantify the oligomeric state of proteins at the plasma membrane 
and in the cytoplasm.  
 
1.1 Membrane proteins 
Membrane proteins can be broken up in to two distinct groups: integral membrane 
proteins and peripheral membrane proteins.  
 
1.1.1 Integral membrane proteins 
Integral membrane proteins are permanent residents of the plasma membrane and 
often completely span the lipid bilayer either in one single pass or in a series of loops that 
double back and forth through the bilayer. They have an amphiphilic structure; with 
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hydrophilic regions that extend into the cytoplasm or the extracellular fluid and 
hydrophobic regions that pass through the membrane. The function of integral membrane 
proteins is varied and includes cell adhesion, energy transduction, and the regulation of 
movement of molecules across the membrane. 
 
1.1.2 Peripheral membrane proteins 
Peripheral membrane proteins, the group of proteins primarily studied within this 
thesis, interact transiently with the plasma membrane and are free to diffuse along the 
plasma membrane as well as between the membrane and the cytosol. They are primarily 
hydrophilic proteins but associate with membrane lipids through one or more of the 
following mechanisms: electrostatic interactions, a covalently attached lipid anchor, a 
cluster of hydrophobic residues, a modular domain that targets specific membrane 
phosphoinositides, or a region that interacts non-covalently with membrane proteins (8–
10).  
Peripheral membrane proteins play a role in signal transduction, membrane 
trafficking, cytoskeleton-membrane linking, and phospholipid metabolism and 
catabolism, to name just a few of their many functions (8–10). Such proteins are often 
recruited to the plasma membrane during cellular processes like cell signaling and 
membrane trafficking (8). In the case of Ras, a signal transduction peripheral protein, the 
activation of a receptor at the membrane promotes the post-translational modification 
(palmitoylation) of Ras and the subsequent translocation of the protein to the membrane 
(11, 12). For other peripheral membrane proteins, the interaction with the membrane 
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induces conformation changes in the protein which are necessary for its function (8). The 
converse is also true, in that changes within the lipid bilayer are often induced by the 
attachment of a peripheral membrane protein to the membrane. For example, 
heterotrimeric G-proteins modulate their immediate lipid environment by inducing 
remodeling of the plasma membrane which can in turn modulate the binding affinity of 
G-proteins to the membrane (13, 14). Overall, since membrane binding is the mechanism 
that defines the structure and function of peripheral membrane proteins (as well as the 
subsequent lipid environment), determining the binding affinity, lipid specificity, and 
oligomeric state of the protein is a crucial step for developing a biophysical model of its 
function.  
 
1.1.3 Cellular signaling – G protein coupled receptors 
The development of assays and techniques to study peripheral membrane proteins 
goes beyond the understanding of biological function and extends into deconstruction of 
disease pathways and development of pharmaceutical treatments. Because of their 
cellular location and role in signaling, cell-surface receptors are often targets of 
pharmaceutical agents. The largest family of cell-surface signaling receptors,, G-protein 
coupled receptors (GPCRs), are the target of ~30% of prescribed drugs on the market 
(15–18). Fundamental cellular and therapeutic processes start with the binding of a ligand 
or drug to the GPCR which causes a conformational change of the receptor. This change 
activates one or more peripheral G-proteins, which initiate signal transduction by 
interacting with other membrane proteins or by dissociating from the membrane in order 
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to communicate with nuclear or cytoplasmic targets (13, 14, 16, 19). For the nuclear 
targets, common G-protein modulated pathways include cell proliferation, differentiation, 
and development (16, 20). Thus, it should not be a surprise that the overstimulation of 
specific GPCR pathways often results in tumor growth and cancer (20).  For the 
understanding and development of future GPCR (and other cell surface receptor) drug 
targets it is important not only to study the binding of ligands and drugs to the receptor 
but to have a technique that can probe the binding and interactions of G-proteins and their 
downstream targets within a live cell environment. More recent studies have suggested 
that the signaling from GPCRs often include G-protein independent pathways (16, 19). 
This more complex picture of the intricate signaling network further suggests the need for 
the development and application of live-cell techniques that can probe protein 
interactions both in the cytoplasm and at the membrane.  
 
1.2 Traditional methods used for studying membrane proteins 
The characterization of membrane proteins is challenging because the interplay 
between the protein and the lipid bilayer is essential for both conformation and function. 
To deal with this issue, many structural and functional studies rely on in-vitro assays 
performed on either isolated membranes or model membrane systems. While the plasma 
membrane is made up mainly of proteins and phospholipids, model membranes have a 
simplified composition; consisting  of one or two types of the phospholipids found at the 
plasma membrane (21–23). The most common forms of model membranes found in 
studies are micelles, unilamellar vesicles, multilamellar vesicles, and supported lipid 
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bilayers (21–23). The advantage of model membranes is their simple composition as this 
allows for an easily controllable platform for studying lipid-protein interactions. This, 
however, is also their disadvantage; they do not accurately represent the actual native 
membrane. Isolated membranes can be used to partially address this issue. Because 
isolated membranes have been extracted from an actual cell, they offer a more realistic 
membrane environment for the study of protein-lipid interactions (21–23). However, 
model membranes are largely preferred by researchers, because isolated membranes are 
hard to prepare and the integral membrane proteins within the isolated membrane 
increase the complexity, thereby making the interpretation of experimental results less 
straightforward. For these reasons, the majority of our knowledge of the affinity and 
specificity of protein-lipid binding comes from studies using model membrane systems 
(21, 22).  
 
1.2.1 Structural assays  
Structural studies of a protein are helpful in providing clues to binding partners, 
interactions, conformational changes, and cellular function. X-ray crystallography and 
nuclear magnetic resonance (NMR) structural studies are two common techniques used to 
determine protein structure which can shed light on the protein’s function. For membrane 
proteins, these methods take on an extra level of complexity because the protein is often 
characterized in a micelle solution after first being separated from the native membrane 
through the use of amphiphilic detergents (24). While this approach yields structural 
information, it also poses an inherent challenge. The micelle may perturb the protein’s 
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native structure, because the lipids within the micelle have a much higher curvature than 
typically found at the plasma membrane (24). In general, structural studies need to be 
supplemented with assays that characterize functional interactions of the protein. This is 
especially relevant for membrane proteins because of the important role protein-lipid 
interactions play in protein conformation and function. A brief discussion of some 
standard functional assays used to probe both protein-lipid and protein-protein 
interactions at the plasma membrane is given below. 
 
1.2.2 Fractionation assay 
Protein-lipid interaction assays can be broken up into biochemical- and optical-
based approaches. On the biochemical side, cellular fractionation is arguably the most 
standard method for determining the relative interaction strength of protein binding to the 
membrane. Fractionation assays separate and quantify membrane-bound and cytoplasmic 
components through either sedimentation (high-speed centrifugation) or flotation (density 
gradient centrifugation) (21, 22). These assays are can be performed on a homogenized 
cell suspension. However, quantitative fractionation of protein/membrane binding 
requires model membrane vesicles because the vesicles can be made to a specific size and 
lack internal membranes. In these studies, large unilamellar vesicles (LUV) of a well-
defined size are incubated with varying concentrations of a peripheral membrane protein. 
Through either sedimentation or flotation, the lipids are separated from the solution into 
either pellets or a layer. The relative amount of protein in the supernatant versus the pellet 
is used to determine the binding affinity of the protein (21, 22). The advantage of this 
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approach is that LUVs are quite easy to produce, the equipment and protocols are well 
established and there is no need for a label. On the other hand, it is hard to quantify a 
fractionation assay from a sample of living cell, fractionation is not a time-resolved 
technique, the measured quantity represents the average from a population of cells, and 
the sample is destroyed during centrifugation. 
 
1.2.3 Fluorescence-based assays 
There is an array of fluorescence techniques for studying protein-lipid 
interactions. These methods typically use a fluorescent molecule or protein to optically 
tag the protein of interest. However, intrinsic fluorescent properties of the protein can be 
exploited as well. A relatively straightforward assay of membrane binding quantifies 
changes in the intrinsic fluorescence from tryptophan residues. The emission of 
tryptophan is extremely sensitive to changes in its immediate environment. A tryptophan 
residue in contact with a hydrophobic environment shifts emission to shorter wavelengths 
coupled with an increase in fluorescence (21, 22, 25). Thus if a peripheral membrane 
protein has a tryptophan residue exposed close to the membrane binding region of the 
protein, the change in fluorescence can be used to characterize the strength of binding to 
model membranes (21, 22, 25). A variation of this technique adds a fluorescently labeled 
lipid to the model membrane. Instead of measuring the shift in tryptophan fluorescence 
the efficiency of fluorescence resonance energy transfer (FRET) between the tryptophan 
(donor) and the fluorescent lipid (acceptor) is measured (21, 22). FRET is extremely 
sensitive to distance between the acceptor and donor molecule. Proximity of both 
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molecules within a few nanometers leads to efficient FRET, while a slightly larger 
distance abolishes the FRET signal (26). The technique has been used to determine 
binding affinity as well as binding geometry (21, 22). FRET has an advantage over 
measuring shifts in tryptophan fluorescence. The tryptophan FRET donor only needs to 
be in the vicinity (~ a few nm) of the lipid acceptor to produce a signal as opposed to the 
molecular contact required to observe the shift in tryptophan emission. In addition, a 
tryptophan or a fluorescent probe can be attached to the protein of interest, if there isn’t a 
tryptophan initially present.  
Fluorescence imaging has been applied to study protein-lipid interactions and 
protein-protein interactions at the plasma membrane. A z-stack of fluorescence confocal 
images provides information about the spatial distribution of fluorescently labeled 
proteins within a cell (27, 28). For example, fluorescence z-stack images  have been used 
to track translocation of peripheral membrane proteins from the membrane to the cytosol 
initiated by an external stimulus by (29–31). The analysis of z-stack images provides a 
detailed record of the kinetics of the process from the time-resolved changes in the 
fluorescence intensity, but lacks the ability to determine the protein concentration at the 
plasma membrane, because a clean separation of the fluorescence signal in membrane-
bound and cytoplasmic components is not feasible. However, these studies have the 
advantage of being performed within living cells rather than on model membranes.  
Total internal reflection fluorescence (TIRF) microscopy is another popular 
technique for studying both the spatial distribution and dynamics of proteins at the 
plasma membrane. The evanescent field at the glass / solution interface only extends 
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~100 nm into solution (32, 33), which efficiently penetrates the plasma membrane in 
contact with the glass coverslip, and offers great contrast for observing membrane 
proteins, because proteins deeper within the cytoplasm are not excited. TIRF microscopy 
has been applied to studying cytoskeletal dynamics, focal adhesions, membrane 
trafficking, intracellular signaling, and many other processes (34). Additionally, when 
used in combination with Number and Brightness Analysis (35), it is possible to 
determine the relative oligomeric state of proteins at the plasma membrane compared to a 
plasma membrane control protein (36–38). One inherent problem with TIRF microscopy 
is once again linked to quantification. The plasma membrane often is not in contact with 
the coverglass at all places over the cell surface. This small but variable distance between 
the membrane and glass leads to fluorescence intensity variations that can complicate 
quantitative analysis.  Furthermore, there is a small but pervasive signal from the 
cytoplasm (especially for peripheral membrane proteins) that must be accounted for in 
order to avoid misinterpretations of the data.  
Fluorescence correlation spectroscopy (FCS) has been widely used to characterize 
the dynamics of both lipids and proteins at the plasma membrane (39–42). The 
implementation of scanning techniques like circular scans (43), line scans (44, 45), and z-
scans (46, 47) has allowed FCS to be effectively applied to proteins with 
characteristically slow diffusion times within the membrane’s spatially constrained 
environment. Brightness measurements at the plasma membrane have also been 
performed, but these studies only account qualitatively for the influence of neighboring 
layers on the measurement (4–6). Because the validity of this approach has never been 
  11 
tested, it is unclear when and where traditional analysis breaks down. Since FFS 
measurements of brightness have tremendous potential for live-cell applications, it is 
imperative to develop FFS into a robust technique with a well-defined theory for the 
quantification of protein association on and off the plasma membrane. 
 
1.2.4 Surface plasmon resonance 
 Surface plasmon resonance (SPR) is an optical technique that senses index of 
refraction changes at a metal surface to probe protein-lipid interactions, as well as 
protein-protein interactions in real time without any label (21, 22, 48, 49). In an SPR set-
up, specialized sensor chips, typically consisting of a thin film of metal placed on a glass 
surface, are covered with immobilized lipids. This chip is placed in a flow cell where 
surface plasmons are generated by directing incident light towards the surface at a critical 
angle (21, 22, 48). A solution containing the protein of interest is then applied to the cell; 
a change in the refractive index occurs if the proteins interact with the lipids. This change 
in refractive index is measured in real time and determines the amount of protein binding. 
By varying the concentration of protein in the solution, the binding parameters between 
the lipid and protein can be determined (21, 22, 48). The advantage of this method is the 
real time measurement of protein-lipid interactions without any external labels. The 
disadvantage is that it is almost entirely restricted to model membrane systems because of 
the specialized sensor chips.  
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1.3 Overview of thesis  
 While the techniques briefly mentioned above have contributed enormously to our 
understanding of protein binding to membranes, they are either restricted to in-vitro 
environments or lack quantitative capabilities when applied to cells. Thus, there is a 
significant need for the development of quantitative techniques that probe proteins at the 
plasma membrane / cytoplasm interface of a live cell, in general, and for probing their 
oligomeric state in particular. Traditional FFS shines when it comes to identifying a 
protein’s oligomeric state in a uniform environment. The presence of the cytoplasm and 
membrane introduces spatial nonuniformity, which leads to a breakdown of traditional 
FFS analysis. Addressing this issue is the main focus of this thesis. 
Many processes within the cell involve hetero-species protein interactions, such 
as a peripheral membrane protein interacting with an integral membrane protein. While 
dual-color FFS characterizes such hetero-interactions, the expression level of the two 
proteins provides an experimental challenge, because variations in the expression ratio 
lead to a large cell to cell scatter of the binding data. In chapter 3, we develop and 
introduce a quantitative model that describes the average as well as the distribution of the 
protein coexpression ratio from a cell population. We show that the expression ratio is 
proportional to the molar plasmid ratio and relate the distribution to the finite number of 
active plasmids in the cell. While the rest of the thesis primarily focuses on homo-
interactions (with single-color measurements) the lessons learned in chapter 3 will help 
construct the competition studies introduced in chapter 6.  
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As previously mentioned, traditional FFS is not equipped to deal with the spatial 
nonuniformity introduced by fluorescence emanating from the cytoplasm and the plasma 
membrane. In chapter 4, we address this issue by developing z-scan FFS, which 
combines an axial scan through the cell with FFS point measurements. Using z-scan FFS 
we were able to simultaneously determine the oligomeric state of proteins in the 
cytoplasm and at the membrane. We applied the technique to study the matrix domain of 
the Gag polyprotein from Human T-cell lymphotropic virus Type 1 (HTLV-1), which 
binds to the plasma membrane, to investigate the early steps of the viral assembly 
process.  
Chapter 5 focuses on the z-scan intensity profile described in chapter 4 and the 
accurate partitioning into its cytoplasmic and membrane-bound fluorescence 
contributions, a process we refer to as z-scan fluorescence profile deconvolution (FPD). 
Using the cellular brightness of enhanced green fluorescent protein (EGFP), the 
fluorescence intensities are converted into concentrations at the membrane and in the 
cytoplasm. We experimentally validate the technique, characterize both the resolvability 
and stability of z-scan measurements and apply z-scan FPD in a time-resolved manner to 
monitor the reversible association of peripheral membrane proteins to the plasma 
membrane. 
In chapter 6, we apply z-scan FPD to quantify the binding curve of proteins to the 
plasma membrane in living cells. Analysis of the experimental binding curve determines 
the binding affinity and the saturation concentration of binding sites. We examined the 
protein-lipid interactions of selected protein binding domains and evaluated the feasibility 
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of competition binding experiments to identify the specificity of lipid-protein interactions 
in living cells.  Finally, we characterize the membrane binding curve of HTLV-1 matrix 
and determine its lipid-specificity.  
Chapters 3, 4, and 5 are based on work that is already published (50, 51). 
Chapters 5 and 6 contain results that have been accepted for publication in Analytical 
Biochemistry (52) and the Biophysical Journal, respectively. 
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2.  Fluorescence Fluctuation Spectroscopy (FFS) 
This chapter provides background information on the instrumentation and analysis 
methods used within this thesis.  
 
2.1 Concept of FFS 
The excitation of fluorescent proteins within a sub-micron observation volume 
created on a microscope gives rise to a fluorescence signal along with fluctuations around 
its mean value (Figure 2.1A). The passage of individual fluorescent proteins in and out of 
the small observation volume (Figure 2.1B) creates fluctuations in the measured 
fluorescence intensity. These fluctuations contain information about molecular brightness 
(a measure of protein association), concentration, and diffusion time of the protein within 
the excitation volume, as conceptually illustrated in Figure 2.1C, where each burst in 
fluorescence corresponds to the transit of a fluorescent protein though the observation 
volume. The burst frequency corresponds to the protein concentration, the burst duration 
corresponds to the protein’s diffusion time, and the burst amplitude corresponds to the 
protein brightness. Because the actual fluorescence signal contains many overlapping 
fluctuations, statistical analysis is needed to extract the brightness, concentration and 
diffusion information. We generally refer to the measurement and analysis of these 
fluorescence fluctuations as FFS.  
A collection of statistical techniques including FCS, moment analysis, photon 
counting histogram (PCH) and others can be applied to analyze FFS data (53–55). FCS 
analyzes the temporal decay of the fluorescence autocorrelation function (ACF) to 
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determine the diffusion time and concentration of fluorescent molecules (56–59), while 
PCH determines the brightness and concentration of fluorescence species by analyzing 
the amplitude distribution of fluctuations (60). Moment analysis, which is based on the 
first two moments of the fluorescence intensity, offers a straightforward option for 
efficient on-the-fly analysis of fluctuations (61). Fluorescence cumulant analysis (FCA) 
extends moment analysis by providing rigorous error analysis of moments (62). Finally, 
time-integrated fluorescence cumulant analysis (TIFCA) improves the signal to noise 
ratio of moment analysis significantly by extending FCA to long sampling times (63). 
The FFS techniques used to analyze the data in this thesis are autocorrelation and 
moment analysis; they will be discussed in more detail below.  
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Figure 2.1 Fluorescence fluctuations from diffusing fluorescent proteins.  
(A) The fluorescence intensity trace illustrates fluctuations around an average value as 
fluorescent proteins move in and out of the excitation volume. (B) The focused laser light 
creates a submicron excitation volume through which the fluorescent protein diffuses. (C) 
Conceptual illustration of the information content of intensity fluctuations. 
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2.2 Instrumentation 
The small observation volume required for fluorescence fluctuation experiments is 
achieved through two-photon excitation (TPE), which involves the quasi-simultaneous 
absorption of two photons that together have enough energy to excite a fluorophore (64). 
TPE was first introduced to FFS by Berland et al. and has proven to be an excellent 
method for measuring in cells, because excitation only occurs at the focal point of the 
objective (65). This results in an inherent optical sectioning along the z-axis and limits 
photobleaching to the focal volume of the TPE spot. An additional advantage of TPE 
over one-photon excitation is the built-in color separation between excitation and 
emission spectra. Excitation occurs at near infrared wavelengths while the fluorescence 
emission is in the visible range, which greatly facilitates the removal of elastically and 
inelastically scattered excitation light from the detector by optical filters. The 
experimental setup of our two-photon microscope is shown in Figure 2.2. A mode-locked 
Ti:Sapphire laser (Tsumami or Mai Tai, Spectra-Physics, Mountain View, CA ) produces 
ultra-short laser pluses (~100 fs) with a frequency of 80 MHz. The beam enters a Zeiss 
Axiovert 200 microscope (Zeiss, Gottingen, Germany) and is reflected onto the objective 
by the dichroic mirror (#740DCSPXR, Chroma, Rockingham, VT). The objective (Plan-
Apochromat 63x oil immersion objective, N.A.=1.4, or C-Aprochromat 63x water 
immersion objective, N.A.=1.2, Zeiss, Gottingen, Germany ) focuses the excitation light 
onto the sample and also collects the fluorescence signal from the TPE. The fluorescence 
signal passes through a dichroic mirror which transmits wavelengths between 400-750 
nm and an additional bandpass filter to remove scattered laser light. For dual-color  
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Figure 2.2 Experimental setup of the two-photon microscope.   
The pulses produced by the Ti:Sapphire laser are steered through a beam expander onto a 
dichroic mirror (#1), which reflects the excitation light through the objective onto the 
sample. The fluorescence emission is collected by the objective and passed through the 
dichroic mirror (#1) to the detector. A second dichroic mirror (#2) can be placed before 
the avalanche photo diodes (APDs), to separate the fluorescence light based on color. 
TTL pulses from the APDs are recorded by a DAQ card and stored on the computer for 
further analysis. 
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measurements a second dichroic mirror splits the emission light into two different 
detection channels based on the emission wavelength. An avalanche photodiode (APD, 
SPCM-AQ-141, Perkin-Elmer, Dumberry, Québec) detects the signal in each channel and 
generates TTL pulses that are recorded by a data acquisition card (ISS, Champaign, IL or 
FLEX02, Correlator.com Bridgewater, NJ). The resulting photon counts are later 
analyzed using programs writing in IDL version 7.1 or later (Exelis Visual Information 
Solutions, Boulder, CO). 
 
2.3 Analysis 
2.3.1 Molecular brightness 
We defined molecular brightness λ as the average number of photons emitted per 
molecule over a specific time period with units of counts per second (cps). A fluorescent 
protein like EGFP will have a distinct brightness that depends on the optics, excitation 
wavelength, excitation power, and detection efficiency (60, 66).  The average fluorescent 
intensity of a protein ensemble is made up of the brightness of the individual protein 
complexes and the number of complexes. 
 
2.3.2 Excitation point spread function 
 The spatial intensity distribution of the focused excitation laser beam plays an 
important factor in FFS theory and is referred to as the instrument’s point spread function 
(PSF). Two different model functions have been widely used to approximate the PSF of 
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FFS experiments on a two-photon microscope. The first model is the squared Gaussian-
Lorentzian (GL) function (65) given by,  
 
4
2
0
2
4
( , ) exp
( ) ( )
GL
w
PSF
w w

 
 
  
   
   
  (2.1) 
with 
 
1/ 2
2
0 2
0
( ) 1w w
z


 
  
 
 . (2.2) 
The variables  and   represent the axial and radial coordinates measured with respect 
to the center of the PSF. The radial and axial beam waists of the PSF are given by 
0
  and 
0
z . The second model function is given by the squared three-dimensional Gaussian 
(3DG) function,  
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with 
0
 and 
0
z  representing the radial and axial beam waists of the PSF. The 3DG-PSF 
was used to fit the autocorrelation data of this thesis.  
The PSF is crucial for modeling, because it establishes a link to the experimental 
observables. For example, the fluorescence intensity at position r  at time t from a 
solution containing fluorescent proteins with brightness  is given by,  
      ( ) ( )F r t c r t PSF r , (2.4) 
where  ( )c r t  is the concentration at that position and time.  
  22 
Other important parameters frequently needed in FFS experiments include the 
volume of the PSF and the gamma factor. The volume of the PSF raised to the r-th power 
is given by:  
 ( , )2r
r
PSF
V PSF d d       . (2.5) 
The variables  and   represent the axial and radial coordinates measured with respect 
to the center of the PSF and the integration was performed over all space.  The gamma 
factor is a beam shape factor needed to recover the brightness of a sample; it is given by 
(67), 
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For the PSF models mentioned in section 2.3.1, the 
2
  values are  2 1 / 2 2   for the 
three-dimensional Gaussian PSF and 
2
0.1875   for the squared Gaussian-Lorentzian 
PSF.  
 
2.3.3 Autocorrelation and moment analysis  
The autocorrelation function (ACF) is defined by, 
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where F(t) is the fluorescence intensity at time t and ( ) ( )F t F t F    is the fluctuation 
about the average fluorescence intensity (67). For fluorescent molecules diffusing 
through a 3DG-PSF, the autocorrelation function is given by (67), 
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where 
0 0
/s z w  is the beam waist ratio. The diffusion time 
D
  of a molecule with 
diffusion coefficient D is given by 2
0
/ 8w D  in the case of TPE. The ACF of an EGFP 
sample is shown in Figure 2.3 together with a fit (line) by Equation 2.8 to determine 
D
  
and the time-zero value G(0), which is also called the fluctuation amplitude.  
The fluctuation amplitude G(0) is inversely proportional to the average number of 
molecules N in the excitation volume and also determines the average protein 
concentration c, 
 2 2(0)
PSF
G
N c V
 
 

,  (2.9) 
where 
PSF
V represents the volume of the PSF and 
2
  is its gamma factor.  
The G(0) value can also be obtained from moment analysis. The first intensity 
moment is given by the average fluorescence intensity F , while the second moment is 
given by the variance in the fluorescent intensity 2F , 
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N is the number of fluorescent molecules within the PSF volume, λ is the molecular 
brightness of the molecules, and 
2
  is the PSF shape factor. While fluorescence 
intensities are in many cases sufficient for modeling data, our experiments  
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Figure 2.3 Autocorrelation curve for EGFP in a cell. 
The autocorrelation curve (diamonds) decays as a function of its lag time τ. The fit (solid 
line) of the data to Eq. 2.8 determines G(0) and 
D
 . The diffusion time 
D
 can also be 
estimated from the graph by identifying the lag time that corresponds to half the 
fluctuation amplitude G(0). 
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do not record fluorescence intensities, but rather photon counts. Because photon counting 
includes shot noise, we have to use photon count moments to properly analyze FFS data. 
The first two moments in terms of photon counts k per sampling time T are (62),  
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where the variance includes and additional term k  to account for the shot noise 
contribution (68, 69). The above equations are valid in the absence of undersampling (63, 
70). Eqs. 2.8 and 2.9 can be used to calculate G(0),  
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2.3.4 Mandel’s Q-parameter 
We calculate Mandel’s Q-parameter, which is directly proportional to brightness, 
by moment analysis (60, 71), 
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The brightness  is calculated from Q  with the help of the sampling time T and the PSF 
shape factor 
2
 . The relation between the Q-parameter and the fluctuation amplitude 
G(0) as can be seen through inspection of Eqs. 2.11 and 2.12. 
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2.3.5 Stoichiometry 
The brightness 
EGFP
  of EGFP can be used to identify the oliogmeric state or 
stoichiometry of a protein complex of interest.   After measuring the brightness  of a 
protein tagged with EGFP, we convert its value into a normalized brightness by dividing 
 by the reference brightness 
EGFP
  of the monomeric label, 
 
E G F P
b


   (2.14) 
As shown in Figure 2.4, the normalized brightness of a monomeric protein is b = 1. A 
dimeric protein complex has two labels per complex and therefore a normalized 
brightness of b = 2. A trimeric complex with three labels per complex will have b = 3, 
and so on. The brightness 
EGFP
  of EGFP has proven to be a robust parameter for 
determining protein stoichiometry in living cells. Chen and colleagues showed that the 
monomeric brightness of EGFP is stable inside a living cell (1) and that it was possible to 
measure a dimer brightness for a tandem EGFP2 complex (2). Our lab has more recently 
demonstrated that brightness analysis can be extended to higher-order complexes (like 
virus-like particles, VLPs) containing hundreds to thousands of protein copies (72–74). 
Quantitative brightness measurements rely on a careful calibration of the 
experimental brightness on a daily basis. We routinely measure EGFP and EGFP2 
expressed in living cells to make sure both brightnesses are stable over an extended 
concentration range and have a 1:2 brightness ratio, respectively (66, 75). Establishing a 
robust monomeric and dimeric protein system that serves as a brightness standard is 
crucial whenever the technique is extended to new sample environments. 
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Figure 2.4 Protein brightness and stoichiometry. 
The normalized brightness of a protein is used to identify a protein’s oligomeric state. 
Calibration measurements of EGFP and a tandem dimeric EGFP2 are used to determine 
the monomer and dimer rungs of the brightness ladder depicted above. 
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2.3.6 Apparent brightness and brightness titration 
Inside of the cell, proteins tagged with EGFP typically exist as a mixture of 
oligomeric states which gives rise to an apparent brightness (2, 66),  
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The apparent brightness corresponds to a weighted average over all the brightness states 
i
b present in the cell with
i
N  representing the number of molecules in the excitation 
volume with brightness 
i
b . We will continue to report the apparent brightness of a 
protein throughout to rest of this thesis, but it will simply be noted as b rather than 
bapparent.  
 We explore the concentration dependence of brightness by performing FFS 
measurements on cells with a wide range of protein expression levels, which we refer to 
as a brightness titration experiment. A plot of the apparent brightness versus the 
monomeric protein concentration characterizes the concentration dependence of protein 
complex formation (2, 75). A purely monomeric protein will remain monomeric while a 
protein that forms a homo-dimer will show a concentration-dependent transition as 
illustrated in Figure 2.5.  
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Figure 2.5 Brightness titration experiment. 
Conceptual plot of brightness as a function of protein concentration for cells expressing 
an EGFP-labeled protein with a dissociation coefficient of 1 µM. The normalized 
brightness increases from 1 to 2 as a function of concentration. 
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2.4 z-scan FFS 
2.4.1 Brightness bias in confined geometries 
Conventional brightness measurements have been performed in solution and 
within thick regions of a cell. These measurments assume that fluorescent molecule 
diffuses through all areas of the PSF with equal probability. This assumption, however, 
breaks down at thin cell sections of the cell because the excitation volume extends 
beyond the sample’s thickness. Under such conditions, the fluorescent molecule cannot 
access all areas of the PSF, which results in an incorrect interpretation of brightness in 
conventional FFS analysis (76). To address this brightness bias our lab developed z-scan 
FFS (51, 76). 
 
2.4.2 Fluorescence intensity profile 
Consider a thin cell slab that starts at z = 0 and ends at z = h. We describe this 
geometry of the cytoplasmic protein in Figure 2.6 with a boxcar shape factor S given by 
(76),  
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Additionally, we introduced a z-dependent generalized PSF volume function that 
accounts for the spatial overlap between the sample and the PSF (76), 
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  31 
 
Figure 2.6 Conceptual cartoon of a z-scan experiment. 
(A) The focused beam is uniformly scanned along the axial direction through a cell 
expressing a homogenously distributed cytoplasmic protein. (B) The resulting z-scan 
fluorescence intensity profile. 
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where the variables  and   represent the axial and radial coordinates measured with 
respect to the center of the PSF. For a homogeneously distributed cytoplasmic protein the 
first two moments of the fluorescence intensity are given by (51, 76), 
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A uniform scan of the PSF along the z-axis of a cell (Figure 2.6A) generates a z-
dependent fluorescence intensity profile (Figure 2.6B), which is described by  F z . 
 
2.4.3 Brightness bias and gamma factor 
 All FFS analysis methods rely on the 
2
  shape factor to recover the brightness of 
the sample. In conventional FFS the shape factor 
2 ,


 remains constant for a given PSF 
model. However, when FFS is performed in thin samples, the gamma factor will depend 
on the z-position and the cell height. To address this issue, we define a z-dependent 
gamma factor as (76), 
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where 2 ( ; )
PSF
V z h  and ( ; )
PSF
V z h  are determined from Eq. 2.17.  
Macdonald et al. demonstrated the need for a proper  
2
  shape factor by 
performing a series of brightness measurements of EGFP in cells and applying 
conventional FFS analysis based on 
2 ,
Q  
 
  . The analysis recovered a monomeric 
brightness of b = 1 at the thickest section of the cell, but erroneously identified an 
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apparent increase to 1.8 at the thinnest layers (76). This artifact was eliminated by 
accounting for the cell thickness in brightness analysis with the z-dependent gamma 
factor (76), 
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When the PSF volume extends beyond the height of the sample 
2
( ; )z h  must replace 
2 ,

  in all brightness calculations.  
 
2.4.4 Improved PSF model 
Initial z-scan experiments revealed that neither the GL nor the 3DG model are 
sufficient to approximate the experimental profile of our PSF (76). This issue was 
resolved by introducing the modified squared Gaussian-Lorentzian function (mGL) (76),  
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where 
0
 and 
0
z are the radial and axial beam waist and the y parameter adjusts the axial 
decay of the PSF while maintaining a radial Gaussian profile. This mGL-PSF is the 
model that will be used for all z-scan experiments described in this thesis.  
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3.  The Statistics of Protein Expression Ratios 
In this chapter we explore the statistics of transient cotransfection and subsequent protein 
coexpression. Fluorescence studies of cellular protein-protein interactions commonly 
employ transient transfection to express two proteins carrying distinct fluorescent labels. 
Because transiently transfected cells differ significantly in their expression level, the 
concentration ratio of the two expressed proteins varies, which in turn influences the 
measured fluorescence signal. Knowledge of the statistics of protein expression ratios is 
of considerable interest both from a fundamental point of view and for cellular 
fluorescence studies. Despite the perceived randomness of transient transfection, we were 
able to develop a quantitative model that describes the average and distribution of the 
protein expression ratio from a cell population. We show that the expression ratio is 
proportional to the molar plasmid ratio and relate the distribution to the finite number of 
active plasmids in the cell. The process of cationic lipid-mediated transfection is explored 
in more detail. Specifically, the influence of lipoplexes on the statistics of the expression 
ratio is examined. We further demonstrate that the transfection model provides a 
quantitative description of fluorescence fluctuation experiments, where only a fraction of 
the proteins are labeled.  
 
3.1 Introduction 
Transient transfection is an important technique for the transfer of DNA into 
cultured mammalian cells. Because transient transfection is simple, fast, and permits the 
convenient transient expression of foreign genes, it has become an essential tool for cell 
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biological studies. A powerful approach for the study of protein behavior inside a cell is 
the direct visualization of the protein by tagging it with a EGFP or one of its derivatives 
(77, 78) . The fluorescent signal from the tagged protein provides important information 
about localization, mobility, transport, and interactions of the protein (79, 80). Thus, 
transient transfection of EGFP-tagged ‘fusion’ proteins is widely utilized in live cell 
studies.  
Experiments that probe protein interactions, such as FRET and FCS often rely on 
dual-color fluorescence studies, where two proteins tagged with distinct fluorescent 
proteins are coexpressed in the same cell (81–83). While it’s known that transient 
transfection results in a large cell to cell variability of protein expression, the properties 
of the expression ratio between two coexpressed proteins is relatively unknown. This 
ratio is important for cellular fluorescence studies because it affects the measured 
fluorescence signal and also provides insights into fundamental aspects of transient 
transfection.  
In this chapter, we aim to quantify transient cotransfection through the 
introduction of a simple model that describes the mean, standard deviation, and 
distribution of the protein coexpression ratio. We explicitly relate the mean of the 
expression ratio to the plasmid DNA molar ratio of the transfection solution and extend 
the model to include the variability of protein expression. The model is compared against 
experimental data and the simplifying assumptions of the model are discussed. Our study 
also sheds light on the cationic lipid-mediated transfection process. Although this 
transfection method was introduced over two decades ago (84), some details are still 
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unclear, and only limited work has examined the process of quantitative cotransfection 
(85). Here, we specifically investigate the role of lipoplexes in the transfection process. 
We demonstrate that only very few lipoplexes contribute successfully to gene expression 
and discuss the resulting consequences for protein expression ratios. Although our model 
simplifies many details of the transfection process, it still reproduces the data remarkably 
well. 
Modeling of the relation between the expression ratio and the molar plasmid ratio 
of the transfection solution is also extremely useful in application. With the model, it is 
now possible to adjust the expression ratio in a predictive fashion, which is desirable for 
optimizing protein interactions in fluorescence studies. Our model predicts that this 
adjustment is limited to a finite range, as is dictated by properties of the transient 
transfection process. Additionally, being able to statistically describe the cell to cell 
variability of the protein expression ratio allows us to study its influence on the outcome 
of specific cellular fluorescence studies.  
We introduce and apply our model to a ‘bright and dark’ fluorescence fluctuation 
experiment, where only a fraction of the proteins carry a fluorescent label. The unlabeled 
protein is non-fluorescent and cannot be directly observed in FFS experiments. For this 
reason, we frequently refer to the unlabeled protein as a dark protein and experiments that 
coexpress a labeled protein together with an unlabeled protein as bright and dark 
experiments. Because labels potentially interfere with the assembly of protein complexes, 
it is useful to establish control experiments that detect such an artifact. A bright and dark 
experiment has the potential to identify label artifacts, but requires knowledge of the 
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statistics of protein expression ratios because the amount of dark protein directly 
influences the measured signal. We demonstrate that the transfection model establishes a 
framework for interpretation of FFS bright and dark experiments.  
 
3.2 Methods and materials 
3.2.1 Experimental setup 
Experiments were performed with the instrument setup described in chapter 2. All 
measurements were taken with a 1000 nm excitation wavelength and an average power 
after the objective of 0.25 mW. For dual-channel measurements, a dichroic mirror with a 
center wavelength of 525 nm split the fluorescence emission into two detection channels. 
The fluorescence in each channel was detected by an avalanche photodiode (APD, 
SPCM-AQ-141, Perkin-Elmer, Dumberry, Quebec). The dichroic mirror was removed 
during single-channel measurements. The TTL output from each APD is recorded by a 
PCI data acquisition card (ISS, Champaign, IL). Data was acquired at a frequency of 20 
kHz for ~10 seconds for intensity fraction measurements and for ~1 minute for brightness 
measurements. The photon counts were analyzed with programs written in IDL 7.1 
(Research Systems, Boulder, CO). 
 
3.2.2 Sample Preparation 
pEGFP-C1 and pEYFP-C1 plasmids were purchased from Clontech (Clontech, 
Palo Alto, CA). Tandem dimeric EGFP (EGFP2), RXRLBD-EYFP, RXRLBD-EGFP, 
and RARLBD-EYFP plasmids were constructed as previously described (2, 3). EGFP-
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endophilin A2 (Endo-EGFP) plasmids were a gift from Dr. Joseph Albanesi (University 
of Texas Southwestern Medical Center). All sequences were verified by automatic 
sequencing.  
CV-1 cells were obtained from ATCC (Manassas, VA) and maintained in 10% 
fetal bovine serum (Hycolone Laboratories, Logan, UT) and DMEM medium. Cells were 
subcultered in eight-well coverglass chamber slides (Naglenunc International, Rochester, 
NY) 12 hours before transfection. Transient transfections were carried out using 
TransFectin (BioRad, Hercules, CA) according the manufacturer’s instructions 24 hours 
prior to measurement. For cotransfections, a standard protocol was followed with the two 
plasmid types mixed together at a given mole ratio prior to adding TransFectin. In one 
specific case, a second cotransfection protocol was employed where TransFectin was 
added to specific plasmids (rather than the plasmid mixture) to form pDNA/lipid 
complexes which only contained one type of pDNA. The pDNA/lipid complexes 
containing each type of pDNA were then mixed together at a given mole ratio. In each 
transfection protocol, ~0.2 µg of total pDNA was added to each well. Immediately before 
measurement, the growth medium was replaced with Dulbecco’s phosphate-buffered 
saline (PBS) with calcium and magnesium (Biowhittaker, Walkerville, MD). 
Measurements of EGFP, EYFP, EGFP2, RXRLBD-EYFP, RXRLBD-EGFP, RARLBD-
EYFP were carried out in the cell nucleus while measurements of Endo-EGFP and Endo 
were carried out in the cell cytoplasm. 
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3.3 Theory 
3.3.1 Dual color expression fraction 
The average detected fluorescence intensity F  is given by  
 F N  (3.1) 
 where the brightness λ is the average photon count rate for a single molecule and N is the 
detected number of molecules (62). In two channel measurements, the emitted 
fluorescence from a single fluorophore is split by a dichroic filter into two detection 
channels (“red” and “green”). The average fluorescence intensity in the green channel is 
( ) ( )g g
F N  and that of the red channel is ( ) ( )r rF N , where ( )g  and 
( )r
  are the 
brightness values of the green and red channel, respectively. Because both detectors see 
the same number of molecules, the fluorescence intensity fraction of the red channel,  
 
( ) ( )
( ) ( ) ( ) ( )
r r
I r g r g
F
f
F F

 
 
 
 (3.2) 
equals the brightness fraction. The emitted color of the fluorescent protein together with 
the dichroic filter determines the intensity fraction.  
In a mixture of two non-interacting proteins with distinct labels, the intensity 
fraction of the red channel is now determined by (3)  
 
( ) ( )( )
( ) ( ) ( ) ( ) ( ) ( )
r rr
G G Y Y
I r g g g r r
G G Y Y G G Y Y
N NF
f
F F N N N N
 
   

 
   
 (3.3) 
where the subscripts G and Y refer to the fluorescent proteins, EGFP and EYFP. For this 
study we assume no FRET is occurring between the two proteins. Chen et al. describes 
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how, if necessary, FRET is taken into account (3). By rewriting Eq. 3.3 we relate the 
protein expression fraction to experimentally determined parameters,  
 
( ) ( ) ( )
( ) ( ) ( ) ( ) ( ) ( )
( )
( )
g r r
I G G GY
N g r g r r r
Y G I G G Y Y G Y
fN
f
N N f
  
     
 
 
     
.  (3.4) 
The calibration parameters ( ( )r
G
 , ( )g
G
 , ( )r
Y
 , ( )g
Y
 ) are the brightness values of the 
fluorescent proteins (G = EGFP, Y = EYFP) in each detection channel (r = ‘red’ channel, 
g = ‘green’ channel) and are determined from separate FFS measurements of cells 
expressing EGFP or EYFP alone. For example ( )r
G
 and ( )g
G
  are the brightness values for 
EGFP in the red and green channel respectively. The brightness values for EGFP and 
EYFP in each channel account for the differences in detected photon count rates; when 
used in combination with the fluorescent intensity fraction (Eq. 3.3) the protein 
expression fraction for any cell can be determined. 
 
3.3.2 Model for protein expression ratios 
We introduce a simple linear model to describe the molar amount of protein 
P
  
expressed in a cell,  
 
P A
x N     (3.5) 
where 
A
N  presents the number of active plasmids in the cell,  is an efficiency factor, 
and x  takes environmental and cell-specific factors that influence protein expression into 
account. The amount of expressed protein is expected to be directly proportional to the 
number of active plasmids 
A
N  presuming that sufficient cellular resources are present. 
The expression efficiency of individual genes within a plasmid varies. For example, 
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mRNA translational efficiency is influenced by its sequence (86). These differences are 
described by the efficiency factor  . More generally, the factor  can be used to account 
for transcription- and translation-related factors influencing expression efficiency. For 
example, we expect that changing the promoter affects the value of the efficiency factor. 
However, this work only considers plasmids with the same promoter. Protein expression 
depends on many additional environmental and cell-specific factors. For example, the 
entry of plasmid DNA (pDNA) into the nucleus after transfection is expected to vary 
from cell to cell, which would lead to a distributed start time of protein production in a 
cell population. The compound effect of these diverse factors on the amount of expressed 
protein is symbolically described by the parameter x . 
The presence of two types of plasmids (pDNA1 and pDNA2) in a cell leads to the 
coexpression of two proteins. The ratio of the molar amount of expressed protein, 
1 2P
r   , is according to Eq. 3.5 directly proportional to the active plasmid number 
ratio, 
1 2A A A
r N N ,  
 1
2
P A A
x
r y r y r
x
     (3.6) 
with 
1 2
y   . It is expected that 
1 2
x x  in the same cell. This statement assumes that 
the variance in the ratio of 
1
x and 
2
x  is sufficiently small such that the protein ratio 
P
r  is 
mainly determined by y  and 
A
r . A summary of the relevant parameters can be found in 
Table 3.1. 
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Table 3.1: Definition of parameters 
  43 
The relative protein ratio in terms of expressed protein concentration, 
1 2P
r c c , is 
experimentally measurable. In contrast, neither y  nor 
A
r  is directly measurable. The only 
other experimental quantity under our control is the molar mixing ratio 
S
r  of pDNA in 
solution. Transfection leads to the uptake of plasmid by the cell. Only a small fraction of 
the transfected plasmids will ultimately be involved in active gene expression (87, 88). 
We refer to such plasmids as active. The events that lead to an active plasmid are not yet 
fully understood, as will be discussed at a later point. Because very few plasmids become 
active, small number fluctuations become important. Thus, the ratio 
A
r  of active plasmids 
of pDNA1 and pDNA2 will vary across cells. However, while the ratio Ar  varies, the 
average of the active plasmid ratio equals the molar mixing ratio of pDNA in solution, 
A S
r r . This statement reflects that cells treat the two types of plasmids as equal. 
Neither uptake nor activation of a plasmid is expected to depend on the particular type of 
plasmid (pDNA1 or pDNA2), as long as the plasmids are of comparable length. Thus, the 
average active plasmid ratio must reflect the plasmid ratio in solution. This statement 
together with Eq. 3.6 predicts that the average protein ratio from a population of cells will 
be proportional to the molar ratio of pDNA in solution scaled by the relative efficiency 
factor, 
 
P A S
r y r y r    . (3.7) 
This linear relationship can be experimentally tested, because both 
P
r  and 
S
r  can be 
measured. 
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Eq. 3.7 describes the average behavior. As mentioned earlier the active plasmid 
ratio will vary from cell to cell. Thus, according to Eq. 3.6 the expressed protein ratio 
P
r  
will reflect these variations in 
A
r . The probability distribution function (pdf) of both 
quantities are related by, 
    pdf pdfP P p A A Ar dr r dr . (3.8) 
The probability distribution function pdf ( )
P P
r  of the expressed protein ratio can be 
measured, but we require a model for the probability distribution function  pdf A Ar  of 
the active plasmids. 
It is advantageous to use fractions instead of ratios for graphing and comparing 
distributions. Thus, we convert each ratio r  into its corresponding fraction  1f r r  . 
By transforming Eq. 3.7 into fractions we get  
 
1 ( 1) 1 ( 1)
A S
P
A S
y f y f
f
f y f y

 
   
 (3.9) 
for the average protein fraction  1P P Pf r r  . The equivalent transformation for the 
probability distribution functions of Eq. 3.8 leads to  
    pdf pdfP P P A A Af df f df  (3.10) 
for the pdf of the protein expression fraction. Note that the distributions of 
P
f  and 
A
f become identical for the special case of 1y  ,  
    pdf pdfP P A Af f . (3.11) 
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3.4 Results 
3.4.1 Average protein expression fraction 
We first examine the relationship between the plasmid mixing fraction 
S
f  and the 
average protein expression fraction 
P
f . These experiments provide a first test of the 
simple linear model postulated in Eq. 3.7. The initial experiments are performed on the 
fluorescent proteins EGFP and EYFP as they will serve as the fluorescent markers of all 
subsequent fusion proteins included in this study. The plasmids pEGFP and pEYFP are 
mixed at specific mole fractions 
S
f . Each plasmid mixture is subsequently used in the 
transfection of CV-1 cells. For each population of cells transfected with a specific 
plasmid mixing fraction the fluorescence intensity of more than 20 cells was recorded in 
a dual-color setup. The protein expression fraction, fp = NEYFP / (NEYFP+NEGFP), was 
determined individually for each measured cell. Figure 3.1A shows the average protein 
expression fraction 
P
f  versus the plasmid mixing fraction fS. The data suggest a linear 
relationship between both fractions. A fit of the data to our proposed model (Eq. 3.9) 
reproduces the data with an efficiency ratio of y = 1.04. An efficiency ratio close to one is 
expected because each of the two plasmids contains the same promoter region and the 
genetic sequence and structure of each protein is nearly identical.  
We further test our model using fusion proteins. For the initial experiments we 
chose the ligand binding domain of the retinoid X receptor protein (RXRLBD) and label 
it with either EGFP or EYFP. The plasmids pEGFP–RXRLBD and pEYFP–RXRLBD, 
which essentially have identical sequences, are mixed at specific mole fractions, and the 
average protein expression fractions are calculated from the intensity  
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Figure 3.1 Relative protein expression for two similar proteins. Average protein 
expression fraction 
1 1 2
/ ( )
P P P P
f N N N   as a function of the plasmid mole fraction 
1 1 2
/ ( )
S p p p
f     . Each data point represents the average of the expression fraction 
from 20-40 cells. (A) Data from cells expressing EYFP and EGFP with P1 = EYFP, P2 = 
EGFP, p1 = pEYFP, p2 = pEGFP. The fit recovered an efficiency ratio of 1.08. (B) Data 
from cells expressing RXRLBD-EYFP and RXRLBD-EGFP with P1 = RXRLBD-EYFP, 
P2 = RXRLBD-EGFP, p1 = pRXRLBD-EYFP, p2 = pRXRLBD-EGFP. The fit of the 
model recovered an efficiency ratio of 1.03 
  47 
fractions of more than 20 cells. Figure 3.1B shows the results for the average protein 
versus plasmid fraction. The data again suggest a linear relationship and a fit to our 
model (Eq. 3.9) yields an efficiency fraction of 1.02, which confirms that both proteins 
have nearly identical expression efficiencies.  
We now examine two proteins that differ substantially in their sequence. In this 
case we still expect the relationship between pDNA mixing and protein expression to be 
given by Eq. 3.9, but with an efficiency ratio that may be different from one. We 
experimentally test this hypothesis by expressing the proteins EGFP and RXRLBD-
EYFP. As in the previous experiments, plasmids for each protein are mixed at specific 
mole fractions and the average protein expression fraction is calculated from a sample of 
more than 20 cells. Figure 3.2A shows the average protein expression fraction versus 
plasmid mixing fraction for this EGFP and RXRLBD-EYFP protein pair. The expressed 
protein fraction varies nonlinearly with plasmid fraction, which indicates an efficiency 
ratio of y ≠ 1. A fit of the data by Eq. 3.9 determines y = 0.22. We repeated the 
experiment for a second protein pair by expressing EGFP and RARLBD-EYFP (retinoic 
acid receptor). Again, we observe a nonlinear relationship between the protein and 
plasmid fraction (Figure 3.2B). Fitting the data to Eq. 3.9 yields y = 0.19.  
The insets in Figure 2 show protein and plasmid ratios instead of fractions to 
highlight the underlying linear relationship postulated in Eq. 3.7. The average protein 
ratio versus the plasmid mixing ratio for each protein pair is given together with a solid 
line representing Eq. 3.7 with the previously fit y values as the linear scaling factor. From 
the insets in Figure. 3.2, one can directly see that the slope (y) is less than 1 for the 
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dissimilar protein pairs; consequently, the relationship between protein and plasmid 
fractions in the main plot is non-linear. The protein fraction plots of Figures. 3.1 and 3.2 
are constrained by the fractional endpoints fS = fP = 0 and fS = fP = 1. Only y = 1 results in 
a linear graph with a slope of 1 (Figure 3.1). For y < 1, the protein represented in the 
numerator is less easily expressed compared to the other protein such that large changes 
in the plasmid mixture are necessary to produce small changes in the expressed protein 
level. Consequently, this leads to an initial linear region of the data with a slope less than 
one followed by a region of increasing slope as we approach the endpoint fS = fP = 1, 
which results in a positive curvature of the data. In contrast, for y > 1, the protein 
represented in the numerator is more easily expressed compared to the other protein; this 
introduces a negative curvature in a plot of fP versus fS with a slope initially greater than 
one, which decreases as we approach the endpoint fS = fP = 1. A fit of the data to Eq. 3.9 
determines y by taking these changes in slope and curvature into account.  
Additionally, we investigated the influence of label selection on the relationship 
between the plasmid mixing fraction 
S
f  and the average protein expression fraction 
P
f  
by repeating the measurement of the EGFP / RXRLBD-EYFP pair with switched labels 
(EYFP / RXRLBD-EGFP). The protein expression fraction, fp = NRXRLBD-EGFP / 
(NEYFP+NRXRLBD-EGFP) was determined individually for each measured cell. Figure 3.2C 
shows the average protein expression fraction versus plasmid mixing fraction  
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Figure 3.2 Relative protein expression for two dissimilar proteins. Average protein 
expression fraction 
1 1 2
/ ( )
P P P P
f N N N   as a function of the plasmid mole fraction 
1 1 2
/ ( )
S p p p
f     . Each data point represents the average of the expression fraction 
from 20-40 cells. (A) Data from cells expressing RXRLBD-EYFP and EGFP with P1 = 
RXRLBD-EYFP, P2 = EGFP, p1 = pRXRLBD-EYFP, p2 = pEGFP. (B) Data from cells 
expressing RARLBD-EYFP and EGFP with P1 = RARLBD-EYFP, P2 = EGFP, p1 = 
pRARLBD-EYFP, p2 = pEGFP. The fit recovered expression efficiency ratios of y = 0.22 
and y = 0.19 for (A) and (B) respectively. (C) Data from cells expressing RXRLBD-
EGFP and EYFP with P1 = RXRLBD-EGFP, P2 = EYFP, p1 = pRXRLBD-EGFP, p2 = 
pEYFP with an expression efficiency ratio of y=0.19. The insets show the average protein 
ratio versus the plasmid mixing ratio for each protein pair with the solid line representing 
Eq. 3.7 using the fitted efficiency ratio. 
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for EYFP and RXRLBD-EGFP. A fit of the data by Eq. 3.9 determines an efficiency 
fraction, y = 0.19. Note, the data are plotted with the x-axis corresponding to a protein 
fraction fp = NRXRLBD-EGFP / (NEYFP+NRXRLBD-EGFP); plots previously shown all have the 
EYFP labeled protein in the numerator of the expression fraction.  The fit of the data 
determined y = 0.22. The uncertainty in fitting the efficiency ratio y is estimated to be 
0.04 for the data of Figures. 3.1 and 3.2. Since the efficiency ratios of both data sets 
(Figures 3.2A, C) differ by less than 0.04 we determine that swapping the protein labels 
has no significant effect on the experiment.  
These results demonstrate that the simple linear model of Eq. 3.7 relating the 
average protein expression ratio to the pDNA mixing ratio is very successful in 
describing actual experiments. Note that the linear relationship between protein and 
plasmid ratios leads to a nonlinear relationship for the fractions (Eq. 3.9), if the efficiency 
ratio y ≠ 1.  
 
3.4.2 Variation in protein expression fractions 
So far we have focused on the average behavior over a whole cell population. We 
now take a closer look at the variability from cell to cell. The distribution of the protein 
expression fractions from a population of cells is best represented by a histogram. 
Figure 3.3 shows the histograms of protein expression fractions 
p
f  for cells transfected 
by a 1:1 pEYFP to pEGFP plasmid ratio. The histogram contains protein expression 
fraction from 120 cells with a bin resolution of 0.05. The y-axis represents the 
experimental probability  pp f  of observing the expression fraction pf  and is 
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normalized by dividing the number of cells  pN f  with protein expression fraction fp by 
the total number of cells sampled. Thus, the histogram directly reflects the experimentally 
determined probability distribution function (pdf) of the protein expression fraction 
 pdf P pf . The data are plotted such that a protein fraction of 0 represents a cell 
expressing only EGFP and a value of 1 represents a cell expressing only EYFP. The 
experimentally measured distribution (solid line) of Figure 3.3 is approximately 
symmetric with respect to its peak at 0.5
p
f  . These properties of the distribution agree 
with the expectations for a 50% / 50% plasmid ratio with an efficiency ratio of y = 1.  
As pointed out in Eq. 3.10, the probability distribution of the protein fraction 
pdf ( )
P P
f  is related to the probability distribution function of the active plasmid fraction 
pdf ( )
A A
f  inside the cell. For the special case of y = 1, the relationship simplifies to 
pdf ( ) pdf ( )
A A P P
f f . In other words, the histogram of Figure 3.3 also represents the 
probability distribution of the active plasmid fraction. Because uptake and activation of a 
plasmid does not depend on whether it is an EGFP or EYFP plasmid, the probability 
y
p  
that a given active plasmid encodes EYFP is expected to be the same as the fraction 
S
f  
of EYFP-encoding plasmid in solution, 
y S
p f .  
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Figure 3.3 Protein fraction distribution for a 1:1 mixture.  
Histogram of protein fractions (solid line) for EGFP and EYFP transfected by a 1:1 
pEGFP / pEYFP mixture. The y-axis represents the number of cells with a protein 
expression fraction fP normalized by the number of cells sampled. A protein fraction of 0 
indicates a cell expressing only EGFP and a value of 1 represents a cell expressing only 
EYFP. The distribution is peaked at a protein expression fraction of 0.5 as expected for a 
1:1 plasmid ratio. Binomial probability distribution (dashed curve) is for M = 20 active 
plasmids and py = 0.5. 
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We now introduce a basic statistical model to describe the distribution of active 
plasmids. Consider a cell with a total of M active plasmids. The probability that 
y
M  of 
the M active plasmids are EYFP plasmids is described by a binomial distribution,  
    , , 1
y
y
M MM
B y y y y
y
M
P M M p p p
M
 
  
 
 (3.12) 
Let us assume that all cells of the population have M active plasmids. The active plasmid 
fraction 
A
f  of a given cell is given by 
A y
f M M . Rewriting of Eq. 3.12 results in a 
distribution describing the probability distribution of the active plasmid fraction,  
    pdf , , , ,A A y B A yf M p P M f M p  . (3.13) 
Our model predicts that the probability distribution of the active plasmid fraction 
follows a binomial distribution. The dashed curve in Figure 3.3 represents a binomial 
distribution with M = 20 and 0.5
y
p  . The distribution accurately represents the central 
peak of the data assuming 20 active plasmids per cell with a 50% probability 
y
p  of a 
given plasmid being pEYFP. This probability matches well with the EYFP plasmid 
fraction in solution, 0.5
S
f  . Although the binomial distribution fails to reproduce the 
tails of the experimental distribution, which are more strongly populated than expected 
by our model, the binomial distribution provides a reasonable model to estimate the 
variability of the protein expression ratios, since the population of the tails is sparse. For 
example, the standard deviation of the experimental protein expression fraction of Figure 
3.3 is 0.12, while the binomial distribution leads to a standard deviation of 0.11.  
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Figure 3.4 Protein fraction distribution for a 3:1 mixture.  
Histogram of protein fractions (solid line) for EGFP and EYFP transfected by a 3:1 
pEGFP / pEYFP mixture. The y-axis represents the number of cells with a protein 
expression fraction fP normalized by the number of cells sampled. A protein fraction of 0 
represents a cell expressing only EGFP and a value of 1 represents a cell expressing only 
EYFP. The binomial probability distribution (dashed curve) is for M = 20 active plasmids 
with py=0.27. 
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We now investigate the distribution function for a plasmid mixing ratio that 
differs from the symmetric 1:1 ratio used above. Cells were transfected with a 1:3 pEYFP 
to pEGFP plasmid ratio and the protein expression fraction was determined from 115 
cells. The pdf of the protein expression fractions fp is shown in Figure 3.4. The 
distribution is asymmetric with a peak shifted to fp = 0.25. The dashed curve in Figure 3.4 
represents a binomial distribution  , ,B p yP f M p  with M = 20 and py = 0.27. Again, the  
binomial distribution approximately describes the central peak of the distribution, but 
fails to reproduce the tail of the distribution. The probability for an EYFP-plasmid py = 
0.27 is in good agreement with the 1:3 pEYFP to pEGFP plasmid ratio (pS = 0.25). Our 
modeling assumed that the number of active plasmids per cell is a constant (M = 20), 
which is unrealistic. The number of active plasmids is expected to be distributed, which 
needs to be accounted for in a refined model. We will return to this point later in the 
discussion section. 
 
 3.4.3 Application of model to FFS bright and dark experiment 
The above experiments relied on two distinctly colored fluorescent proteins to 
develop a model describing the statistics of the protein expression fraction from a 
population of transfected cells. We now apply this model to an FFS study where two 
proteins are expressed, but only one of the two protein species is labeled. This bright and 
dark experiment provides a promising approach for identifying the presence of adverse 
label effects. To illustrate, let us consider the ideal case where the fluorescent label has 
no influence on protein assembly. In this case, we expect a specific reduction in the 
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measured brightness, because the dark protein is not visible, but competes with labeled 
protein in the formation of complexes. For example, an n-meric protein complex with a 
fraction 
P
f  of labeled proteins and a corresponding fraction (1 )
PD P
f f   of unlabeled 
proteins leads to a normalized brightness of (89)  
 ( 1)
PD
b n f n   . (3.14) 
The normalized brightness, 
EGFP
b   , as defined in Cchapter 2, is the ratio 
between the measured brightness  of the complex and the brightness 
EGFP
  of the label 
EGFP, and reflects the oligomerization state of a homo-protein complex (3). This 
property yields a normalized brightness of n for an n-meric complex if all proteins are 
labeled. Introducing dark proteins reduces the brightness to a value that depends only on 
the fraction of unlabeled protein. Although the exact value of the unlabeled protein 
fraction 
PD
f  is unknown to us, the model of protein coexpression fractions introduced 
earlier allows us to predict the distribution and average normalized brightness from a 
bright and dark experiment. For example, we expect according to Eq. 3.14 an average 
normalized brightness of  
 ( 1)
PD
b n f n   . (3.15) 
The coexpression model (Eq. 3.9) relates the average protein fraction 
PD
f  to the 
fraction of plasmids encoding the dark protein 
S
f .We test this relationship by conducting 
an FFS bright and dark experiment on the homo-dimeric protein Endophilin A2.  
First, we conduct FFS measurements in the cytoplasm of cells expressing EGFP 
and the tandem-dimer EGFP2 as a control experiment to confirm brightness doubling  
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Figure 3.5 Normalized brightness of Endo-EGFP.  
The normalized brightness of Endo-EGFP is nearly identical to EGFP2 which suggests 
that Endo-EGFP forms a tight dimer over the concentration range studied. The average 
normalized brightness for EGFP2 is 1.99±0.03 and the average normalized brightness for 
Endo-EGFP is 1.95±0.04. 
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(1, 2). The normalized brightness as a function of protein concentration shown in 
Figure 3.5 yields an average normalized brightness of 1.99±0.03 for EGFP2
 
(2). In 
addition, we measured the brightness of EGFP labeled Endophilin A2 (Endo-EGFP) as a 
function of protein concentration (Figure 3.5). Our data with an average normalized 
brightness of 1.95±0.04 confirm the dimeric state of cellular Endophilin A2 as recently 
shown by Ross et al. (90). After establishing the dimeric nature of Endophilin A2, a 
bright and dark experiment with a 50% / 50% mole ratio of unlabeled (pEndo) and 
labeled (pEndo-EGFP) protein is performed. The normalized brightness values from 120 
cells were measured and are plotted in Figure 3.6 as a histogram with a bin resolution of 
0.1. The average normalized brightness of the population of cells measurement is 
b  1.51. This drop in brightness indicates according to Eq. 3.15 an average fraction for 
the expressed dark protein of 0.5
PD
f  , which is identical to the fraction of plasmids 
encoding the dark protein, 0.5
S PD
f f  . This result further implies that the 
expression efficiency ratio y is one according to Eq. 3.9. Thus, our data demonstrate that 
quantitative interpretation of the average brightness from bright and dark experiments 
provides a measure of the efficiency ratio y. Extending this study to other values of the 
dark protein-encoding plasmid fraction would provide independent measurements of the 
efficiency ratio y. A systematic inconsistency in the recovered y values would be 
indicative of interference by the label.  
We now turn to the distribution of the measured brightness values. According to 
Eq. 3.11 the brightness is determined by, ( 1)
AD
b n f n   , where 
AD
f  is the active 
plasmid fraction encoding dark protein. For a dimer this reduces to 1
A
b f  , where 
A
f ,  
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Figure 3.6 Bright and dark brightness distribution. 
Histogram of the normalized brightness from cells transfected with a 1:1 pEndo-EGFP / 
pEndo mixture. The histogram (solid line) contains the normalized brightness from 120 
cells with a bin resolution of 0.1. (short dashed line) A binomial distribution for M = 20 
active plasmids. (long dashed line) The convolution of a binomial distribution for M = 20 
active plasmids with a Gaussian distribution with a standard deviation of 0.19. . 
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the labeled active plasmid fraction, is related to 
AD
f  by (1 )
A AD
f f  . This relationship 
relates the brightness to the active plasmid distributions,    pdf pdf 1Ab b  . 
Straightforward application of our binomial model (Eq. 3.13) with M = 20 active 
plasmids and 
PD S
p f  = 0.5 fails to reproduce the measured brightness distribution  
 (short dashed line in Figure 3.6). We need to account for the inherent uncertainty of 
measuring a brightness value inside cells. The standard deviation in brightness calculated  
from the data in Figure 3.5 is 10% for EGFP and EGFP2 and 13% for Endo-EGFP. Thus, 
we convolute the binomial distribution with a Gaussian distribution representing a 
relative uncertainty of 13% with respect to the mean brightness of 1.5. The convoluted 
distribution (long dashed line in Figure 3.6) provides a good approximation of the 
experimental brightness distribution. Thus, dark experiments contain two significant 
sources of noise, the inherent uncertainty of the brightness measurement and the 
variations in the dark protein fraction. Both noise sources are independent and their 
standard deviations add up as 
2 2
1 2
    . A 13% uncertainty in the brightness 
measurement (
1
0.19  ) and the uncertainty due to the active plasmid fraction 
(
2
0.11  ) leads to    0.22, which is in good agreement with the standard deviation of 
0.25 of the experimental data.  
 
3.5 Discussion 
It is well known that the protein expression level from transient transfection varies 
widely from cell to cell. Despite this seemingly random behavior of the absolute 
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expression level, the protein expression ratio of two simultaneously transfected proteins 
is surprisingly well-behaved. We developed a simple model for the average protein 
expression ratio, its variance, and distribution function. The core of the model is based on 
the assumption that the vast majority of cellular factors influencing gene expression 
affect both plasmids in the same way. Thus, these common factors cancel in the ratio of 
the protein expression, and the only two factors remaining are the expression efficiency 
ratio y and the active plasmid ratio rA. Neither of these factors are known a priori, but 
over a whole cell population, the mean of rA equals the ratio rS of plasmids in the 
transfection solution, 
A S
r r . This statement provides a testable hypothesis in the form 
of Eqs. 3.7 and 3.9, because it relates the average protein expression ratio 
P
r  to the 
plasmid ratio 
S
r  with y as the only unknown. We tested this relation by experiment and 
found that the data agree with the hypothesis. Fitting of the data provides the efficiency 
ratio y. Further, we describe the cell to cell variation in the expression fraction 
P
f  
through the introduction of a distribution model of the active plasmid fraction. This was 
based on a binomial distribution with a total of M active plasmids from both sources, 
pDNA1 and pDNA2. Clearly, assuming that each cell has a fixed number M of active 
plasmids is unrealistic. This number is expected to be distributed. In this sense, the value 
of M = 20 used in this study represents an approximation for the mean number of active 
plasmids.  
Despite the simple nature of the model, it very closely approximates the 
experimental data. This descriptive power of the model should be useful for predicting 
the feasibility and outcome of many coexpression fluorescence experiments. Our data 
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demonstrate that the mean protein expression ratio can be adjusted in a controlled and 
predictable fashion by changing the plasmid ratio. This degree of control is useful for 
selecting conditions that optimize the detection of protein-protein interactions. For 
example, if one protein expresses much less than the other, this imbalance can be 
corrected for by adjusting the molar plasmid ratio accordingly. This control over protein 
coexpression is limited by the finite number of active plasmids present in each cell. The 
binomial distribution model with M = 20 plasmids describes the spread in the 
experimental data which corresponds to ~10 active copies for each type of plasmid in a 
1:1 transfection mixture. In trials where pEGFP and pEYFP are mixed at ratios of 1:13 
and 1:27, the expressed protein distribution is skewed to be almost entirely EYFP (data 
not shown). Thus, once protein expression ratios need to be modified by a factor of more 
than 10, adjusting the pDNA ratio will not produce the desired outcome. This effect was 
encountered in a study where the large difference in expression efficiency prevented the 
use of the full-length coactivator SRC-1 (91). The binomial distribution model should be 
tested for each specific cell line and transfection method used in a study to establish the 
number of active plasmids, because its value determines the accessible range of 
expression ratios.  
The binomial distribution model is further useful for fluorescence experiments, 
because it imposes limits on the cell to cell variations in brightness values and FRET 
efficiencies due to different expression ratios. This model predicts the spread in the 
experimental data and provides a quantitative estimate of the standard deviation of the 
measured signal. Our experimental data show that a few cells do deviate significantly 
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from the binomial distribution model (Figure 3.3). Thus, it is expected that fluorescence 
experiments on cells will produce a few measurement values that differ substantially 
from the bulk of the values. However, because the majority of the cells follow the 
binomial distribution model, the experimental standard deviation is not significantly 
affected by the few outliers.  
We applied the cotransfection model to a bright and dark experiment on 
endophilin A2. The cotransfection model provides a quantitative explanation for the drop 
in the average brightness. The model further explains the increased scatter in brightness 
due to variations in the expression ratio. These results demonstrate that quantitative 
interpretation of FFS bright and dark experiment is feasible once the statistics of 
coexpression is known. A previous study employed the concept of the bright and dark 
experiment to check for a labeling effect in the Gag copy number of HIV virus-like 
particles (72). Brightness measurements of virus-like particles containing labeled and 
unlabeled Gag demonstrated that the fluorescent label did not interfere with the particle 
assembly process. However, the analysis was based on the assumption that the plasmid 
ratio is proportional to the expression ratio of labeled and unlabeled Gag. The work 
presented here justifies this assumption and provides a solid foundation for future bright 
and dark experiments. 
It is remarkable that the outcome of a complicated process like transient 
cotransfection is captured by a model that omits the details of the transfection process. In 
the following we examine the details of cationic lipid mediated transfection and their 
influence on the data. Cationic lipids interact with pDNA to form spontaneous complexes 
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called lipoplexes through electrostatic interactions. The overall positive charge of the 
lipoplex aids in the endocytotic uptake by the cell (92–95). In order for transcription to 
occur the lipoplex must escape the endosome and the pDNA must disassociate from the 
lipid en route to or inside the nucleus. The number of lipoplexes involved in the 
dissociation process, the nature of the dissociation process, and the entry into the nucleus 
are not yet understood. For example, although there is evidence that pDNA fully 
dissociates from the cationic lipid upon exiting the endosome, there are also conflicting 
observations (92, 96–99). We are able to use the statistics of expression fractions to 
contribute to the understanding of some of these details.  
Kriess et al. reported that a single lipoplex contains ~37.5 kbase of pDNA (100). 
Since the EGFP and EYFP plasmids are 4.5 kbase in length, we estimate that in our study 
a single lipoplex contains ~8 plasmids. Using this as the average number of plasmids per 
lipoplex, the complete uncoating of two to three lipoplexes is sufficient to provide ~20 
active plasmids as currently required by our model. Thus, we predict that the number of 
lipoplexes contributing to protein expression is very small. Since both the number of 
plasmids per lipoplex and the number of uncoating events are likely distributed, some 
cells will only experience the uncoating of a single lipoplex. If this lipoplex contains a 
small number of plasmids, then the probability that they all encode the same protein is 
much higher than for the bulk of M = 20 active plasmids. This scenario provides a 
plausible explanation for the highly populated tails of the distribution in Figure 3.3.  
We now test this hypothesis by altering the transfection protocol. So far, our 
studies involved lipoplexes carrying a statistical mix of two plasmids, but now we switch  
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Figure 3.7 Distribution of protein fractions from a binary transfection. 
Histogram of protein fractions for EGFP and EYFP transfected by a 1:1 lipoplex 
(pEGFP) / lipoplex (pEYFP) mixture. The histogram representing the probability 
distribution contains protein expression fraction from 140 cells with a bin resolution of 
0.05. The y-axis represents the number of cells with a protein expression fraction fP 
normalized by the number of cells sampled. A protein fraction of 0 represents a cell 
expressing only EGFP and a value of 1 represents a cell expressing only EYFP. 
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to a mix of two types of lipoplexes where each type carries the same plasmid. Lipoplexes 
that carry pEGFP are denoted as pEGFP-lipolexes, while lipoplexes carrying pEYFP are 
labeled as pEYFP-lipoplexes. In this binary transfection method, we transfected cells 
with a solution containing a 1:1 molar ratio of pEGFP-lipoplexes to pEYFP-lipoplexes. 
The distribution of protein expression fractions of this experiment (Figure 3.7) is 
distinctly different from Figure 3.3. If many lipoplexes are uncoated, the chance that all 
active plasmids are of the same type is vanishingly small. Such events contribute 
exclusively to the center of the distribution, which is not representative of the 
experimental data. On the other hand, the uncoating of a single lipoplex leads to cells 
expressing only EGFP or EYFP which populate the tails of the distribution ( 0
P
f   and 
1
P
f  ). While this model reproduces the tails of the experimental data, we also need to 
include the uncoating of two to a few lipoplexes in order to account for the middle of the 
distribution representing the expression of both proteins. Thus, our experiment 
convincingly demonstrates that very few lipoplexes contribute to protein expression. This 
discussion provides some additional insight. First, because although the total amount of 
pDNA (active and inactive forms) present in a transfected cell is very high (87, 88, 101), 
the dissociation of active plasmid from the complex is a very rare event. Second, our 
cotransfection model, although it does not account for the existence of lipoplexes, is 
adequate provided plasmids are mixed together before adding the lipid reagent.  
Our model provides a novel quantitative characterization of the average and 
standard deviation of protein coexpression ratios within living cells. With such a model, 
it is now possible to predict and control relative protein expression through manipulation 
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of pDNA ratios prior to transfection, which is of interest for fluorescence studies of 
protein-protein interactions and for FFS bright and dark experiments. The distribution 
model also provides a prediction for variations in the fluorescence signal due to different 
expression ratios. Additional studies using different cell lines and other transfection 
protocols will be needed to test the robustness and generality of our findings. It is 
worthwhile to again point out that all the plasmids of this study use the same promoter. It 
would be interesting to repeat the study for plasmids with different promoters and check 
if the model still applies by using a modified expression efficiency ratio. Nevertheless, 
the model of expression fractions established in this chapter provides insight into the 
cationic lipid mediated transfection process and should serve as a quantitative platform 
for future studies of protein coexpression and fluorescence applications in cells.  
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4.  Quantifying Protein-Protein Interactions of Peripheral 
Membrane Proteins with z-scan FFS 
In this chapter we apply z-scan FFS to quantify the brightness of peripherial 
membrane proteins in the cytoplasm and at the plasma membrane. Fluorescently labeled 
proteins that are found both in the cytoplasm and at the plasma membrane, such as 
peripheral membrane proteins, create stratified fluorescent layers that present a 
challenging environment for brightness studies with FFS. The geometry of each layer 
along with fluorescence and brightness contributions from adjacent layers generates a 
convoluted raw brightness that conceals the underlying brightness of each individual 
layer. Because the brightness at a layer establishes the oligomeric state of the 
fluorescently labeled protein at said layer, we developed a method that connects the 
experimental raw brightness with the physical brightness at each layered compartment. 
The technique determines the oligomerization in each compartment from an axial 
intensity scan through the sample, followed by an FFS measurement at each layer. We 
experimentally verify the technique with H-Ras-EGFP as a model system and determine 
its oligomeric state at both the plasma membrane and in the cytoplasm. Furthermore, we 
study the oligomerization of the Gag matrix domain of Human T-lymphotropic virus 
Type 1. The matrix domain targets the Gag polyprotein to the plasma membrane where 
subsequently viral assembly occurs. We determine the oligomerization of matrix in the 
cytoplasm and observe the onset of protein-protein interactions at the membrane. These 
observations shed light on the early assembly steps of the retrovirus.  
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4.1 Introduction 
 Peripheral or extrinsic membrane proteins associate temporarily with the 
membrane to perform a variety of cellular processes including signal transduction, 
cytoskeletal membrane interactions, membrane trafficking and enzymatic activities like 
phospholipid metabolism and catabolism. Membrane association and dissociation of 
peripheral membrane proteins provide a mechanism for triggered conformational changes 
that serve to regulate protein-protein interactions and biological activity (8–10, 102, 103). 
This work introduces a method based on FFS to study the oligomeric state of peripheral 
membrane proteins that reside in the cytoplasm and at the plasma membrane. FFS 
techniques like FCS (56, 57, 104) and brightness analysis of fluctuations (60–62) have 
been successfully used to study protein behavior both at the membrane and in the 
cytoplasm of living cells (1–3, 43, 44, 47, 65, 105). Here, we focus on the use of 
brightness analysis for studying the interactions of peripheral membrane proteins that 
reside concurrently in the cytoplasm and at the plasma membrane.  
Because peripheral membrane proteins associate reversibly with the membrane, 
they often exist in two pools: a membrane-bound form and a free soluble form in the 
cytoplasm. This leads to three distinct layers in a cell adherent to a coverslip (see Figure 
4.1A). The first layer consists of the basal or bottom plasma membrane in contact with 
the glass. The second layer is the cytoplasmic compartment, followed by the apical or top 
membrane as the last layer. The axial extent of the optical excitation is much larger than 
the thickness of the membrane which ensures coexcitation of proteins in the membrane-
bound and cytoplasmic pools. The fluorescence fluctuation contributions from both 
  70 
sources need to be disentangled to reliably identify the brightness and oligomeric state of 
proteins at the membrane and in the cytoplasm. 
Z-scan FFS provides a method for untangling the fluorescence contributions of a 
multi-layered protein system, and allows the brightness of the sample at each layer to be 
established. The technique was previously introduced to properly account for 
fluorescence fluctuations in thin cytoplasmic sections (76) and is based off earlier work 
on z-scan FCS by Hof and coworkers (46). This study extends the theory of z-scan FFS 
to multiple strata, converts the theoretical concepts into a measurement strategy, and 
applies z-scan FFS to peripheral membrane proteins. We investigate the protein H-Ras as 
a model system and determine its oligomeric state at the plasma membrane and in the 
cytosol. 
The Gag polyprotein plays a pivotal role in the assembly and release of 
retroviruses (106). Recent studies indicated fundamental differences between the early 
assembly events of two retroviruses, human T-cell leukemia virus type 1 (HTLV-1) and 
human immunodeficiency virus type 1 (HIV-1) (107, 108). While HIV-1 Gag requires 
the onset of cytoplasmic Gag-Gag interactions to promote translocation to the inner 
leaflet of the plasma membrane (109–111), HTLV-1 Gag appears to engage the plasma 
membrane as a monomer (108). Since the matrix (MA) domain of Gag is the primary 
driver of Gag association with the inner leaflet of the plasma membrane (112–116), this 
study investigates the peripheral membrane protein MA by z-scan FFS to shed light on 
the ability of HTLV-1 Gag to bind to the membrane as a monomer and to identify its 
oligomeric state at the membrane. 
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4.2 Material and methods 
4.2.1 Experimental setup 
Experiments were performed on a modified two-photon microscope, described in 
chapter 2. Measurements were taken with a Zeiss 63x C-Apochromat water immersion 
objective (N.A.=1.2) at an excitation wavelength of 1000 nm and an average power, after 
the objective, of 0.3 mW. The data was acquired at a frequency of 20 kHz for a duration 
of ~60 seconds. Photon counts were detected by an avalanche photodiode (APD, SPCM-
AQ-141, Perkin-Elmer, Dumberry, Quebec), recorded by a Flex02-01D card 
(correlator.com, Bridgewater, NJ), and analyzed with programs written in IDL 8.2 
(Research Systems, Boulder, CO). For dual-channel measurements, a dichroic mirror 
with a center wavelength of 580 nm split the fluorescence emission into two detection 
channels. The green channel had an additional 84-nm-wide bandpass filter centered at 
510 nm (Semrock, Rochester, NY) to eliminate the reflected fluorescence of mCherry.  
Z-scans were performed by using an arbitrary waveform generator (Model No. 
33250A, Agilent Technologies, Santa Clara, CA) to move a PZ2000 piezo stage (ASI, 
Eugene, OR) along the z-axis. A triangular function with a peak-to-peak amplitude of 2.4 
V and a period of 10 seconds was used for the z-scan experiments. This waveform 
corresponded to 24.1 μm of axial travel in 5 s with the cells occupying roughly 3-4 μm in 
the center of each pass. Data was acquired at a frequency of 20 kHz for either a few 
seconds for a single z-scan or over several minutes for sequential z-scans. 
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4.2.2 Sample preparation and plasmid construction 
The pEGFP-C1 and pEGFP-N1 plasmids were purchased from Clontech 
(Clontech, Mountainview,CA). The mCherry-C1 plasmid was cloned from the mCherry 
pRSET B plasmid which was a kind gift from Dr. R. Y. Tsien (University of California, 
San Diego). mCherry was amplified by PCR with a 5’ primer that encodes an NheI 
restriction site and a 3’primer that encodes an XhoI site. The PCR fragment of mCherry 
was then ligated into the backbone of pEGFP-C1 (Clontech, Mountainview,CA). The 
EGFP-H-Ras plasmids were a kind gift from Dr. Mark Phillips (New York University 
School of Medicine). The MA domain of both HIV-1 Gag and HTLV-1 Gag were cloned 
from their full Gag sequence and amplified by PCR with a 5’ primer that encodes an XhoI 
restriction site and a 3’ primer that encodes an EcoRI site. The HIV-1 MA and HTLV-1 
MA cDNAs were then ligated into the pEGFP-N1 plasmid. All sequences were verified 
by automatic sequencing. 
All studies were performed using transiently transfected U2OS cells that were 
obtained from ATCC (Manassas, VA) and maintained in 10% fetal bovine serum 
(Hycolone Laboratories, Logan, UT) and DMEM medium. Cells were subcultered in 
eight-well coverglass chamber slides (Nalge Nunc International, Rochester, NY) 12 hours 
before transfection. Transient transfections were carried out using TransFectin (BioRad, 
Hercules, CA), according the manufacturer’s instructions, 24 hours prior to measurement. 
Immediately before measurement, the growth medium was replaced with Dulbecco’s 
phosphate-buffered saline (PBS) with calcium and magnesium (Biowhittaker, 
Walkerville, MD). 
  73 
4.2.3 Brightness calibration 
The brightness from the FFS data was computed as detailed in section 2.3.3 (70, 
117). In addition, calibration measurements of the brightness of EGFP were performed in 
the thick section of 10-20 cells expressing EGFP. The average brightness 
EGFP
  from this 
calibration experiment served as the normalization factor to convert an experimentally 
measured brightness   into a normalized brightness /
EGFP
b   . 
 
4.2.4 Z-scan calibration 
A z-scan calibration procedure was carried out to determine specific parameters 
of the mGL-PSF as described by Macdonald et (76). A series of eight z-scans were 
performed on a cell expressing EGFP starting at the nucleus and moving to thinner 
sections of the cell. A collective fit of the z-scan intensity profiles using the PSF defined 
by Eq. 4.9 resulted in 
0
z  = 0.95 ± 0.1 µm and y = 1.95 ± 0.14 for a radial beam waist of 
0
w =0.47μm. These values are consistent with previously reported parameters (76) and 
will remain fixed for the remainder of the experiment. 
 
4.2.5 Z-scan FFS procedure 
In a three-layer protein system, an intensity trace is measured along the z-axis of 
the cell. A fit of the z-dependent intensity data provides the location for the point FFS 
measurements: the bottom membrane layer 
BM
z , the top membrane layer 
TM
z , and the 
midpoint of the cytoplasmic layer   / 2mid BM TMz z z  . Point FFS measurements are 
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then performed by focusing the excitation PSF at 
BM
z , 
TM
z  and 
mid
z . Movement of the 
cell or focus drift during the FFS measurements would compromise the result. We 
performed an intensity z-scan directly before and after the FFS measurement as a control. 
Changes in the intensity profile between the first and second z-scan indicate the presence 
of motion. We only accepted FFS data for brightness analysis when the intensity profiles 
agreed.  
 
4.2.6 Z-scan data analysis 
For all the z-scan experiments described within this thesis, the photon counts 
sampled at 20 kHz were rebinned by a factor of 80 by software, which corresponds to a z-
scan sampling time of 4
z
T  ms. The z-scan speed 
z
v  4.82 µm/s resulted in a step size 
19.3
z z
z v T   nm between binned photon counts 
z
k . Fluorescence intensity was 
determined by   z zF z k T . The experimental z-scan intensity profile  F z  was 
analyzed in IDL 8.3 by least-squares fitting to a model intensity profile with a 
Levenberg–Marquardt algorithm, where the PSF parameters 
R
z  and y were fixed to the 
calibrated values, and the standard deviation 
binned
  of the binned photon counts was 
estimated from the standard deviation 
k
  of the unbinned counts by binned k BN  , 
with 80
B
N   representing the number of samples in a single bin. The fit of the data to 
the delta-slab-delta model (Eq. 4.6) determined the position of the bottom and top 
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membrane (
BM
z , 
TM
z ) as well as the maximum fluorescence intensities of the bottom 
membrane, the top membrane, and the cytoplasm (
,maxBM
F , ,maxTMF , ,m axC ytoF ). 
 
4.3 Results 
4.3.1 Z-scan FFS of a single layer 
Scanning the two-photon excitation spot uniformly along the z-axis of a cell (Figure 
4.1B) results in a z-dependence of the fluorescence signal (Figure 4.1C). For a cell 
expressing a homogeneously distributed cytoplasmic protein like EGFP, the first two 
moments of the fluorescence intensity have been described previously in chapter 2 (Eq. 
2.18) and by Macdonald et al. (76),  
 
   
   
1
2 2
2
F z c V z
F z c V z


  
 
. (4.1) 
The fluorescence intensity  F z  and variance  
2
F z  of the fluorescence depend 
on the cytoplasmic brightness   and concentration c  of the fluorescently labeled 
protein. The z-dependence is introduced by the generalized volume function 
   , ( ) 2
r
r
V z PSF S z d d         , which depends on the point spread function 
(PSF) raised to the r
th
 power and the sample shape factor S(z). The shape factor for a 
cytoplasmic protein is given by a slab geometry starting at the bottom plasma membrane 
(BM) and ending at the top plasma membrane (TM). If we mark the location of both 
membranes by 
BM
z  and 
TM
z  (Figure 4.1B), the shape factor of the cytoplasmic protein is 
described by a Boxcar function starting at 
BM
z  and ending at 
TM
z , 
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  
1,
; ,
0, otherwise
BM TM
Cyto BM TM
z z z
S z z z
 
 

. (4.2) 
The fluorescence intensity profile  F z  for the slab geometry is depicted by the solid 
line in Figure 4.1C and reaches its peak at mid-height (   / 2mid BM TMz z z  ) of the slab, 
because the volume overlap between the point spread function and the sample is 
maximized. 
The fluorescence brightness  is determined from Mandel’s Q-parameter (70, 71),  
  
 
 
2
F z
Q z
F z

 . (4.3) 
By inserting Eq. 4.1 we show that Q is the product of the brightness and a z-dependent 
gamma factor      2 2 1/z V z V z   as described previously,    2Q z z    (76). The 
z-dependent Q-parameter for the slab geometry is illustrated by the solid line in Figure 
4.1D. This is an extension of conventional FFS, where the sample volume is considered 
to be infinite. Conventional FFS is characterized by a z-independent Q-parameter, 
2 ,
Q  

  , where 
2 ,


 specifies the conventional gamma-factor. 
 
4.3.2 Z-scan FFS of multiple layers 
The above equations have been successfully applied to a single geometric layer to 
determine the brightness of proteins in thin cytoplasmic sections and to identify their 
stoichiometry (76). In this chapter, we expand z-scan FFS to describe geometries 
comprised of several layers. A simple example of such a system is realized by a protein 
that resides both in the cytoplasm and at the plasma membrane. We expect that the  
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FIGURE 4.1 Concept of z-scan FFS. 
  
(A) Three distinct cell layers: the bottom membrane, cytoplasm, and top membrane. The 
axial length of optical excitation (solid oval) leads to coexcitation of layers. (B) The slab 
model defines the geometry by specifying the location of the bottom and top membrane 
by 
BM
z   and 
TM
z , respectively. The cytoplasmic layer extends from 
BM
z  to 
TM
z . The 
two-photon excitation spot is scanned along the z axis. (C) Sketch of the average 
intensity for a cell expressing cytoplasmic EGFP (solid line) and a membrane bound-
EGFP fusion protein (dotted line). (D) Q-parameter versus z position for the same 
parameters as panel C.  
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presence of the protein at the plasma membrane gives rise to two additional peaks in the 
intensity profile (dotted line, Figure 4.1C) and the Q-parameter profile (dotted line, 
Figure 4.1D), reflecting the contributions from fluorescent proteins at the bottom and top 
plasma membrane. 
To treat membrane-bound proteins and other complex layered geometries requires 
a generalization of the theory beyond that given in the previous section. Since the first 
and second moment of the fluorescence intensity from multiple independent sources are 
additive, for a multi-layered sample the contributions from each layer are added up to 
give the total average fluorescence intensity and its variance as 
 
     
     
1,
2 2 2
2 ,
i i i i
i i
i i i i
i i
F z F z c V z
F z F z c V z

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 
 
. (4.4) 
The i-th layer is described by its brightness 
i
 , concentration 
i
c  and shape factor 
 iS z , which make up the fluorescence intensity  iF z  and variance  
2
i
F z  of the 
layer as described in Eq. 4.1. 
We are specifically interested in modeling proteins found concurrently at the 
plasma membrane and in the cytoplasm. This situation is best described by a three-layer 
system, which we refer to as a delta-slab-delta model, consisting of a bottom membrane 
(BM) located at 
BM
z , a cytoplasmic layer (Cyto), and a top membrane (TM) located at 
TM
z . Because a membrane is much thinner than the linear dimension of the PSF, its 
geometric shape factor is well approximated by a delta function. We refer to membranes  
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FIGURE 4.2 Z-dependent fluorescent intensity profile in kilo counts/s. 
 
(A) The profile (solid line) from EGFP-H-Ras and its fit (shaded line) to Eq. 4.6 (reduced 
χ2=1.4). (Dotted-dashed line) Contribution from the cytoplasmic (slab) layer; (dotted 
lines) contribution from the membrane (delta) layers. (B) The intensity profile (solid line) 
from the combined fluorescence of EGFP-H-Ras and mCherry and its fit (shaded line) to 
Eq. 4.6 (reduced χ2=1.3). The increase in the cytoplasmic intensity (dotted-dashed line) 
stems from the addition of the mCherry signal.  
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as delta layers to contrast their geometry with that of the slab model used for the 
cytoplasm. Thus, the geometry is described by    BM BMS z z z   for the bottom 
membrane layer,    TM TMS z z z   for the top membrane layer, and  ; ,Cyto BM TMS z z z  
for the cytoplasmic layer. 
 The fluorescence intensity and fluctuations of a delta layer are still described by 
Eq. 4.1, but with a reinterpretation of some parameters. The volume concentration c  is 
replaced by the surface concentration   at the membrane and the generalized volume 
function  rV z  now represents an area function (76). These changes are a consequence of 
the delta-function and provide a rigorous interpretation of z-scan intensity parameters. 
The z-dependence of the fluorescence intensity of the three-layer system is given 
by 
        BM C yto TMF z F z F z F z   . (4.5) 
For fitting purposes it is more convenient to express Eq. 4.5 as 
        ,max ,max ,maxBM BM Cyto Cyto TM TMF z F v z F v z F v z   , (4.6) 
where 
,m axi
F  represents the peak amplitude of the fluorescence profile  iF z  from the i-
th layer and ( )
i
v z  is the scaled volume function  ( ) ( ) m ax ( )i i iv z V z V z . The Q-
parameter for the three-layer model is directly computed from Eq. 4.4 by inserting the 
appropriate shape factor into the generalized volume function  ,r iV z , 
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   
2 , 2 ,
2 ,
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Q z z f z z f z
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
. (4.7) 
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Each layer is specified by its Q-factor, 
2,
( ) ( )
i i i
Q z z   , and fractional intensity, 
( ) ( ) ( )
i i
f z F z F z . The total Q-factor is given by summing the Q-factor of each layer 
weighted by its fractional intensity ( )
i
f z .  
It is convenient to report the brightness of each layer 
i
  as a normalized value by 
comparing it to the brightness 
EGFP
  of EGFP, i i EGFPb   . A normalized brightness 
1
i
b   indicates a monomeric protein, while 2
i
b   indicates a dimer in the i-th layer. 
For measurements of stoichiometry, it is helpful to convert the Q-factor into a z-
dependent normalized brightness  bˆ z  by dividing  Q z  by the brightness of EGFP and 
the conventional gamma factor 
2 ,


,  
 
         
   
ˆ
         
BM BM BM Cyto Cyto Cyto
TM TM TM
b z z f z b z f z b
z f z b
 

 

 (4.8) 
where we introduced the gamma factor ratio 
2 , 2 ,i i
  

 . We stress that 
BM
b , 
TM
b , and 
C yto
b  are the proper brightness values of the three layers. However, these values are not 
directly experimentally accessible. The experimental brightness  bˆ z  at each z-position 
is a complex composite containing the brightness from each layer. Because  bˆ z  requires 
further processing to extract the oligomeric state of proteins at each layer, we refer to it as 
raw brightness throughout the rest of the chapter. 
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4.3.3 Experimental intensity profiles of multiple layers 
Applying the above theory to experimental data requires one more crucial 
ingredient, the PSF, because it connects the shape factor with the generalized volume 
function  rV z . The experimental PSF is commonly approximated by either the 3DG 
function, or the squared GL function. However, neither of these functions sufficiently 
approximates the axial profile of our PSF. As noted in chapter 2, we chose to model 
experimental z-scan data with the mGL function (76)  
  
(1 )
2 2 2
0 0
2 2 2 2 2
0 0 0
4
, exp
y
mGL
z z
PSF
z w z

 
 

   
    
    
. (4.9) 
The radial and axial beam waist are characterized by 
0
w  and 
0
z , while y adjusts the axial 
decay of the PSF. The 
0
z  and y parameters of the PSF were determined experimentally as 
described in section 4.2.4.  
The plasma membrane protein EGFP-H-Ras expressed in U2OS cells served as a 
multi-layer test system. The z-dependent intensity trace shows a distinct double peak (see 
Figure 4.2A, black line) suggesting that the protein is predominately located at the cell 
membrane. We initially fit the experimental intensity profile with a two-layer model by 
setting  C ytoF z  in Eq. 4.5 to zero. The result of this fitting was unsatisfactory, because 
systematic deviations between data and model were observed (reduced χ-squared of 2.8). 
We suspected that the misfit was caused by the presence of cytoplasmic EGFP-H-Ras. 
We removed the constraint   0CytoF z   and successfully refit the EGFP-H-Ras 
intensity profile with the general three-layer model. The fit (Figure 4.2A, solid grey line) 
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shows no systematic deviations and has a reduced χ-squared of 1.4. In fitting the data, 
information was obtained about the z-dependent intensity for the cytoplasmic component 
(dotted-dashed line), the z-dependent intensities from the membrane components (dotted 
lines), and cell height 
TM BM
h z z  . Since the cytoplasmic contribution to the signal was 
small, EGFP-H-Ras is a useful model system for a predominantly membrane-bound 
protein distribution. 
Finally, we varied the ratio of cytoplasmic to membrane-bound protein by 
coexpressing mCherry and EGFP-H-Ras in U2OS cells. The mCherry protein populated 
the cytoplasmic pool, while EGFP-H-Ras contributed mainly to the membrane-bound 
component. Expressing two differently colored fluorescent proteins provided a 
convenient method to quickly select transfected cells expressing each protein at the 
desired intensity ratio. Although the fluorescence was split into a green and red detection 
channel, we combined the photon counts of both channels in software to mimic the 
fluorescence signal of a single-colored fluorescent protein found in the cytoplasm and at 
the membrane. The z-scan intensity profile (solid line) of the combined signal from a 
coexpressing cell is shown in Figure 4.2B together with a successful fit (shaded line) of 
the data by Eq. 4.6 with a reduced χ-squared of 1.3. While the additional presence of 
mCherry made the cytoplasmic intensity more prominent than in Figure 4.2A, each 
membrane layer along with the cytoplasmic layer was still cleanly resolved by the fit. 
Thus, the three-layer model successfully described the z-dependent intensity profiles for 
proteins with membrane-bound and cytoplasmic populations. 
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4.3.4 Brightness measurements in multi-layer protein geometries 
Before taking brightness measurements it is illustrative to consider the influence 
of the three-layer geometry on the raw brightness by studying the z-dependence of 
Eq. 4.8 for a few select cases. For a purely cytoplasmic monomeric protein, such as 
EGFP, Eq. 4.8 reduces to  
ˆ( ) ( )
Cyto Cyto
b z z b   
with 1
C yto
b  . The corresponding raw brightness curve (see Figure 4.3A, shaded line) for 
a thick (5μm) cytoplasmic layer approaches one as the focus of the beam reaches the 
center of the sample where 1
cyto
  , because the entire PSF is embedded in the sample. 
These are the conditions where conventional FFS, which ignores sample geometry, is 
valid. 
Next, consider a monomeric protein only found at the bottom plasma membrane, 
which simplifies Eq. 4.8 to  
ˆ( ) ( )
B M B M
b z z b   
with 1B Mb  . The brightness curve (Figure 4.3A, solid line) has a single peak with a 
maximum at the position of the bottom membrane. We notice that the raw brightness at 
the bottom membrane exceeds one. This increase is caused by the sample geometry, 
which is reflected in the gamma factor ratio   2, 2 ,( )BM BM BM BMz z    . In fact, one 
may think of the gamma factor ratio ( )
i
z  as the bias factor in brightness due to sample 
geometry. The bias factor of a delta layer is   1.8BM BMz   for our PSF. Thus, 
conventional FFS analysis of a protein at the membrane overestimates brightness by ~1.8 
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due to the thin geometry. The raw brightness curve for a monomeric protein at the top 
membrane (Figure 4.3A, dashed black line) is identical to that of the bottom membrane 
except for a shift in the z-position, reflecting the different location of the membrane. 
The general case involves proteins occupying the cytoplasm and the membranes. 
The resulting raw brightness curve is, according to Eq. 4.8, the superposition of the raw 
brightness curve from each layer (Figure 4.3A) weighted by its fractional intensity ( )
i
f z . 
The dependence of the raw brightness ˆ( )b z  on the fractional intensity, the geometric bias 
factor, and the brightness of each layer, leads to a convoluted signal that is not 
straightforward to interpret. We illustrate this point in Figure 4.3B by plotting Eq. 4.8 for 
a slab with a thickness of 3 µm with monomeric EGFP ( 1)
BM C yto TM
b b b    distributed 
between the bottom membrane, the cytoplasm and the top membrane with an intensity 
ratio 
,max ,max ,max
: :
BM Cyto TM
F F F  of 3:1:3. We see that the raw brightness peaks at the 
membranes are reduced as compared to the value of 1.8 expected for a monomeric 
protein at the membrane as discussed earlier. The raw brightness at the center of the 
cytoplasmic slab is less than the expected value of 1. Thus, quantitative analysis of the 
raw brightness curve is essential to link ˆ( )b z to the actual brightness of each layer.  
Measuring the complete raw brightness curve  bˆ z  and fitting it to Eq. 4.8 is very 
time consuming, because an FFS measurement at a single z-position takes tens of 
seconds. A closer look at Eq. 4.8 reveals that measuring  bˆ z  at three different locations 
(
BM
z ,
TM
z ,
mid
z ) is sufficient to calculate the brightness of each layer (
BM
b ,
C yto
b ,
TM
b ). The 
additional information needed for Eq. 4.8 is obtained by a fit of the intensity profile  
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Figure 4.3 Modeling of raw brightness as a function of z-position.  
(A) The raw brightness is calculated assuming a cell with a height of 5 μm. (Shaded line) 
Raw brightness ˆ( )b z  for EGFP in a cell. (Solid and dashed lines) Raw brightness 
ˆ( )b z for a monomeric membrane protein labeled with EGFP located at either the bottom 
or top plasma membrane. (B) The raw brightness ˆ( )b z is calculated assuming a cell with a 
height of 3 μm and a monomeric protein distributed between the cytoplasm and the 
plasma membrane with an intensity ratio of FBM,max : FCyto,max : FTM,max of 3:1:3. The raw 
brightness in the cytoplasm and also at the plasma membrane is suppressed as compared 
to (A) due to the coexcitation of fluorescent proteins across adjacent sample layers. 
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( )F z , which provides the fluorescence signal ( )iF z  from each layer as well as the 
location (
BM
z ,
TM
z ) of the membrane layers. This information serves to calculate the 
gamma factor ratios and fractional intensities that appear in Eq. 4.8. For the three raw 
brightness values  bˆ z  we chose to measure at the bottom membrane, at the top 
membrane, and at mid-height in the cytoplasm. The experimental values  ˆ BMb z , 
 ˆ TMb z , and  
ˆ
mid
b z  together with the fit of the intensity profile ( )F z  and Eq. 4.8 
supply three equations  
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  
     
     
      
         
, (4.10) 
where the matrix elements are given by      i i iz z f z  . Inverting the above equation 
determines the parameters 
BM
b ,
C yto
b , and 
TM
b .  
To test multi-layer brightness analysis at the plasma membrane, cells expressing 
the membrane protein EGFP-H-Ras were used as an experimental trial system. An 
intensity z-scan was followed by point FFS measurements at the top plasma membrane 
(
TM
z ), the bottom plasma membrane (
BM
z ), and in the cytoplasm (
mid
z ). The brightness 
values measured at the top and bottom membrane exceeded 1, brightness measured in the 
cytoplasm scattered between 0.3 and 1 (see Figure 4.4A). By analyzing the raw 
brightness  bˆ z  as described above we identify the brightness from each layer (Figure 
4.4B). The analysis reveals that in U2OS cells, EGFP-H-Ras is monomeric both at the 
membrane and in the cytoplasm for all measurements.  
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FIGURE 4.4.  Z-scan brightness analysis of EGFP-H-Ras. 
  
(A) (Top Panel) Raw brightness ˆ( )
membrane
b z  measured at the top (shaded circles) and 
bottom (solid circles) membrane versus the fluorescence intensity (mean and standard 
deviation (SD) of 1.72 0.13 ). (Bottom Panel) Raw brightness ˆ( )
mid
b z  from the mid-
point in the cytoplasm (open triangles) (mean and SD of 0.59 0.22 ). (B) (Top panel) 
True EGFP-H-Ras brightness 
membrane
b  at the top (shaded circles) and bottom (solid 
circles) membrane (mean and SD of 1.00 0.06 ); (bottom panel) true brightness 
cyto
b (open triangles) in the cytoplasm (mean and SD of 1.01 0.06 ). (C and D) EGFP-H-
Ras z-scan plots for two cells with different thicknesses. (Bottom panels) Intensity traces 
in kilo counts/s (solid line) and fit (shaded line) along with the fitted profiles from each 
layer. (Top panels) Measured raw brightness (shaded circles) at 
BM
z , 
mid
z , and 
TM
z . The 
raw brightness curves (solid line) are generated for the lower-panel intensity curves 
assuming monomeric proteins at both membranes and in the cytoplasm. (E) Z-scan FFS 
experiment of a cell expressing EGFP-H-Ras and EGFP. The graphs and labeling are 
identical to (C). 
  89 
We provide a detailed analysis of two separate z-scan FFS experiments performed 
on cells expressing EGFP-H-Ras to illustrate the dependence of  bˆ z  on geometry. The 
bottom panel of Figure 4.4C shows the intensity profile of a cell with a wider separation 
of the membranes than the cell in Figure 4.4D. After fitting the intensity profile of both 
cells, the raw brightness curves  bˆ z  were calculated assuming a brightness of 1 at the 
membrane and in the cytoplasm. Thus, the raw brightness curves shown in the top panels 
of Figure 4.4C and 4.4D represent the case of monomeric EGFP-H-Ras, and the 
measured brightness values bˆ  (shaded dots) at the membranes and in the center of the 
cytoplasmic slab are in good agreement with the raw brightness curve. The raw 
brightness bˆ  at the membrane in Figs. 4.4C and 4.4D is close to the value of 1.8. The 
slight reduction in brightness reflects the coexcitation of cytoplasmic protein that leads to 
a drop in the fractional intensity at the membrane. Because the intensity contributions 
from the cytoplasm are small, the decrease in the fractional intensity at the membrane is 
minor and the raw brightness bˆ  predominantly reflects the brightness of a purely 
membrane-bound protein enhanced by the geometric bias factor of 1.8 (see Figure 4.3A).  
The raw brightness  ˆ midb z  in the cytoplasm, on the other hand, is significantly 
affected by the thickness of the cell at the position of the z-scan. While a thick slab 
(Figure 4.4C) leads to very little suppression of bˆ  due to contributions of the membrane 
signal, a thinner slab (Figure 4.4D) leads to a significant reduction in bˆ . This 
coexcitation dependence on brightness is largely responsible for the scatter in the 
measured raw brightness values of Figure 4.4A.  
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The coexcitation dependence also affects the brightness at the membrane when a 
large relative pool of protein exists in the cytoplasm. Since cytoplasmic protein levels for 
EGFP-H-Ras alone were relatively low, we demonstrated this effect by increasing the 
pool of cytoplasmic fluorescent proteins through coexpression of EGFP and EGFP-H-
Ras. Figure 4.4E shows the z-scan FFS analysis of a cell expressing both proteins in 
which the fluorescence of the cytoplasmic pool (Figure 4.4E, bottom panel) is much 
larger than for EGFP-H-Ras alone. This leads to a significant reduction of the raw 
brightness at the membrane position from the value of 1.8 (Figure 4.4E, top panel), 
because the larger cytoplasmic fluorescence introduces a pronounced drop in the 
fractional intensity of the membrane signal. 
 
4.3.5 Matrix domain of HTLV-1 Gag 
While assembly of the retrovirus requires the full-length Gag protein, the process 
is complex and involves hundreds to thousands of Gag copies that pack together into 
individual Gag puncta. We chose to simplify the problem by investigating the MA 
domain of Gag, because MA is the primary driver of Gag association with the inner 
leaflet of the plasma membrane, but it lacks the ability to multimerize into large 
complexes (114, 116). We first assessed the potential of MA-EGFP to bind to the plasma 
membrane. Z-scans were performed on U2OS cells transiently expressing either HTLV-1 
MA-EGFP or HIV-1 MA-EGFP. Visual inspection of the z-scan intensity trace from each 
protein (see Figure 4.5A) identified distinct differences in behavior. HIV-1 MA-EGFP 
(shaded line) appears to be a cytoplasmic protein, while HTLV-1 MA-EGFP (solid line) 
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has a significant membrane-bound component as indicated by the double peak in the 
intensity profile.  
A fit of the data to the three-layer model confirmed that the HIV-1 MA-EGFP 
trace has no detectable protein component at the membrane, while HTLV-1 MA-EGFP 
has the majority of its intensity coming from the membrane, suggesting a strong plasma 
membrane component. Repeating z-scan measurements on cells expressing the protein at 
various concentrations confirmed these observations (data not shown). HIV-1 MA-EGFP 
is only found in the cytoplasm, while HTLV-1 MA-EGFP has a significant membrane-
bound component. While we often observed differences in the intensity peaks at the top 
and bottom membrane, there was no systematic trend favoring one membrane over the 
other. The differential binding of MA to the plasma membrane for these two retroviruses 
agrees with a previous study (108). 
Raw brightness measurements were taken for HIV-1 MA-EGFP in the cytoplasm 
and z-scan FFS analysis, as previously described for a single layer, and were used to 
determine the cytoplasmic brightness (76). HIV-1 MA-EGFP displayed monomeric 
brightness at all concentrations (data not shown). This is consistent with the literature 
which suggests that the HIV-1 MA protein does not exhibit appreciable homo-
interactions at physiological concentrations (118, 119). For HTLV-1 MA-EGFP we 
measured raw brightness bˆ  values at both plasma membranes and at the mid-section in 
the cytoplasm (Figure 4.5B). The top panel of Figure 4.5B shows the raw brightness bˆ  
(shaded dots) as well as a theoretical raw brightness curve determined from the z-  
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Figure 4.5 z-scan brightness analysis of MA domain of Gag proteins. 
(A) Normalized intensity of HIV-1 MA-EGFP (light dotted line) and fit (shaded line) to 
cytoplasmic slab model and of HTLV-1 MA-EGFP (dark dotted line) and fit (solid line) 
to Eq. 4.6. (B) Brightness and intensity data from a cell expressing HTLV-1 MA-EGFP. 
The raw brightness (shaded circles) taken at the bottom membrane, cytoplasm, and top 
membrane (top panel) together with a modeled brightness curve generated for the 
intensity trace (bottom panel) assuming a monomeric protein in the cytoplasm and a 
dimeric protein at the plasma membrane. (C) Brightness from a population of cells 
expressing HTLV-1 MA-EGFP. The brightness at the membrane (solid circles) as a 
function of the areal protein density (µm
-2
) shows a concentration-dependent monomer to 
dimer transition. Dimer binding curve (solid line) with a dissociation coefficient of ~300 
µm
-2
 and ± 10% error bounds (dotted lines) for brightness at the membrane. The 
brightness in the cytoplasm (shaded triangles) as a function of the volume protein density 
(µm
-3
) is monomeric at all measured concentrations.  
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intensity trace (bottom panel). We note that bˆ  at the membrane exceeds 1, while bˆ  in the 
cytoplasm is typically less than 1 which reflects the multi-layer nature of the sample. For 
this specific HTLV-1 MA-EGFP measurement, the raw membrane brightness bˆ  
exceeded 3 which suggested the presence of protein-protein interaction at the membrane. 
After applying Eq. 4.10 to the raw brightness values we determined that the true 
brightness values are 1.97 0.21
BM
b   , 1.97 0.21
TM
b   , and 1.06 0.12
cyto
b   .  
To further study the behavior of HTLV-1 MA-EGFP at the plasma membrane we 
performed z-scan FFS measurements on a population of cells with varying HTLV-1 MA- 
 EGFP concentrations. We applied the matrix analysis of Eq. 4.10 to the experimental bˆ  
data to isolate the membrane brightness (
BM
b , 
TM
b ) and cytoplasmic brightness (
C yto
b ) of 
the tagged HTLV-1 MA protein (Figure 4.5C). The cytoplasmic brightness 
C yto
b  is 
concentration independent, 1.01 0.12cytob   . The brightness of HTLV-1 MA-EGFP at 
the plasma membrane, on the other hand, exhibits a concentration dependent increase 
from approximately one at low concentration to a value of two at high concentration. 
Thus, the data reveal that HTLV-1 MA-EGFP undergoes a monomer to dimer transition 
with the solid line representing a binding curve with a dimerization dissociation 
coefficient of ~300 molecules/μm2 
 
4.4 Discussion 
Our results demonstrate that properly identifying the brightness of fluorescently-
labeled proteins found both at the plasma membrane and in the cytoplasm is challenging. 
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A few earlier studies have noted that fluorescence from neighboring layers qualitatively 
affects the measured brightness (4–6). In addition, brightness bias at the membrane due to 
delta-layer geometry was mentioned, but could not be experimentally identified (7). This 
study demonstrates that there are primarily three factors that confound quantitative  
interpretation of brightness measurements: the geometry of the layer, the intensity 
contribution from adjacent layers, and the brightness of adjacent layers. We briefly 
discuss each of these factors. 
The first factor is the geometric effect, which for a stratified layer boils down to 
the thickness of each layer. When applying conventional FFS, a layer that is thinner than 
the axial length of the excitation PSF will lead to an increase in the raw brightness as 
originally reported by Macdonald et al (76). In the extreme case of a delta layer, as is 
used to describe the plasma membrane, the raw brightness is increased by ~1.8 for our 
excitation PSF.  
The second factor accounts for the presence of background fluorescence from 
neighboring layers. The fluorescence signal of a layer is diluted by this background 
signal, which lowers the fractional intensity and thereby the raw brightness.  
The third factor accounts for differences in brightness at neighboring layers. To 
illustrate its effect, we used Eq. 4.8 to calculate the raw brightness ˆ( )
BM
b z  at the bottom 
membrane as a function of the fractional intensity ( )
BM BM
f z  for a cell with both 
membrane-bound and free cytoplasmic protein populations (see Figure 4.1A). In Figure 
4.6, we systematically changed the actual brightness at the membrane from a monomer to 
a trimer, while keeping the cytoplasmic protein a monomer in all cases. The raw  
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Figure 4.6 Modeled raw brightness.  
 
The modeled raw brightnenss ˆ( )
BM
b z at the bottom membrane is given as a function of 
the fractional intensity ( )
BM BM
f z  for a cell with both membrane-bound and cytoplasmic 
protein populations. ˆ( )
BM
b z  was modeled for monomeric, dimeric, and trimeric protein at 
the membrane while keeping the cytoplasmic protein a monomer in all cases. The raw 
brightness ˆ( )
BM
b z  decreases as a function of fractional intensity in all cases but decreases 
more rapidly as the brightness difference between the cytoplasm and membrane 
increases.  
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brightness bˆ  decreases as a function of fractional intensity for all cases, but the slope 
differs significantly. In general, a larger brightness difference between the cytoplasmic 
and membrane-bound protein leads to a steeper drop in raw brightness with fractional 
intensity. This issue is significant because membrane binding frequently promotes 
oligomerization of the protein at the membrane while the cytoplasmic fraction remains in 
monomer form. Thus, the fluorescence background from the cytoplasm and the 
brightness difference between the membrane-bound and cytoplasmic fractions lead to a 
reduced measured brightness at the membrane, which hampers the proper identification 
of the oligomeric state. 
Although this work used a mGL-PSF model for fitting the data, it is important to 
emphasize that the z-scan method is not tied to any particular PSF model. The only 
requirement is an accurate parameterization of the experimental PSF. Extension of the z-
scan method to one-photon excitation only requires a proper parameterization of the one-
photon PSF. To be more precise, one-photon excitation uses the observation volume 
 ,O    instead of the PSF to account for the effect of the pinhole on the collected 
fluorescence emission. This observation volume can be modeled by multiplying the 
excitation PSF by a collection profile function (120). Once a proper parameterization of 
 ,O    has been obtained, z-scan analysis with one-photon excitation can be performed 
by replacing the PSF of Eq. 4.9 with  ,O   . 
If a protein resides exclusively at the plasma membrane, then the problem reduces 
to a single layer, provided the top and bottom membrane are sufficiently far apart to 
avoid coexcitation. In this case the brightness of a protein at the plasma membrane can be 
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measured directly (5, 6, 121). Relating the measured brightness with the oligomeric state 
of the protein relies on a calibration experiment with a monomeric membrane protein to 
identify the monomeric brightness value. H-Ras appears to be an acceptable monomeric 
brightness standard for U2OS cells. In Appendix A we added a tandem dimeric EGFP 
label to H-Ras (EGFP2-H-Ras) and measured its brightness at the plasma membrane. The 
data show that labeled H-Ras provides a suitable brightness standard in U2OS cells. 
However, in MDCK cells, we observed both monomeric and higher brightness states for 
EGFP-H-Ras (data not shown). It was recently reported that H-Ras was found in both 
monomeric and cluster form at a ratio of 70/30 for each respective species (122) in BHK 
cells. Thus, identifying a brightness standard for membrane measurements appears 
challenging, because the cell line and cell environment can potentially alter the 
oligomerization and clustering of the protein.  
To avoid these potential complications we suggest a straightforward alternative to 
establish the monomeric brightness at the membrane. A routine measurement of the 
fluorescent protein in the cytoplasm or nucleoplasm determines the true monomeric 
brightness m onom er . We account for the delta layer geometry of the membrane by 
multiplying m onom er  by the geometric bias factor  M Mz  for a membrane, which is 
calculated as described earlier. The product  
 ˆmonomer M M monomerz    
represents the calibration brightness for a monomer at the membrane. This calibration 
procedure works as long as the brightness near the membrane and in the cytoplasm are 
the same. A constant brightness is an essential property of any fluorescent protein suited 
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for quantitative brightness experiments and needs to be established independently for 
each new fluorescent label (75). For example, EGFP has a stable brightness that remains 
unchanged when tagged to another protein, as well as, when measured in the nucleus, 
cytoplasm and in vitro (1, 75). As expected and shown by our data, the brightness of 
EGFP at the plasma membrane and in the cytosol is the same as long as geometry is 
accounted for. Thus, the above calibration procedure should prove useful for any 
fluorescent protein suited for quantitative brightness experiments.  
Fluorescence from neighboring layers also affects the raw brightness in the 
cytoplasm, although this issue has not received much attention yet. A recent study 
observed unphysically low brightness values in the cytoplasm when studying HIV-1 and 
HTLV-1 Gag interactions in cytoplasm (107), which were traced back to the presence of 
fluorescence from a membrane-bound fraction of labeled Gag proteins. Here we observed 
the same phenomenon for H-Ras (Figure 4.4A) and HTLV-1 MA (Figure 4.5B). 
However, unlike the earlier study we used quantitative z-scan FFS to identify the correct 
brightness in the cytoplasm and at the membrane. Studying the MA domains of both 
HIV-1 Gag and HTLV-1 Gag revealed a purely cytosolic distribution of HIV-1 MA-
EGFP, while HTLV-1 MA-EGFP was distributed between the cytoplasm and the plasma 
membrane, which agrees with recent observations (108) and implies fundamental 
differences between the early steps in HIV-1 and HTLV-1 assembly.  
Our study further provides evidence that cytoplasmic HTLV-1 MA-EGFP binds 
the plasma membrane as a monomer, since HTLV-1 MA-EGFP was entirely monomeric 
in the cytoplasm and only exhibited a concentration-dependent monomer to dimer 
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transition at the plasma membrane. This observation is supported by immunoprecipitation 
and immunoblotting studies which identified the presence of stable MA dimers at the 
plasma membrane (123). Because we measure both cytoplasmic and membrane-bound 
pools of HTLV-1 MA-EGFP, our brightness data provide evidence that links the 
monomeric MA in the cytoplasm with the observed dimers at the membrane through the 
presence of MA-MA interactions that occur in the membrane-bound form. Of course, 
dimerization is only the first step towards assembly of the complete viral-like particle. 
Observing additional steps requires future experiments with the full-length Gag protein to 
account for the additional interactions outside the MA domain that play a role in the 
formation of high-order Gag complexes (124). The advances in brightness experiments 
presented here not only provide the foundation for future work with the full-length 
HTLV-1 Gag protein, but also should prove useful for studies of any protein that is 
distributed across stratified layers within the cell. 
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5.  z-scan FPD of Cytosolic and Membrane-associated Protein 
Populations 
This chapter introduces a technique that characterizes the spatial distribution of 
peripheral membrane proteins that associate reversibly with the plasma membrane. An 
axial scan through the cell generates a z-scan intensity profile of a fluorescently labeled 
peripheral membrane protein. This profile is analytically separated into membrane and 
cytoplasmic components by accounting for both the cell geometry and the point spread 
function. We experimentally validated the technique and characterized both the 
resolvability and stability of z-scan measurements. Further, using the cellular brightness 
of green fluorescent protein, we were able to convert the fluorescence intensities into 
concentrations at the membrane and in the cytoplasm. We applied the technique to study 
the translocation of the pleckstrin homology domain of phospholipase C-delta1 labeled 
with EGFP upon ionomycin treatment. Analysis of the z-scan fluorescence profiles 
revealed protein-specific cell height changes and allowed for comparison between the 
observed fluorescence changes and predictions based on the cellular surface area to 
volume ratio. The quantitative capability of z-scan fluorescence profile deconvolution 
offers opportunities for investigating peripheral membrane proteins in the living cell that 
were previously not accessible. 
 
5.1 Introduction 
Peripheral membrane proteins associate reversibly with cellular membranes 
through non-covalent interactions with lipids and integral membrane proteins. They 
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constitute a broad and diverse class of proteins involved in various membrane-mediated 
cellular processes including but not limited to cell signaling, cytoskeletal structure, lipid 
homeostasis, and electron transport (8, 10, 125). The ability to transition between a 
soluble and membrane-bound form has been recognized as an important regulation and 
control mechanism of cells. The interaction with the membrane provides a mechanism to 
induce conformational changes in the protein that modulate its activity. Vice versa, the 
interactions with the membrane-associated protein can also change the composition, 
dynamics, and shape of cellular membranes (126–129). As we mentioned in chapter 1, 
this complex, bidirectional interplay between peripheral membrane proteins and cellular 
membranes is only beginning to be unraveled through the use of model membrane 
systems and cellular studies. 
The energetics and dynamics of the interaction process has been primarily studied 
with model membranes (21, 22). These experiments provide quantitative information 
about protein interactions with lipids, but like all in vitro studies cannot reproduce the 
environment and complex interaction network found in cells. Live-cell studies monitor 
peripheral membrane proteins in their natural habitat and are an essential complement to 
ex situ methods. Cellular translocation studies of fluorescent protein-tagged proteins 
provide a powerful and convenient approach to visualize the subcellular distribution of 
peripheral membrane proteins and their dynamic relocation in real time by fluorescence 
imaging methods, such as confocal or TIRF microscopy (29–31, 130). 
Translocation studies typically report qualitative differences in the subcellular 
distribution of proteins, which reflects the difficulty of identifying the concentration of 
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the membrane-bound and soluble protein from fluorescence intensity data (29, 30). 
Attempts at quantifying the fluorescence signal to gain information about the relative 
strength of the interaction between protein and membrane have been restricted to 
heuristic approaches that are unable to analytically separate the fluorescence signal. The 
current study addresses this problem and introduces a fluorescence-based approach for 
measuring the time-resolved distribution of proteins at the plasma membrane and in the 
cytosol of a living cell.  
We specifically focus on characterizing the interaction of a fluorescently labeled 
cytoplasmic protein with the plasma membrane. An axial scan of the two-photon PSF 
through the cell generates a z-scan intensity profile as illustrated in Figure 4.1. By 
accounting for the cell geometry and the PSF we recover the distinct cytoplasmic and 
membrane-bound protein fluorescence contributions from the intensity profile, a process 
we refer to as z-scan fluorescence profile deconvolution (FPD). The intensity profile was 
first introduced in the z-scan FFS studies of chapter 4 where it served as a byproduct for 
determining the proper weighing factors that connected the FFS data to the oligomeric 
state of proteins at the plasma membrane and in the cytoplasm. Here we focus 
exclusively on the z-scan intensity profile to demonstrate that it offers a powerful 
approach for studying protein binding at the plasma membrane without the need for time-
consuming FFS measurements.  
We first examined the resolvability limits of FPD analysis of the fluorescence 
intensity profile by systematically varying the cytoplasmic intensity relative to the 
membrane fluorescence intensity and studied the stability of z-scan measurements over a 
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prolonged sampling time. We applied the technique to investigate the translocation of the 
EGFP labeled pleckstrin homology (PH) domain of Phospholipase C-delta1 (PH-PLCδ-
EGFP) in U2OS cells from the plasma membrane to the cytoplasm upon treatment with 
ionomycin. Quantitative analysis of the z-scan intensity profiles taken before and after 
treatment identified movement of the membrane position and allowed direct comparison 
between the fluorescence change at the membrane and in the cytoplasm.  
 
5.2 Materials and methods 
5.2.1 Experimental setup 
All data were taken with a Zeiss 63x C-Apochromat water immersion objective 
(N.A.=1.2) on a home-built two-photon microscope as described in chapter 2. The 
experimental protocols for data collection and z-scanning are described in section 4.2.1. 
In addition to z-dependent fluorescence intensity scans, we performed independent 
measurements on cells expressing the fluorescent label EGFP to determine its brightness 
EGFP
  as previously described in section 4.2.3. This brightness serves as a calibration 
factor for the conversion of fluorescence intensities into concentrations.  
 
5.2.2 Sample preparation and cell measurements 
The pEGFP-C1 and pEGFP-N1 plasmids were purchased from Clontech 
(Mountainview, CA), and the mCherry-C1 plasmid has been previous described (131). 
The EGFP-H-Ras plasmid was a gift from Dr. Mark Phillips (New York University 
School of Medicine). The PH-PLCδ-EGFP plasmid was a gift from Dr. Joseph Abanesi 
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(University of Texas-Southwestern). All sequences were verified by automatic 
sequencing. The cellular studies were performed using transiently transfected U2OS cells 
(HTB-96) that were obtained from ATCC (Manassas, VA) and maintained in 10% fetal 
bovine serum (Hycolone Laboratories, Logan, UT) and DMEM medium. Cells were 
subcultered in eight-well coverglass chamber slides (Nalge Nunc International, 
Rochester, NY) 12 hours before transfection. Transient transfections were carried out 
using GeneJet (Thermo Scientific, Pittsburgh, PA) according to the manufacturer’s 
instructions, 24 hours prior to measurement. Immediately before measurement, the 
growth medium was replaced with 200 µL of Leibovitz's L-15 Medium, no phenol red 
(Gibco, Life Technologies, Grand Island, NY). 
For kinetic studies, repeated z-scans were performed on individual cells. An 
objective heater with a thermal controller (MATS-ULH, Tokai Hit, Japan) was used to 
maintain a medium temperature of 32°C. Prior to scanning, 100 µL of medium was 
removed from the well. Pre-warmed L-15 medium (100 µL) containing Texas Red and 
ionomycin calcium salt (Life Technologies, Carlsbad, CA) was later added to the well, 
for a final concentration of 1.26 mM for Ca
2+
 and 5 or 10 µM for ionomycin. Texas Red 
served as a tracer to identify the time of delivery of ionomycin at the cell and was 
monitored in the red detection channel. 
The delta layer model was created by using a layer of rhodamine fibronectin 
(Cytoskeleton, Inc, Denver, CO). The fibronectin layer was created by pipetting a 
solution of 200 µl of buffer (0.5M NaCl, 0.5M Tris, pH=7.5) mixed with 13 µg of 
fibronectin into a chamber of an eight-well coverglass slide. The 8-well was then placed 
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in an incubator for 24 hours before the remaining liquid was pipetted out and replaced 
with 200 µl of Dulbecco’s phosphate-buffered saline (PBS) with calcium and magnesium 
(Biowhittaker, Walkerville, MD). For the semi-infinite model, a dilute fluorescein 
solution was added to a well of the chamber slide. 
 
5.2.3 Z-scan calibration of PSF  
As discussed in chapter 2, a mGL-PSF, 
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, (5.1) 
first introduced by Macdonald et al. (76), provides a good approximation of the PSF of 
our two-photon microscope and serves as the model for this study. A z-scan calibration 
procedure was performed as described previously in section 4.2.4 to determine the free 
parameters of our model. The calibration resulted in 0z  = 1.02 ± 0.1 µm, y = 2.20 ± 0.3 
μm, and 0w =0.47 ± 0.05 μm, where 0w  and 0z  describe the radial and axial beam waist, 
while y adjusts the axial decay of the PSF. Z-scan analysis relies on the radially 
integrated point spread function RIPSF, which for the mGL-PSF is given by (76),  
      
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The mGL PSF volume is given by  
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and the cross-sectional area at the center of the mGL PSF is determined by 
2
0
0
4
w
A

 (76).  
5.2.4 Z-scan data analysis 
The experimental protocol used for rebinning and fitting z-scan photon counts is 
described in section 4.2.6. To explore the resolvability of z-scan fitting, simulations were 
performed as follows. A z-scan intensity profile  modelF z  for a membrane-cytoplasmic-
membrane geometry was calculated from Eq. 5.6 using the calibrated PSF parameters and 
experimental step size z . The calculated intensity profile was converted into simulated 
data  simF z  using a Poissonian random number generator  PoissonP   to account for shot 
noise,  
  modelPoisson z
sim
z
P F z T
F z
T

 . 
5.3 Results 
5.3.1 z-scan intensity profile of single layers 
A scan of the TPE spot along the z-axis of a cell generates a fluorescence 
intensity profile  F z . This intensity profile results from the convolution of the PSF of 
the instrument with the concentration profile  Mc z  of the fluorescently labeled protein 
along the scan axis. We assume in this study that the concentration only varies along the 
z-direction, which reflects a geometry based on stratified layers. For a single layer a scan 
along the z-direction results in a fluorescence intensity function (76) 
      R IPSFF z c S z d   


  , (5.3) 
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where   is the monomeric brightness of the labeled protein, c  represents the 
concentration of the labeled protein expressed as monomers, and RIPSF is the radially 
integrated point spread function (76). The function  S z  describes the geometric shape of 
the single layer (76) and will be discussed in more detail later. We define the 
concentration profile as the product of the protein concentration and the geometric shape 
function,    Mc z c S z .  
We consider three basic geometries and their associated intensity profiles: the 
delta-layer, the slab, and the semi-infinite layer. The concentration profile of the slab 
layer    ; ,M B Tc z c z z z   is constant between Bz  and Tz  (Figure 5.1A), which 
corresponds to a geometric shape function  ; ,B Tz z z  that equals 1 for B Tz z z   and 
0 everywhere else. The fluorescence intensity profile for the slab layer is obtained from 
Eq. 5.3,  
    ; ,V B TF z F z z z , (5.4) 
which introduces the fractional PSF volume  ; ,V z a b =  R IPSF
b z
a z
d V 


  to 
describe the incomplete overlap of the PSF with the sample (51). This description differs 
from conventional FFS, where we assume a PSF that is completely embedded within the 
sample. In essence, conventional FFS corresponds to a shape function ( ) 1S z   and a 
constant concentration profile  Mc z c . In this case Eq. 5.3 reduces to a z-independent 
fluorescence intensity, F cV  . Conversely for a thinner cell section, the PSF only 
achieves partial overlap with the sample, which is accounted for by a fractional PSF 
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volume    VV z V z . The z-scan intensity profile through a cell expressing a 
fluorescently labeled cytoplasmic protein is well approximated by a fit to the slab model 
(Figure 5.1B). The maximum intensity maxF  of the z-scan occurred at the midsection 
between the bottom and top layer,  12mid B Tz z z  , and is less than the limiting value of 
F
 , because the cell thickness at the scan location is not sufficiently thick to completely 
embed the PSF (  ; , 1V mid B Tz z z  ).  
The concentration profile of the semi-infinite layer (Figure 5.1C) is similar to the 
slab layer, but with Tz   , which leads to an intensity profile    ; ,V BF z F z z  . 
A good example of such an intensity profile is given by a z-scan through the microscope 
coverslip into a fluorescent solution as shown in Figure 5.1D together with a fit to the 
model. The intensity increases as the PSF moves deeper into the solution and reaches a 
maximum of F  once it is completely embedded in the solution. 
The delta-layer describes a very thin section, such as the plasma membrane, with 
a thickness which is much less than the axial size of the PSF. Its concentration profile is 
given by    M Mc z z z   , where  z  is the delta-function,   represents the 
surface concentration of the layer, and Mz  is the axial position of the thin layer (Figure 
5.1E). The intensity profile for a delta-layer located at Mz  is obtained from Eq. 5.3,  
      maxRIPSF M A MF z z z F z z     . (5.5) 
The RIPSF value at a specific location z may be interpreted as an area determined by the 
cross section of the PSF with the delta layer,    RIPSFA z z . The maximum of the  
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Figure 5.1 z-Dependent concentration and intensity profiles. 
Z-dependent concentration function for a slab (A), semi-infinite (C), and delta (E) layer. 
The lower panels show an experimental intensity profile 
exp
( )F z  (solid line) and fit to a 
model intensity profile 
mod
( )F z  (shaded line) for each concentration function. (B) The 
intensity profile 
exp
( )F z of a fluorescent cell is described by the slab model (
2
r
 =1.2). 
The maximum intensity 
max
F  is less than the intensity F

 for the infinite sample. (D) 
Intensity profile of a fluorescent solution matches the semi-infinite model (
2
r
 =1.1). (F) 
Intensity profile of thin fibronectin layer is in good agreement with 
mod
( )F z  for a delta 
layer (
2
r
 =1.0). 
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intensity 
max
F  is reached when the PSF is centered on the membrane (
M
z z ), which 
corresponds to max 0 0F A  with  0 0A A . We define a fractional PSF area by 
    0A M Mz z A z z A     to describe the intensity profile of Eq. 5.5 in compact form. 
A coverslip covered with a thin layer of fluorescently labeled fibronectin served as a 
model system for a delta-layer. A fluorescence intensity z-scan through the sample and its 
fit to Eq. 5.5 is shown in Figure 5.1F. 
 
5.3.2 z-scan intensity profile of multiple layers 
A peripheral membrane protein found at the plasma membrane and in the 
cytoplasm is described by a delta-slab-delta concentration profile  dsdc z  consisting of a 
delta layer for the bottom membrane located at Bz , followed by a slab layer and another 
delta layer representing the top plasma membrane located at Tz . This concentration 
profile (Figure 5.2A) can be written as 
       ; ,dsd B B Cyto B T T Tc z z z c z z z z z         , 
where B  and T  denote the surface concentrations of the fluorescently-labeled protein 
at the bottom and top membrane, while C ytoc  is the cytoplasmic protein concentration. As 
we first introduced in chapter 4, the corresponding fluorescence intensity profile is the 
sum of the intensity profiles from each layer (51),  
        , ; ,dsd B A B Cyto V B T T A TF z F z z F z z z F z z        (5.6) 
  111 
with BF  and TF  being the maximum fluorescence intensity at the membrane layers and 
,C yto
F
  represents the limiting cytoplasmic intensity of a thick layer. We introduce the 
membrane intensity fraction 
M
f  as a measure for the relative amount of fluorescence 
intensity coming from the membrane,  
 
,
M
M
M C yto
F
f
F F



, (5.7) 
 distinguishes between the bottom and top membrane, we further introduce the intensity 
fraction Bf of the bottom membrane and the intensity fraction Tf of the top membrane, 
which are defined by replacing MF  with BF  and TF  in Eq. 5.7, respectively. High 
membrane intensity fractions are easy to resolve, because the z-scan intensity profile 
displays two prominent peaks, as illustrated by the EGFP-H-Ras data (Figure 5.2B; fB = 
0.96 and fT = 0.97). Conversely, we expect a larger uncertainty in determining Mf  from 
data with lower membrane intensity fractions. 
We transfected cells with EGFP-H-Ras and mCherry to experimentally determine 
the limits of resolvability of Mf . H-Ras is predominantly membrane-bound, while 
mCherry is entirely cytoplasmic. The presence of two differently colored fluorescent 
proteins provided a straightforward method to select cells expressing each protein at the 
desired intensity ratio. This approach allowed us to systematically vary the membrane 
intensity fraction over a wide range. Because the fluorescence was split into a green and 
red detection channel, we combined the photon counts of both channels in software to  
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Figure 5.2 Delta-slab-delta model.  
(A) Concentration profile. (B) Z-scan intensity profile for EGFP-H-Ras (solid line) and fit 
(shaded line) to Eq. 5.6 (fB = 0.92, fT = 0.95, 
2
r
 = 1.2) with normalized residuals in lower 
panel. (Dotted-dashed line) Contribution from the cytoplasmic layer; (dotted lines) 
contribution from the membrane layers. (C) and (D) Intensity profile of cells expressing 
EGFP-H-Ras and mCherry fit to delta-slab-delta model (
2
r
  of 1.3 and 1.1).  
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mimic the fluorescence signal of a single-colored fluorescent protein found in the 
cytoplasm and at the membrane. 
We selected two cells that illustrate z-scan intensity traces with low membrane 
intensity fractions. The intensity profile of Figure 5.2C retains a slight double peak, and 
the fit to the three layer model returns membrane intensity fractions of 0.32
B
f   and 
0.36
T
f  . The next intensity profile (Figure 5.2D) lacks the double peak, which is 
consistent with a fit returning lower membrane intensity fractions than in the previous 
case ( 0.19Bf  , 0.12Tf  ). We performed a systematic study by selecting cells based 
on the relative membrane intensity fraction and performed 10 consecutive z-scans at a 
thick section of each cell. After fitting the intensity profile of each scan the average and 
standard deviation of the 10 membrane intensity fractions was calculated and is plotted as 
stars in Figure 5.3A. The experiments were performed on cells with cytoplasmic 
intensities ,C ytoF   ranging from 100 to 1000 kcps and scans were taken at cell heights 
ranging from 2.2 µm to 4.1 µm (mean of 3.1 µm).  
We further performed simulations to compare the experimental uncertainties with 
predictions based on our model. Intensity traces were calculated according to Eq. 5.6 with 
shot noise added to account for the photon detection noise. Parameters were chosen that 
mimic the experimental conditions as explained in section 5.2.4. The cell height was 3 
µm for all simulations. The membrane intensity fraction was varied between 0.05 and 0.9 
for cytoplasmic intensities of 
,C yto
F

 of 10 kcps, 100 kcps, and 1000 kcps. Multiple traces 
(n = 1000) were simulated for each choice of parameters and analyzed analogous to the  
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Figure 5.3 Resolvability of membrane intensity fractions.  
(A) Relative error (stars) versus the membrane intensity fraction 
M
f . Each data point was 
determined from fits of 10 consecutive scans. All intensity profiles were taken from cells 
with cytoplasmic intensities Fcyto,∞ between 100 and 1000 kcps. Relative error in Mf  from 
simulated intensity profiles (n=1000) for Fcyto,∞ = 10 kcps (squares), 100 kcps (triangles), 
1000 kcps (diamonds). (Inset) Relative error versus mean of z-scan intensity profiles 
from cells with Fcyto,∞ between 11 and 16 kcps. Relative error from individual scans (open 
circles) is reduced by summing groups of 10 scan profiles (solid circles). (B) Relative 
error in 
M
f  as a function of the number of summed intensity profiles for one cell 
(squares) from the inset. 
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experimental data described above to determine the standard deviation of the membrane 
intensity fraction. The result of the simulations, plotted as lines with filled symbols in 
Figure 5.3A, demonstrate that higher intensities and higher membrane intensity fraction 
reduce the uncertainty. Our experimental results closely match the simulation results in 
that the experimental data are scattered between the simulation results for cytoplasmic 
intensities of 
,C yto
F

 of 100 kcps and 
C yto
F  of 1000 kcps. This suggests that shot noise is 
the dominant factor shaping the experimental uncertainty. At lower membrane intensity 
fractions ( 0.1Mf  ) the uncertainty increases rapidly, which imposes a practical limit 
for resolving very small signal contributions from the membrane. Since the experimental 
and simulated results demonstrate the feasibility of resolving membrane intensity 
fractions ≥ 0.1 from z-scan intensity profiles, we limited our study to cells with 
0.1
M
f  . 
 
5.3.3 Stability of cellular z-scan intensity profiles 
The study of time-dependent changes in the membrane-bound population of 
cellular proteins requires a series of z-scans over a prolonged period of time. Any process 
that alters the binding conditions of the peripheral membrane protein will be reflected in a 
time-dependent evolution of the membrane intensity profile. The changes in the 
cytoplasmic and membrane-bound populations of the protein can be identified from 
analysis of the z-scan profiles provided that the instrument is stable and introduces no 
artifacts. We investigate the stability of our setup by performing a series of repeated z-
scans through the same x-y position in a cell. By fitting the intensity profiles from the  
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Figure 5.4 Repeated z-scans: EGFP-H-Ras. 
Repeated z-scans performed at the same x-y position in an U2OS cell expressing EGFP-
H-Ras are fit by Eq 5.6. (A) Top (black circles) and bottom (shaded circles) membrane 
position as a function of time show parallel movement with ~0.5 μm of z-drift over a 
period of 12 minutes. (B) Cell thickness (solid line) stays approximately constant. (C) 
Top (dashed line) and bottom (solid line) membrane intensity as a function of time is 
constant (FBM=88.8 ± 3.1 kcps, FTM=108.4 ± 3.1 kcps). (D) Cytoplasmic intensity (dot-
dashed line) remains stable (Fcyto=16.2 ± 0.9 kcps). 
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repeated scans to Eq. 5.6, membrane movement, cell height changes, and instrument z-
drift can be studied over time. Figure 5.4A shows the top and bottom membrane position 
of a U2OS cell expressing EGFP-H-Ras over a 750 s period. An offset was added to the 
data to place the midpoint of the cell initially at zero. The position of the top membrane, 
drifts by approximately 0.5 μm (standard deviation of 0.12 μm) in parallel with the 
position of the bottom membrane during the repeated scans. This parallel motion of the 
two cellular surfaces is indicative of focal drift in the instrument, while the cell height 
(Figure 5.4B), T Bh z z  , stays approximately fixed (standard deviation of 0.02 μm). 
The fastest drift rate estimated from Figure 5.4A is 10 nm/s, which is small enough to 
have a negligible influence on the shape of the intensity profile, because the PSF only has 
significant overlap with the cell for ~1s during the scan.  
Despite drift and occasional changes in cell height, the fluorescence intensities 
determined from fits to Eq. 5.6 remain remarkably constant as demonstrated by Figure 
5.4 C & D. The average membrane intensity fractions for the top and bottom membrane 
are 0.87Tf   and 0.85Bf   with a standard error of 1%. The experimental uncertainty 
agrees well with the simulations from Figure 5.3A, which predict an uncertainty of 1% 
for ,C ytoF  =10 kcps for a membrane fraction of 0.9. Because we also collected intensity 
fluctuations, our experiments were capable of converting fluorescence intensities to 
concentrations. The relation ,C yto C ytoF c V   connects the cytoplasmic concentration 
and intensity. The PSF volume was calculated as explained in section 5.2.3and the 
brightness of the monomeric protein was determined as described in chapter 4 (51). 
Similarly, the surface concentration of the protein at the top and bottom membrane are 
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given by 0T TF A  and 0B BF A . Applying these relations we obtained B = 
1260 μm-2, T = 1530 μm
-2
 for Figure 5.4C and C ytoc = 340 μm
-3
 for Figure 5.4D. The 
intensity variations over the measurement period of 750 s lead to a relative uncertainty of 
less than 5% for all concentrations.  
The data and simulations illustrate that the uncertainty of determining membrane 
intensity fraction strongly depend on the fluorescence intensity (Figure 5.3A). Thus, 
quantifying small intensity fractions when the cellular protein concentration is low will 
be hampered by large uncertainties. Since shot noise appears to be the dominant noise 
limiting the resolvability of membrane intensity fractions, collecting more photons in the 
z-scan profile should reduce the uncertainty. Because cell height stays fixed over 
prolonged periods of time, this suggests the possibility of taking consecutive z-scans and 
aligning the individual z-scan intensity profiles by software to correct for offsets 
introduced by focal drift. The photon count signal of the aligned intensity profiles are 
then added up to create a summed profile with a larger signal, which is expected to result 
in a reduction in the uncertainty of the fit parameters. To test this procedure and facilitate 
the early detection of small membrane intensity fractions in cells with low cytoplasmic 
proteins concentrations, we selected cells with cytoplasmic intensities ranging from 11 to 
16 kcps. We collected 100 z-scan intensity profiles from each cell and divided the scans 
into groups of N, which were aligned and summed. Each of the summed profile was fit to 
Eq. 5.6 and the average and standard deviation of the fitted membrane intensity fraction 
M
f  were determined. The inset in Figure 5.3A shows the relative uncertainty in Mf  of 
individual scans (open circles, N = 1) together with the uncertainty of the summed 
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intensity profiles (solid circles, N = 10). Summing 10 intensity profiles lead to an average 
reduction in the relative uncertainty of 2.8 with a standard deviation of 0.6. The decrease 
of the relative error with N is illustrated in Figure 5.3B for one of the data sets. The 
results are consistent with the expected 1 N  behavior and demonstrate the feasibility to 
improve the signal-to-noise ratio of dim samples by combining the signal from several 
fast z-scan intensity profiles.  
 
5.3.4 Kinetic studies of peripheral membrane protein partitioning 
Time-dependent changes in the distribution of a membrane-bound protein can be 
quantitatively characterized through a series of repeated z-scans. Here we study the PH 
domain of PLCδ which binds with high affinity to phosphatidylinositol 4,5-bisphosphate 
(PI(4,5)P2) lipids at the plasma membrane (132). When fluorescently labeled, PH-PLCδ-
EGFP maps the distribution of PI(4,5)P2 within a cell and exhibits a z-dependent intensity 
profile with a prominent double peak. Ionomycin induces depletion of internal Ca
2+
 
stores and stimulates store-operated Ca
2+
 entry, which raises the Ca
2+
 concentration in the 
cytoplasm (133). The increased Ca
2+
 concentration in turn activates PLC-mediated 
hydrolysis of PI(4,5)P2 into diacylglycerol (DAG) and inositol triphosphate (IP3) (134). 
This process leads to the displacement of PH-PLCδ-EGFP from the plasma membrane to 
the cytosol, because the hydrolysis depletes the membrane binding site of the protein 
(135). 
We investigate the time-resolved distribution of PH-PLCδ-EGFP by performing a 
series of repeated z-scans through the same x-y position in a cell and fitting the intensity 
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profiles from the repeated scans to Eq. 5.6. Figure 5.5A shows the fluorescent intensities 
from the top membrane, bottom membrane, and cytoplasm over a period of 210 s within 
the cell. Ionomycin containing solution was added at the 60 s time point, and a dramatic 
redistribution of fluorescent intensities from the membrane to the cytosol was observed 
~60 s after ionomycin treatment. In the cytoplasm the pre-treatment signal was ~100 kcps 
and post treatment the signal was ~700 kcps. At the membrane both signals decreased; 
for the top membrane the signal dropped from ~200 kcps to ~0 while the bottom 
membrane signal dropped from ~200 kcps to ~100 kcps. The fit of the z-scan profile to 
Eq. 5.6 also recovered the cell’s height which destabilized upon treatment with 
ionomycin. This was particularly evident in cells expressing PH-PLCδ-EGFP where the 
time trace (Figure 5.5B) identified a reduction in cell height of 0.33 µm after ionomycin 
treatment. The change in height was calculated by comparing the average height from the 
interval between 0-60s to the average height in the interval from ~140-200 s. This loss of 
height was typical for PH-PLCδ-EGFP cells following addition of ionomycin and will be 
discussed in more detail later. The data further show that the delay between adding 
ionomycin and fluorescence response cannot be explained by slow mixing of the 
ionomycin solution with cell medium as demonstrated by the fluorescence intensity trace 
(Figure 5.5C) of Texas Red that was included with the ionomycin solution. 
As a control, ionomycin solution was also added to cells expressing EGFP and 
cells expressing EGFP-H-Ras. The z-scans were fit to a slab model for EGFP and a delta-
slab-delta model for EGFP-H-Ras. The fluorescence intensities of EGFP in the cytoplasm  
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Figure 5.5 Time-resolved study of PH-PLCδ-EGFP. 
Kinetics from repeated z-scans of an U2OS cell expressing PH-PLCδ-EGFP. (A) Top 
membrane (dashed line), bottom membrane (solid line), and cytoplasmic (dotted-dashed 
line) intensity as a function of time. Ionomycin solution was added at 60 s. (B) Cell 
height (solid line) as a function of time. Average height from 0-60 s (dotted line) and 
from 140-200 s (dotted-dashed line) shows a reduction of 0.34 µm. (C) Intensity time 
trace of Texas Red from the ionomycin solution. 
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Figure 5.6 Time-resolved studies of EGFP and EGFP-H-Ras. 
Kinetics from repeated z-scans of U2OS cells with ionomycin solution added at 60 s. (A) 
EGFP expressing cell with cytoplasmic intensity (top panel) and cell height (bottom 
panel) as a function of time. (B) EGFP-H-Ras expressing cell with intensity from top 
membrane (top panel, dashed line), bottom membrane (top panel, solid line), and 
cytoplasm (middle panel, dotted-dashed line). (Bottom panel) cell height.  
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as well as the cell height remained approximately constant before and after addition of 
ionomycin at t = 60 s (Figure 5.6A). Similarly for EGFP-H-Ras, we observed no 
significant change in cell height, the fluorescence at the membrane, and the fluorescence 
in the cytoplasm upon adding ionomycin (Figure 5.6B). 
We used box and whisker plots to characterize the changes in cell height, 
cytoplasmic intensity and membrane intensity before and after treatment with ionomycin  
for all cells measured. The “pre” period represents 60 seconds before the addition of 
ionomycin. For PH-PLCδ-EGFP, the “post” period was defined to start when the 
redistribution of the intensity approached its final point and lasted for 60 seconds. PH-
PLCδ-EGFP (10 cells) showed the largest change in cell height (
post pre
h h h   ), with a 
mean loss of -0.37 μm after ionomycin treatment (Figure 5.7A). Conversely, both EGFP 
(10 cells) and EGFP-H-Ras (8 cells) only changed their average cell height slightly 
(Figure 5.7A). The distributions of both are scattered around zero with average values of 
-0.14 μm for EGFP-H-Ras and -0.10 μm for EGFP. Figure 5.7B displays the cytosolic 
intensity ratio of post- to pre-treatment with ionomycin. Both EGPF and EGFP-H-Ras 
have ratios close to unity (mean of 1.04 for EGFP and 1.07 for EGFP-H-Ras), which 
demonstrates the absence of a strong ionomycin-specific effect, in agreement with the 
data of Figure 5.6. The cytosolic intensity ratio of PH-PLCδ-EGFP has a mean value of 
5.13 which corresponds to a five-fold increase in the cytosolic intensity following the 
addition of ionomycin. The membrane intensity ratio of post-ionomycin to pre-ionomycin 
values is shown in Figure 5.7C. Because EGFP-H-Ras has an intensity ratio of ~1 (mean  
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Figure 5.7 Summary of time-resolved studies. 
Box plots of changes in cell height and intensity between pre- and post-ionomycin 
treatment of U2OS cells expressing PH-PLCδ-EGFP (n = 10), EGFP (n = 10), or EGFP-
H-Ras (n =8). (A) Difference in cell height 
pre post
h h h   . (mean of –0.37 µm for PH-
PLCδ-EGFP, –0.10 µm for EGFP, –0.14 µm for EGFP-H-Ras). (B) Cytoplasmic 
intensity ratio ( /
post pre
F F ) with a mean values of 5.13 for PH-PLCδ-EGFP, 1.04 for 
EGFP, 1.07 for EGFP-H-Ras. (C) Membrane intensity ratio ( /
post pre
F F ) with mean 
values of 0.60 for PH-PLCδ-EGFP and 0.98 for EGFP-H-Ras. 
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of 0.98), the distribution of proteins at the membrane is essentially not affected by the 
ionomycin treatment. PH-PLCδ-EGFP has a membrane intensity ratio centered at 0.60 
reflecting the redistribution of PH-PLCδ-EGFP proteins from the membrane to the 
cytoplasm. 
Although changes in the EGFP-H-Ras signal with ionomycin treatment were 
relatively small, we observed a measurable difference in the cytoplasmic 
(
, ,cyto cyto post cyto pre
F F F   ) and membrane-bound (
, ,m em m em pre m em post
F F F   ) intensity for 
each treated cell. The difference 
mem
F  was calculated using the average of both 
membranes. We next compared the changes in the observed cytoplasmic and membrane-
associated intensity by graphing the ratio 
cyto
F / memF  for all of the HRas-EGFP cells 
studied (Figure 5.8). The median of the ratio is close to one for the majority of cells 
(median of 0.58 and mean of 0.89) and is relatively stable considering the small observed 
signal.  
In contrast to HRas-EGFP the redistribution of PH-PLCδ-EGFP from the 
membrane to the cytoplasm resulted in a large change in the cytoplasmic intensity 
coupled with a smaller change in the intensity at the membrane (Figure 5.5). The ratio of 
the cytoplasmic to membrane-associated intensity difference ( /
cyto m em
F F  ) for all of the 
PH-PLCδ-EGFP cells studied (Figure 5.8) varied from ~3 to 15 with a mean of 8.4, 
which is considerably larger than observed for HRas-EGFP.  
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Figure 5.8 Summary of fluorescence redistribution. 
Box plots of the ratio of 
, ,cyto post cyto pre
F F  and , ,m em pre m em postF F  for ionomycin treated 
U2OS cells expressing PH-PLCδ-EGFP (n = 10) and EGFP-H-Ras (n =8).  
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As described earlier, the fluorescence intensity is connected to brightness, 
concentration and PSF volume or area, which leads to  , ,cyto cyto post cyto preF c c V     and 
 , , 0mem mem pre mem postF A     . Thus, the ratio of the intensity difference relates to 
concentration changes in the cytoplasm and at the membrane along the scan path,  
 
, ,
, , 0
cyto cyto post cyto pre
m em m em pre m em post
F c c V
F A 

 

 
. (5.8) 
If we assume that the protein is approximately uniformly distributed inside the cell and at 
the membrane, then the intensity ratio can be connected to the plasma membrane area 
mem
S  and the cell volume 
cell
V . The number of PH-PLCδ-EGFP or EGFP-H-Ras 
molecules before and after ionomycin treatment has to be conserved, which implies  
 
, , , ,m em post m em cyto post cell m em pre m em cyto pre cell
S c V S c V    . (5.9) 
Inserting Eq. 5.9 into Eq. 5.8 leads to  
 
0
cyto mem
mem cell
F S V
F V A




. (5.10) 
The equation states that the intensity ratio is directly related to the ratio of the membrane 
surface area 
mem
S  over the cell volume 
cell
V  provided the protein is uniformly distributed. 
When accounting for the PSF volume and area of the experimental setup (
0
A  0.18 µm
2
 
and V

 0.24 µm
3
) the average of /
cyto m em
F F   predicts a surface to volume ratio 
( /
mem cell
S V ) of 6.7 µm
–1
 for PH-PLCδ-EGFP and 0.7 µm–1 for EGFP-H-Ras. These two 
predictions differ widely, which will be discussed later in more detail.  
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5.4 Discussion 
Distinguishing cytoplasmic and membrane-bound protein populations relies on 
the accurate breakdown of the z-scan intensity profile into its individual components. A 
prerequisite for this deconvolution is an accurate PSF model and parameterization. It is 
crucial to test the selected PSF model on experimental z-scan traces with well-defined 
geometries. The delta-layer is optimal to test the PSF model, because it directly probes 
the radially integrated PSF (RIPSF) profile (Figure 5.1F). A second important test model 
is the semi-infinite layer (Figure 5.1D). The same PSF parameters that describe the delta 
layer also need to model the z-scan intensity profile of the semi-infinite layer. Because 
the semi-infinite layer probes the PSF deeper into the solution than the delta layer, depth-
changes in the PSF, such as those caused by spherical aberrations, are easily noticed. 
There should be no deviation between the model and the experimental intensity profile, at 
least to a depth that covers the size of the object to be scanned, which in the case of 
adherent cells is a few micrometers. A PSF model that passes the above tests is viable for 
z-scan FPD analysis. We previously demonstrated that the modified Gaussian-Lorentzian 
PSF model (51, 76) is suitable for our two-photon instruments and identified the PSF 
parameters.  
Identifying the cytoplasmic and membrane-bound intensities is based on fitting of 
the z-scan intensity profile. Reliable extraction of the fit parameters requires the correct 
assignment of measurement uncertainties in addition to selecting an accurate PSF model. 
We calculated the uncertainty based on shot noise, which resulted in fits with reduced 
chi-squared values of ~1 for the experimental intensity traces. This result implies that 
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shot noise due to the photon detection process is the dominant source of noise of 
experimental z-scan intensity traces, which is further corroborated by the simulated z-
scan intensity profiles that give rise to uncertainties in the fractional membrane intensity 
that closely match the experimental data (Figure 5.3A). 
Extracting the intensities from the membrane and cytoplasm relies on the shape of 
the intensity profile. Thus, the cell at the scan location has to be sufficiently thick to 
generate a profile with the two membrane intensity peaks readily distinguishable. As a 
rule of thumb the thickness should be at least twice the axial beam waist 
0
z  of the PSF, 
which implies a minimum thickness of ~2 μm for our setup. This condition was satisfied 
for all cell measurements presented in this study. Furthermore, the amplitude of the 
membrane intensity peaks needs to be strong enough to measurably influence the shape 
of the intensity profile. While peaks are no longer visible when the membrane intensity 
fraction falls below 25%, quantitative analysis of the z-scan intensity profile extends to 
lower membrane intensity fractions. The experiments and simulation identify a practical 
lower limit for the membrane intensity fractions of ~0.1 (Figure 5.3A).  
The uncertainty in the fit parameters increases rapidly at low membrane intensity 
fractions. Collecting more photons during the scan reduces the fit uncertainty, but 
increasing laser power is limited by the onset of photobleaching of the sample, which 
distorts the intensity profile. Slowing down the z-scan speed would collect more photons, 
but this approach requires a very stable instrument and may not be an option in many 
cases. Our instrument requires relatively fast scans to counteract the distorting influence 
of focal drift. Measurements over several months identified a maximum drift rate of 
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~10 nm/s. In this study we collected a complete intensity profile in 5 s (half a scan 
period), which is sufficiently fast to render the influence of drift negligible. While we 
observed slow changes in cell height in some cases, the cell thickness at the scan location 
is usually remarkably constant for prolonged periods of time. A stable cell thickness 
provides an alternative to improve the signal-to-noise ratio of the measurement that does 
not rely on a slow scan speed. We demonstrated that summing the signal from repeated, 
fast z-scans is feasible and results in a lower uncertainty in the fit parameters. Together, 
these results establish that quantitative z-scan analysis can be performed on a regular 
microscope without the need for specialized hardware that corrects focus drift. 
FPD analysis of the z-scan intensity determines the intensity from each 
fluorescent layer and the separation between layers. The scanning rate used to collect 
fluorescence intensity profiles is fast enough that the layer intensity and separation can be 
applied to time-resolved studies of protein binding to the membrane, as demonstrated by 
the data in Figure 5.5. Furthermore, it is possible to relate intensities to concentration 
through the use of a conversion factor from an independent control experiment. In our 
case, we determined the brightness 
EGFP
  of monomeric EGFP in an independent cell 
experiment. The protein concentration in the cytoplasm and at the membrane is 
calculated from the intensities and the brightness as explained in the results section. 
Because 
EGFP
  corresponds to the brightness of monomeric EGFP, the calculated 
concentration is expressed in terms of monomer. In contrast to the z-scan intensity 
profile, z-scan FFS is a slow technique which is not suited for time-resolved studies 
because the additional FFS measurements lead to data acquisition times approaching 
  131 
100 s. Thus, z-scan FFS measurements only have an advantage over z-scan FPD, if the 
oligomeric state of proteins at the plasma membrane and in the cytoplasm needs to be 
identified. 
In this chapter we applied z-scan FPD with a time resolution of 5 s to quantify the 
redistribution of PH-PLCδ-EGFP from the plasma membrane to the cytoplasm upon 
ionomycin treatment. Since the time scale of the cellular response to signaling events 
typically is longer than a minute (136), a resolution of 5 s should be sufficient in most 
cases. We monitored the appearance of Texas Red fluorescence to account for the 
variability in the mixing time upon adding ionomycin solution (Figure 5.5C), which 
served to identify the exact time point of ionomycin delivery to the cell. The experiment 
recorded a time delay between ionomycin delivery and the onset of the fluorescence 
intensity redistribution (Figure 5.5). The delay of ~30s is consistent with studies of Ca
2+
 
cell signaling which showed that Ca
2+
 reached maximum levels 30 - 60s after ionomycin 
treatment (133, 137, 138).  
The membrane translocation kinetics of peripheral membrane proteins like PH-
PLCδ-EGFP have been studied by fluorescence imaging methods. Initial studies used 
confocal imaging to show the redistribution of PH-PLCδ-EGFP from the membrane to 
the cytoplasm after ionomycin treatment or PFA receptor stimulation (29, 30). Both 
studies used the intensity profile from a line segment of the image to quantify the relative 
change in fluorescence around the membrane region over time. While this captured the 
kinetics of the process, the profile itself provides no direct measure for separating 
cytoplasmic and membrane-bound components. Loew and colleagues noted another 
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problem with intensity profiles linked to membrane movement. They imaged PH-PLCδ-
EGFP and observed bradykinin stimulation-induced cell shape changes and membrane 
movement (31). To address this issue, a region of interest including membrane and 
cytoplasm was selected, followed by a thresholding step to segment the membrane 
region. The average intensity above the threshold was used to estimate the intensity at the 
membrane (31). While this approach was judged to avoid issues associated with 
membrane movement, the local cell geometry within the region of interest and a precise 
PSF model were not taken into account, which prevented a truly quantitative separation 
of membrane-associated and cytoplasmic fluorescence. Z-scan FPD overcomes these 
shortcomings and achieves quantitative separation of the intensity profile by analytically 
accounting for cell geometry and PSF shape. 
The inherent quantitative nature of z-scan FPD analysis allowed us to measure 
membrane movement that had been mentioned as a concern but was not quantified (31). 
PH-PLCδ-EGFP showed a significant reduction in cell height upon ionomycin treatment 
(Figure 5.7A). Control experiments on cells expressing EGFP and EGFP-H-Ras revealed 
a negligible effect of ionomycin on cell height. Because PH-PLCδ-EGFP lacks enzymatic 
activity of its own, the results imply that the observed change in cell height was specific 
to the dissociation of PH-PLCδ-EGFP from the plasma membrane and that the interaction 
of the peripheral membrane protein with the lipid had an influence on the plasma 
membrane and the cell shape. This observation agrees with other studies that have 
pointed out that protein-membrane interactions can change properties of the membrane 
itself (126–129), as well as, modulate the adhesion strength between the cytoskeleton and 
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membrane lipids (139). For example, PH-PLCδ-EGFP has been shown to induce positive 
membrane curvature in model membranes when it binds to PI(4,5)P2 lipids (140). While 
the previous study was performed ex situ, our results demonstrate that PH-PLCδ-EGFP 
binding also affects the membrane inside a living cell. In addition, we observed a slight 
asymmetry in the response of the top and bottom membrane upon ionomycin treatment. 
While the fluorescence intensity from PH-PLCδ-EGFP associated with either membrane 
was approximately identical before treatment, the top membrane showed consistently a 
more pronounced decrease in fluorescent intensity than the bottom membrane following 
ionomycin treatment (Figure 5.5A). The cause for this difference is currently not known 
and will require further study. However, since the rigidity of the glass substrate can alter 
the bottom membrane’s properties (141, 142), the membrane-glass attachment might 
contribute to the observed effect. Z-scan FPD provides the means to quantitatively study 
differences at the top and bottom membrane, which is not readily accessible by other 
fluorescence techniques. The influence of substrate rigidity can be explored in future 
experiments by coating the glass coverslips in order to change the substrate stiffness. 
An estimate of the surface area to volume (SA/V) ratio of U2OS cells based on a 
simple model of the cell as a cylinder with a cross-sectional area of ~400 µm
2
 and a 
volume of ~1pl (143) leads to a value on the order of 1 µm
-1
. This estimate predicts that 
changes in fluorescence at the plasma membrane and in the cytoplasm due to 
translocation results in a ratio 
cyto
F / memF  of ~1 (Eq.5.10) provided that the 
concentration at the membrane and in the cytoplasm are uniform. As mentioned above, 
the SA/V ratio for EGFP-H-Ras is 0.7 µm
-1 
which is in good agreement with the above 
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estimate, but for PH-PLCδ-EGFP we arrived at a ratio (SA/V=6.7 µm-1) that is 
inconsistent with the model. The ratio is significantly larger than the expected value 
which indicates the appearance of more protein in the cytoplasm than is expected from 
the loss at the plasma membrane. This outcome could be achieved by the additional 
release of PH-PLCδ-EGFP from internal membranes like the golgi, but studies have 
found very little association of PH-PLCδ-EGFP with internal membranes (144, 145). 
Another source that could account for the large ratio is the presence of plasma membrane 
areas outside the z-scan location that carry a higher protein concentration. It has been 
shown that PI(4,5)P2 and PH-PLCδ-EGFP are more highly concentrated in membrane 
ruffles (144, 146–149) compared to other regions of the membrane. The ruffles of U2OS 
cells are located closer to the periphery of the cell, a region that was not sampled in our 
study, because it is too thin for z-scan FPD analysis. Thus, a likely explanation for the 
high ratio is the release of additional PH-PLCδ-EGFP located at membrane ruffles.  
In summary, z-scan FPD analysis introduces a method to decompose the 
fluorescence contributions from the cytoplasm and membrane of a peripheral membrane 
protein in the living cell. Only three elements are required, the fluorescent intensity 
profile along the axial dimension of the cell, a well characterized point spread function, 
and a model of the cell geometry. Intensities both at the membrane and in the cytoplasm 
are readily converted into concentrations by including a brightness calibration 
measurement taken in EGFP expressing cells. The quantitative nature of z-scan FPD, as 
demonstrated by our results, opens new opportunities for investigating peripheral 
membrane proteins in cells. It will be interesting to explore combining this method with 
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lateral scanning in future development work. Such an extension of the technique would 
allow probing lateral heterogeneity of protein density at the membrane, such as the 
presence of punctate structures, while still retaining the ability to quantitatively 
distinguish fluorescent intensities contributions from cytoplasmic and membrane layers. 
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 6.  In situ quantification of protein binding to the plasma 
membrane 
This chapter presents a fluorescence-based assay that allows for direct 
measurement of protein binding to the plasma membrane inside living cells. An axial 
scan through the cell generates a fluorescence intensity profile that is analyzed to 
determine the membrane-bound and cytoplasmic concentrations of a peripheral 
membrane protein labeled by EGFP. The membrane binding curve is constructed by 
mapping those concentrations for a population of cells with a wide range of protein 
expression levels, and a fit of the binding curve determines the number of binding sites 
and the dissociation coefficient. We experimentally verified the technique, using myosin-
1C-EGFP as a model system and fit its binding curve. Furthermore, we studied the 
protein-lipid interactions of the membrane binding domains from lactadherin and 
phospholipase C-delta 1 to evaluate the feasibility of using competition binding 
experiments to identify specific lipid-protein interactions in living cells. Finally, we 
applied the technique to determine the lipid specificity, the number of binding sites, and 
the dissociation coefficient of membrane binding for the Gag matrix domain of Human 
T-lymphotropic virus Type 1, which provides insight into early assembly steps of the 
retrovirus. 
 
6.1 Introduction 
The attachment of peripheral membrane proteins to lipid bilayers plays a critical 
role in many cellular functions, such as lipid metabolism, cytoskeletal structure, vesicle 
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trafficking, signal transduction, cell differentiation, growth, and apoptosis (8–10). Since 
membrane binding is crucial for the cellular function of these proteins, characterization of 
the membrane binding curve is a prerequisite for understanding the function and 
regulation of peripheral membrane proteins. As we noted in chapter 1, most studies of 
protein–lipid interactions are based on in vitro assays with membranes in the form of 
lipid vesicles, supported lipid bilayers, or lipid monolayers (21–23). In some cases 
isolated membranes have been used to go beyond simple lipid membranes (150, 151). 
However, these traditional assays study the protein and membrane ex situ, and are unable 
to reproduce the native conditions that give rise to the complex organization and dynamic 
behavior of cellular membranes. Thus, a technique that directly studies the membrane 
binding curve of proteins in living cells is highly desirable, not only to validate previous 
ex situ results, but also to explore the binding process in its natural environment.  
This chapter describes a method for measuring the binding of a fluorescently 
labeled protein with the plasma membrane of a living cell. The technique utilizes an axial 
scan through the cell to generate a z-scan fluorescence intensity profile. The intensity 
profile is deconvolved into its cytoplasmic and membrane-bound fluorescence 
contributions by accounting for the local cell height and the PSF of the instrument. The 
membrane binding curve is generated from the deconvolved cytoplasmic and membrane 
intensity contributions for a population of cells covering a sufficiently wide range of 
protein expression levels. We further converted fluorescence intensities into 
concentrations in the cytoplasm and at the membrane by applying the brightness of the 
fluorescent label EGFP. Information about the binding affinity and the number of binding 
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sites was recovered from a fit of the experimental data with a Langmuir isotherm. 
Moreover, competition binding experiments with different peripheral membrane proteins 
provided information about specific protein-lipid interactions at the plasma membrane. 
Our z-scan FPD approach, which we introduced in chapter 5, is related to z-scan 
FFS and earlier work by Hof and coworkers (46). However, unlike z-scan FFS (51, 76) of 
chapter 4, which characterizes the axial dependence of intensity fluctuations, z-scan FPD 
focuses specifically on information contained within the axial fluorescence intensity 
profile to generate the experimental binding curve. We applied z-scan FPD to investigate 
the interaction of myosin-1C with the plasma membrane, generated the experimental 
membrane binding curves, and determined its binding parameters. We also performed 
binding experiments with a variety of peripheral membrane proteins with known lipid 
targets to demonstrate the feasibility of competitive binding assays in the cell. Finally we 
applied our technique to study the membrane interactions of the matrix domain of HTLV-
1 Gag. We previously observed that the Gag polyprotein and matrix (MA), its membrane-
binding domain, of HTLV-1 interact with the plasma membrane at low cytoplasmic 
concentrations, which is in stark contrast with the corresponding proteins of HIV-1 (51, 
107, 108). Here we expand our investigation of HTLV-1 virus assembly by 
characterizing the membrane binding curve for the MA domain of HTLV-1 Gag and the 
lipid-specificity of the interaction.  
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6.2 Materials and methods 
6.2.1 Experimental setup 
Experiments were carried out on a modified two-photon microscope, as described 
in chapter 2. The experimental protocols for data collection and z-scanning are described 
in section 4.2.1 of chapter 4.  
 
6.2.2 Sample preparation and plasmid construction 
The pEGFP-C1 and pEGFP-N1 plasmids were purchased from Clontech 
(Mountainview, CA) and the mCherry-C1 plasmid has been previous described (131). 
The EGFP-H-Ras plasmid was a gift from Dr. Phillips (New York University School of 
Medicine). The Myosin1C-EGFP (Myo1C-EGFP) plasmid and the EGFP labeled PH 
domain of Phospholipase C-delta (EGFP-PLCδ-PH) plasmid were gifts from Dr. 
Albanesi (University of Texas-Southwestern). The EGFP labeled C2 domain of 
lactadherin (Lact-C2-EGFP) plasmid was purchased from addgene (Plasmid 22852). The 
Lact-C2-mCh plasmid was sub-cloned from the Lact-C2-EGFP plasmid into an mCherry-
c1 backbone. The miniGAP-EGFP plasmid (the first 10AA of GAP43) was a gift from 
Dr. Digman (UC-Irvine). The miniGAP-mCh plasmid was cloned from miniGAP-EGFP 
and amplified by PCR with a 5’ primer that encodes an XhoI restriction site and a 3’ 
primer that encodes an EcoRI site. The HTLV-1 MA-EGFP plasmid has been previously 
described (51). All sequences were verified by automatic sequencing. 
All cellular studies were performed using transiently transfected U2OS cells that 
were obtained from ATCC (Manassas, VA) and maintained in 10% fetal bovine serum 
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(Hycolone Laboratories, Logan, UT) and DMEM medium. Cells were subcultered in 
eight-well coverglass chamber slides (Nalge Nunc International, Rochester, NY) 12 hours 
before transfection. Transient transfections were carried out 24 hours prior to 
measurement using GeneJet (Thermo Scientific, Pittsburgh, PA) according to the 
manufacturer’s instructions. Immediately before measurement, the growth medium was 
replaced with Dulbecco’s phosphate-buffered saline (PBS) with calcium and magnesium 
(Biowhittaker, Walkerville, MD). For binding competition studies, cotransfections were 
performed with the two plasmid types mixed together at a given mole ratio prior to 
adding GeneJet. Specifically, pLact-C2-EGFP: pLact-C2-mCh was mixed at a 1:3 ratio, 
while for all other competition experiments plasmids were mixed at a 1:6 (EGFP labeled : 
mCh labeled) ratio. During measurement, the fluorescence intensity ratio of the green and 
red detection channel was used to select cells that express both proteins at a concentration 
ratio that matched or exceeded the plasmid ratio (50, 131). This selection ensured that 
each measured cell contains a sufficient excess of the competitor over the probed protein. 
 
6.2.3 z-scan calibration of PSF 
As discussed in chapter 2, the point spread function (PSF) for our two-photon 
microscope is well-approximated by the mGL-PSF, 
  
(1 )
2 2 2
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2 2 2 2 2
0
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, exp
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z z
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 
 
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   
    
 (6.1) 
as originally described by Macdonald et al. (76). The radial and axial beam waist are 
characterized by 
0
w  and 
R
z . The y parameter adjusts the axial decay of the PSF while 
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maintaining a Gaussian cross section. The PSF parameters were determined by a z-scan 
calibration procedure as previously reported in section 4.2.4, which provided values of 
R
z  
= 1.02 ± 0.1 µm, y = 2.20 ± 0.3, and 
0
w =0.47 ± 0.05 μm. The mGL-PSF volume is 
determined by e
 
 
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22
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V w z
y

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 and the cross-sectional area at the center of 
the PSF is given by 
2
0
0
4
w
A

  (76). 
 
6.2.4 z-scan intensity profile 
As noted in chapter 5, the modeling of the z-scan intensity profile is based on the 
radially integrated PSF given by    
0
RIP SF PSF , 2 d    

  . It is convenient to 
use the radially integrated PSF to define a scaled volume function 
   
1
; , R IPSF
T
B
z z
V B T
z z
v z z z d
V
 



   and a scaled area function 
   
0
1
; R IPSF
A M M
v z z z z
A
   (76). The z-scan fluorescence intensity profile  F z  can 
be represented using the scaled volume and scaled area functions. For a cytoplasmic 
protein with the top and bottom membrane located at 
B
z  and 
T
z  the intensity profile is 
given by    0 ; ,V B TF z F v z z z , while the intensity profile of a protein bound to a 
membrane located at 
M
z  is given by    0 ;A MF z F v z z  (51, 76).  
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Calculating the RIPSF function for the mGL-PSF described by Eq. 6.1 yields 
   
2
20
R IP SF 1 ( )
4
y
R
w
z z z
 
  . Evaluating the scaled volume function for the mGL-
PSF leads to (76) 
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with    22 1, 1 2 , , 3 2 ;y x F y x x    and  2 1 , , ;F a b c x  represents the hypergeometric 
function. The scaled area function is given by  
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. (6.3) 
The scaled volume and area function were implemented in IDL 8.3 (Research Systems, 
Boulder, CO) for data analysis.  
 
6.2.5 z-scan data analysis 
The experimental protocol used for rebinning and fitting z-scan photon counts is 
described in Section 4.2.6. In addition, traditional  brightness measurements were carried 
out in the thick cytoplasmic sections of 10-20 cells expressing EGFP as previously 
described in chapter 4 (51, 76). The average brightness   from this calibration 
experiment was computed (70, 117) and served as the monomeric brightness value to 
convert intensities into concentrations. 
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6.3 Results 
6.3.1 z-scan intensity profile of peripheral membrane proteins 
A scan of the excitation spot along the z-axis of a cell records the fluorescence 
intensity profile  F z  of the labeled protein. The intensity profile of a protein found at 
the plasma membrane and in the cytoplasm contains the signal contributions from three 
distinct cellular layers. The first layer is given by the bottom plasma membrane located at 
B
z , followed by a cytoplasmic layer and the top plasma membrane located at 
T
z . Once 
again, we introduce the delta-slab-delta fluorescence intensity profile of this geometry,   
        ,; ; , ;dsd B A B Cyto V B T T A TF z F v z z F v z z z F v z z   , (6.4) 
with 
B
F  and 
T
F  being the maximum fluorescence intensity at the membrane layers and 
,C yto
F

 representing the limiting intensity of a thick cytoplasmic layer. The scaled volume 
V
v and area 
A
v  function are defined by Eqs. 6.2 and 6.3.  
We measured z-scan intensity profiles from U2OS cells expressing Myo1C-
EGFP. The panels of Figure 6.1 display intensity profiles taken from two cells that differ 
in their protein expression level. Each experimental intensity profile (solid line) was fit to 
Eq. 6.4 to isolate the fluorescence contributions from each membrane (dotted line) and 
from the cytoplasm (dotted-dashed line), which are represented by the three terms of 
Eq. 6.4. The sum of these three terms determines the fitted z-scan intensity profile 
(shaded line). The relative contributions to the intensity profile from membrane-bound 
and cytosolic protein differ significantly for the two cells. Deconvolving the intensity  
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Figure 6.1 Myo1C-EGFP z-scan fluorescence profiles. 
Z-scan intensity profile (solid line) for Myo1C-EGFP in two U2OS cells. The fit (shaded 
line) to Eq. 6.4 together with the membrane intensity components (dashed lines) and 
cytoplasmic component (dotted-dashed line). (A) Profile from a cell with a low 
cytoplasmic intensity and fit (
2
red
  =1.4, ,C ytoF  =14.8 kcps, TF =51.9 kcps, BF =56.9 
kcps). (B) Profile from a cell with a high cytoplasmic intensity and fit (
2
red
  =1.5, 
,C yto
F
 = 
103 kcps, 
T
F = 52.6 kcps, 
B
F = 53.9 kcps).  
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profile into its components allowed us to quantify these differences. We will follow this 
approach in the rest of the chapter to generate a membrane binding curve by analyzing 
intensity profiles from a population cells with different protein expression levels. 
We expect the fluorescence intensity values to stay constant if the binding process 
of the peripheral membrane protein is at equilibrium. As a control we performed repeated 
z-scans on cells expressing H-Ras-EGFP over extended time periods. Each z-scan is fit 
by Eq. 6.4 to identify the cell height and the fluorescence intensities in each of the three 
layers as illustrated in Figure 6.2. The top (Figure 6.2A, dashed line) and bottom (solid 
line) membrane intensity, as well as the cytosolic intensity (Figure 6.2B, dotted-dashed 
line), remained remarkably stable even when the cell height (Figure 6.2C, solid line) 
changed during the experiment. The fluorescence intensities at the top and bottom 
membrane were matched, which suggests that the affinity of binding to either membrane 
was the same. The concentration 
C yto
c  of cytoplasmic H-Ras-EGFP is determined from 
the cytosolic fluorescence intensity by 
,C yto C yto
F c V
 
 , where V

 is the PSF volume 
and   represents the brightness of the EGFP protein that was measured by an 
independent control experiment. The protein concentration 
M
  at the membrane is 
determined from the intensity 
M
F  at the membrane by a similar relation, 
0M M
F A  , 
where V

 is replaced by the PSF area 
0
A . Applying these relations to the data of Figure 
6.2 yielded surface concentrations of B = 900 μm
-2
 and T = 920 μm
-2
 for the bottom 
and top membranes and a cytoplasmic concentration C ytoc = 71 μm
-3
.  
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Figure 6.2 Repeated z-scans: EGFP-H-Ras. 
Fit parameters of consecutive z-scan intensity profiles taken in an U2OS cell expressing 
EGFP-H-Ras. (A) Fluorescence intensities at the top (dashed line) and bottom (solid line) 
membrane remain stable (
B
F =93.7 ± 3.2 kcps, 
T
F =95.6 ± 4.3 kcps,). (B) Cytoplasmic 
intensity (dot-dashed line) is constant (
,C yto
F

=10.0 ± 0.8 kcps). (C) The cell thickness 
(solid line) changed within the first few minutes and then remained approximately 
constant.  
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6.3.2 Membrane binding curve 
Cells transiently transfected with EGFP labeled Myo1C were selected and their z-
scan intensity profile measured. The membrane and cytoplasmic intensity were 
determined by a fit of the intensity profile and are plotted in Figure 6.3A. The uncertainty 
in the fitted membrane and cytoplasmic intensities was on the order of or smaller than the 
symbol size and therefore was not plotted. The same condition applied to all membrane 
binding plots shown in this work. The membrane fluorescence intensity versus 
cytoplasmic fluorescence intensity displays a concentration dependent response, which 
saturates at high cytoplasmic intensities. Fluorescence intensities from the bottom 
membrane (open triangles) and the top membrane (solid triangles) are in close 
agreement. The data represent the binding curve  ,M CytoF F   of the peripheral membrane 
protein to the plasma membrane. To model the experimental data consider a cytoplasmic 
protein P that binds a free membrane binding site M with dissociation coefficient K to 
become a membrane-associated protein MP, M P M P
K
  . The fractional saturation 
 of the membrane binding sites is described by the Langmuir isotherm, 
 
0
C ytoM
C yto
c
K c



 

, (6.5) 
where 
C yto
c  and 
M
  are the cytoplasmic and membrane-bound protein concentrations, 
while 
0
  represents the concentration of the total number of membrane binding sites 
0
M M M P  . 
We relate the Langmuir-isotherm to fluorescence intensities to facilitate the 
analysis of the data in Figure 6.3A. The cytoplasmic and membrane-bound protein 
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concentrations are connected to the fluorescence intensities as described earlier, 
,C yto C yto
F c V
 
  and 
0M M
F A  . We further introduce the saturating fluorescence 
intensity at the membrane, 
0 0 0
F A  , and 
K
F K V

  to relate both the maximum 
binding site concentration and the dissociation coefficient to an intensity. Inserting these 
relations into Eq. 6.5 provides an alternate formulation of the Langmuir isotherm in terms 
of fluorescence intensities, 
 
0 ,
0
,
C yto
M
K C yto
F F
F F
F F



 

. (6.6) 
A fit of the intensity data in Figure 6.3A to Eq. 6.6 with 
0
F  and 
K
F  as free parameters is 
shown as solid line with 24 5
K
F    kcps and 
0
83 10F    kcps. We use the EGFP 
brightness  , the PSF volume V

 and the area 
0
A  to convert these values into the 
dissociation coefficient 
3
160 30 μm 270 50 nMK

     and saturation concentration 
2
0
750 90 μm

  . 
An alternate way to represent membrane binding is to graph the membrane 
intensity fraction 
 
,
M
M
M C yto
F
f
F F



 (6.7) 
versus the cytoplasmic intensity 
,C yto
F
 . Because the z-scan intensity profile distinguishes 
between the bottom and top membrane, we further introduce the intensity fraction 
B
f of 
the bottom membrane and the intensity fraction 
T
f of the top membrane, which are 
defined by replacing 
M
F  with 
B
F  and 
T
F  in Eq. 6.7, respectively. The membrane 
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intensity fraction of the Myo1C data as a function of cytoplasmic intensity is shown in 
Figure 6.3B. The dashed line represents the Langmuir isotherm model,  
 0
, 0
M
K Cyto
F
f
F F F


 
, (6.8) 
with values for 
0
F  and 
K
F  as determined above. The membrane intensity fraction decays 
monotonically with cytoplasmic concentration, because an increase in protein 
concentration leads to a further depletion of the available membrane binding sites. 
Evaluating Eq. 6.8 for a cytoplasmic concentration 
,
0
C yto
F

  determines the maximum 
limiting value 0
0
M
K
F
f
F F


 for the membrane intensity fraction, which for the Myo1C 
data is 0.78. Thus, the saturation concentration 
0
  and the dissociation coefficient K are 
not independent variables, but linked by 
M
f . If the data of the fluorescence membrane 
binding curve  ,M CytoF F   are insufficient to identify 0  and K unambiguously, an 
extrapolation of the measured fractional membrane intensity 
M
f  can be used to identify 
the ratio of both parameters, which for intensity-based notation is given by 
 0 1K M MF F f f  . 
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Figure 6.3 Fluorescence membrane binding curve of Myo1C-EGFP.  
(A) Fluorescence intensity at the bottom (open triangles) and top (solid triangles) 
membrane versus fluorescence intensity in the cytoplasm. The fit (dotted line) to Eq. 6.6 
recovers F0 =83 kcps and FK =24 kcps. The top and right axes specify the cytoplasmic 
and membrane-bound protein concentrations. (B) Membrane intensity fraction versus 
fluorescence intensity in the cytoplasm (open triangles) is well approximated by Eq. 6.8
(dotted line) with the same F0 and FK as determined in A.  
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6.3.3 Lipid binding protein domains 
Lactadherin is a peripheral membrane protein shown to interact with phosphatidylserine 
(PS) lipids through its C2 domain (152, 153). We measured U2OS cells transiently 
transfected with an EGFP-labeled Lact-C2 fragment (Lact-C2-EGFP) and determined the 
experimental membrane-binding curve (see Figure 6.4, open triangles). A fit (solid line) 
to the Langmuir-isotherm binding model leads to a saturation concentration 
2
0
4100 1100 μm

   and a dissociation coefficient 700 310K   nM. In a follow-up 
experiment we cotransfected Lact-C2-EGFP and Lact-C2-mCh using a plasmid ratio of 
1:3. We selected cells that express both proteins and measured the membrane-binding 
curve (open squares) of Lact-C2-EGFP from the fluorescence intensity traces in the 
green detection channel. The membrane saturation intensity 
0
F  is much lower than in the 
previous experiment, reflecting the presence of Lact-C2-mCh that competes with the 
green-labeled protein. We divided the amplitude of the Lact-C2-EGFP Langmuir-
isotherm curve (solid line) by four to account for the binding site competition provided 
by Lact-C2-mCh. The binding curve (dashed line) with the rescaled amplitude is in good 
agreement with the experimental data and illustrates the feasibility of binding 
competition assays. 
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Figure 6.4 LactC2-EGFP fluorescence membrane binding curves. 
Fluorescence membrane binding curve (open triangles) for LactC2-EGFP in U2OS cells 
with fit (solid line) to Eq. 6.6 (F0 =530 kcps, FK = 68 kcps). Competitive binding curve 
for LactC2-EGFP coexpressed with LactC2-mCh at a 1:3 ratio (open squares) agrees 
with predicted binding curve (dashed line).  
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We also examined the plasma-membrane binding curve of the PH domain of 
PLCδ, which is known to interact with PI(4,5)P2 lipids (132). The experimental 
membrane-binding data (Figure 6.5A, open circles) of EGFP-labeled PH-PLC were 
determined in U2OS cells and fit to a Langmuir isotherm model (solid line) with 
0
6200 1300   µm
-2
 and 5.3 1.4K   µM. Next, we coexpressed PH-PLC-EGFP with 
miniGAP-mCh. We selected cells that express both proteins and determined the 
membrane-binding curve (Figure 6.5A, solid stars) of the PH-PLC-EGFP from the 
intensity signal of green detection channel. The presence of miniGAP led to a drastic 
change in the binding curve for PH-PLC, which was also reflected by the fit of the 
binding data to a Langmuir isotherm model (dashed line). Plotting the same data with a 
reduced scale allowed the behavior at low intensities to be more clearly visualized (See 
Appendix B). The marked decrease in the amplitude of the binding curve implied that 
miniGAP and PH-PLC compete for the same binding sites at the membrane. This 
observation is consistent with the fact that both proteins are known to interact with 
PI(4,5)P2 (154, 155).  
For a control experiment, we coexpressed PH-PLC-EGFP and Lact-C2-mCh in 
U2OS cells. The data in Figure 6.5B revealed that the experimental membrane-binding 
data of PH-PLC-EGFP in the presence (asterisks) or absence (open circles) of Lact-C2 
closely track one another. In vitro studies reported that PH-PLC interacts with PI(4,5)P2, 
while Lact-C2 interacts with PS (152, 153). Thus, both proteins are expected to target 
different binding sites at the membrane, which is corroborated by our experimental 
binding data.  
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Figure 6.5 Membrane binding competition experiments of LactC2-EGFP.  
(A) Binding curve for PH-PLCδ-EGFP (open circles) and fit (solid line) by Eq. 6.6 (F0 
=909 kcps, FK = 620 kcps). Competitive binding curve for EGFP-PLCδ-PH coexpressed 
with MiniGAP-mCh (solid stars) and fit (dotted line) by Eq. 6.6 (F0 =76kcps, FK = 71 
kcps). (B) Binding curve for PH-PLCδ-EGFP (open circles) and fit (solid line) as shown 
in A. Competitive binding curve for PH-PLCδ-EGFP coexpressed with LactC2-mCh 
(asterisks) closely tracks the binding curve for PH-PLCδ-EGFP alone.  
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6.3.4 HTLV-1 matrix 
In chapter 4, we investigated the MA domain of Gag in an effort to uncover the 
initial assembly steps of the retrovirus HTLV-1 Gag. MA was chosen as a simplified test 
system for initial studies of the assembly process, because it is the primary driver of Gag 
association with the inner leaflet of the plasma membrane, but lacks the ability to 
associate into large multimers (114, 116). Previous work has shown that HTLV-1 MA 
Gag forms homo-complexes at the plasma membrane, but is monomeric in the cytoplasm 
(51, 107, 108, 156). Since the membrane binding mechanism of HTLV-1 MA is not well 
understood, we decided to investigate the lipid specificity, binding affinity, and saturation 
concentration of the process. We transiently transfected U2OS cells with EGFP-labeled 
MA and determined the cytoplasmic and membrane-bound fluorescence intensities from 
multiple cells. The data (Figure 6.6A, open triangles) show a concentration-dependent 
increase in the fluorescence signal at the membrane. A fit (solid line) of the data to a 
Langmuir-isotherm resulted in a dissociation coefficient of 230 130K    nM and a 
membrane saturation concentration of 
0
2800 700    µm
-2
.  
Further, we performed competition studies to probe the lipid specificity of HTLV-
1 MA binding to the plasma membrane. We first coexpressed HTLV-1 MA-EGFP with 
miniGAP-mCh to probe binding to PI(4,5)P2. In Figure 6.6B, the binding curve (solid 
squares) of HTLV-1 MA-EGFP in the presence of miniGAP-mCh overlaps with the 
binding data (open triangles) taken for HTLV-1 MA-EGFP alone. This observation 
suggests that PI(4,5)P2 is not the main lipid target of HTLV-1 MA. We next coexpressed  
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Figure 6.6 HTLV-1 MA-EGFP membrane binding curves. 
(A) Fluorescence membrane binding curve (triangles) for HTLV-1 MA-EGFP expressed 
in U2OS cells. The same data are shown in B and C as gray symbols. The fit (solid line) 
to Eq. 6.6 leads to F0 =18 kcps and FK =288 kcps. (B) Competitive binding curve (solid 
squares) of MA-EGFP coexpressed with miniGAP-mCh. (C) Competitive binding curve 
(solid diamonds) of MA-EGFP coexpressed with LactC2-mCh and fit (dashed line) to 
Eq. 6.6 (F0 =8 kcps, FK = 68 kcps). 
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HTLV-1 MA-EGFP with Lact-C2-mCh to probe PS binding. The presence of Lact-C2-
mCh led to a strong change in the binding curve of HTLV-1 MA-EGFP (see Figure 6.6C, 
solid diamonds) as compared to HTLV-1 MA-EGFP alone (open triangles). This result 
indicates that PS lipids are an important binding target of HTLV-1 MA. The dashed line 
represents the fit curve to a Langmuir-isotherm with a dissociation coefficient of 
130 16K    nM and a membrane saturation concentration of 0 840 110   µm
-2
. 
 
6.4 Discussion 
Our data demonstrate that it is feasible to measure the membrane binding curve of 
fluorescently-labeled proteins inside living cells with z-scan FPD analysis. The technique 
relies on the deconvolution of the intensity profile with the help of an accurately 
parameterized PSF. We have found that the modified Gaussian-Lorentzian model 
provides a very faithful representation of the PSF for the two-photon instruments in our 
lab (51, 76). An additional consideration is the cell height at the scan position, which 
must be sufficiently large to distinguish membrane and cytoplasmic contributions by the 
deconvolution process. In our experience, the cell thickness should be at least twice the 
axial beam waist 
R
z  of the PSF, which implies a minimum thickness of ~2 μm for our 
setup, a condition that was satisfied for all cell measurements presented in this study. 
Thus, while our study focused on U2OS cells, z-scan FPD has the potential to be 
expanded to other cell types as long as their minimum height is ~2 μm. 
Analysis of z-dependent intensity distributions of fluorescently labeled cells is not 
a novel concept in itself. For example, z-stack image analysis has been widely used in the 
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fluorescence field to determine protein localization which includes work from Scarlatta 
and coworkers where they segment the z-dependent intensity distribution of Gq and 
Phospholipase Cβ into membrane and cytoplasmic regions (27, 28). However, 
segmentation does not result in a quantitative separation of fluorescence signals from 
different compartments, because the PSF blurs the signal contributions. Modeling 
approaches have been used to account for the effect of the PSF, including recent work 
which used a 3D Gaussian PSF to identify the membrane-bound and free intensities of 
tBid in an in vitro environment (157). However, an accurate and quantitative analysis 
requires a parameterized PSF to avoid systemic biases. Z-scan FPD achieves this goal 
and partitions the intensity profile into its membrane and cytoplasmic components. While 
the current study was performed on a two-photon microscope, we expect that the same 
types of experiments are feasible on a one-photon confocal instrument. Extension of the 
z-scan method only requires a proper parameterization of the one-photon observation 
volume O (120), which replaces the PSF of two-photon excitation.  
In this work we focused on the binding of a number of different protein domains 
to PI(4,5)P2 and PS lipids. It has been estimated that the surface density of PI(4,5)P2 lipid 
on the cell membrane is between 3000-5000 molecules/µm
2
 (31) and that PH-PLCδ binds 
to PI(4,5)P2 with a dissociation coefficient ranging from 2 to 3 µM in vitro (132, 158). 
Fitting the binding curve of PH-PLCδ-EGFP (see Figure 6.5B) determined a surface 
concentration of 6200±1300 molecules/µm
2
 and a binding dissociation coefficient of 
K=5.3±1.4 µM in situ, which are close to the previously reported in vitro values. The 
binding curve of miniGAP-EGFP to the plasma membrane can be found in Appendix C. 
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We also applied our technique to study the binding of Lact-C2-EGFP to PS lipids. 
Estimates of the lipid composition at the plasma membrane indicate that PS is more 
abundant than PI(4,5)P2 (31). Thus, we expected to measure a higher surface density than 
for PH-PLCδ-EGFP, but experimentally observed a surface density of 4100 
molecules/µm
2
 for Lact-C2-EGFP (see Figure 6.5A), which is less than what we 
measured for PH-PLCδ-EGFP. However, the z-scan binding assay does not measure the 
lipid concentration, but the protein concentration at the membrane. Thus, accessibility to 
the targeted lipid as well as competition for binding sites from other cellular protein will 
modulate the saturation concentration at the membrane. The binding affinity of LactC2 
for PS on lipid vesicles has been measured by FRET experiments with reported in vitro 
dissociation coefficients of K=290 – 350 nM (159, 160) which agrees within a factor of 
two with our result.  
Myo1C, a member of the myosin I superfamily, is known to associate with 
plasma membrane lipids (PI(4,5)P2 and PS) through electrostatic interactions involving 
the tail domain (161, 162). Hokanson and Ostap studied the binding of the Myo1C tail 
fragment to LUVs containing 2% PI(4,5)P2 and reported KD values that depended on 
labeling and ranged from 230 to 530 nM (163, 164). We determined a K=270 nM for full 
length Myo1C-EGFP in U2OS cells, which is in close agreement with the in vitro results 
from the Myo1C fragments. Finding the same affinity for the fragment and the full-length 
protein suggests that the tail domain of Myo1C is the main determinant for the membrane 
binding energy. This property has also been found in other proteins. For example, PLCδ 
and its PH domain bind with a very similar affinity (147). Further results for Myo1C can 
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be found in the appendices. We characterized the protein’s oligomeric state at the 
membrane and its lipid specificity in Appendices D and E. 
We used the matrix domain of HTLV-1 Gag to probe the early assembly steps of 
this retrovirus. The MA domain of Gag contains a myristoyl moiety and a highly basic 
region, which are both important for membrane binding (reviewed (165)). For HIV-1 the 
MA domain and full length Gag only associate with the plasma membrane at high protein 
concentrations, where protein-protein interactions trigger the exposure of the sequestered 
myristoyl moiety (108, 165). In contrast, the MA domain and full length Gag of HTLV-1 
have been found to associate with the plasma membrane even at the lowest measurable 
fluorescence intensities (108). While this observation seems to imply a very high binding 
affinity, the data in Figure 6.6 indicate a dissociation constant of several hundred 
nanomolar, which is a lower affinity than originally expected. This apparent 
inconsistency can be resolved by considering the limiting value 
M
f  of the membrane 
fraction as the cytoplasmic protein concentration approaches zero, which depends on the 
surface concentration of binding sites and the affinity. The fit parameters of the binding 
curve for MA result in 0.92
M
f  , which reflects the large ratio of 
0
F  to 
K
F . In other 
words, a sufficient high number of binding sites compensates for a lower binding affinity 
and results in a significant population of membrane-bound proteins even at the lowest 
expression levels. In the case of MA over 90% of the protein is at the plasma membrane 
at very low cytoplasmic protein concentrations. 
The membrane binding partner of HTLV-1 Gag is still an open question. It has 
been shown that HIV-1 Gag binding with PI(4,5)P2 is essential for function (114). 
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However, when Inlora et al. recently studied the interaction between PI(4,5)P2 and the 
MA domain of HTLV-1, they concluded that PI(4,5)P2 was not essential for particle 
assembly (166). This finding is corroborated by our in situ competitive binding assay (see 
Figure 6.6B) which demonstrates that PI(4,5)P2 is not an essential binding partner of MA. 
Instead we found that HTLV-1 MA-EGFP binds to PS lipid at the plasma membrane 
(Figure 6.6C). This observation agrees with in vitro work reporting that HTLV-1 Gag 
binds to liposomes containing PS (166).  
The same study argued that HTLV-1 MA interacts with lipids primarily through 
electrostatic and not lipid-specific interactions. If electrostatic interactions are the main 
driver for membrane association, we would expect to observe competition for the 
PI(4,5)P2 binding site, because the net charges of PI(4,5)P2 at neutral pH is expected to be 
−3 or −4 (147), while for PS it is −1. However, the data in Figure 6.6B show no or at best 
only weak interaction between HTLV-1 MA and PI(4,5)P2, since the competitive binding 
curve (solid squares) is only slightly lower than the binding curve for MA alone (open 
triangles). A potential explanation for the stronger interaction with PS lipids might be 
found in the distribution of basic residues in the matrix protein. Unlike HIV-1 MA, the 
basic residues of HTLV-1 MA are distributed throughout the sequence (167). The higher 
abundance of PS over PI(4,5)P2 at the inner leaflet of the plasma membrane might lead to 
a larger number of local interactions with the distributed basic residues of the protein, 
which would result in an increased binding energy. Thus, our data suggest that interaction 
with PS lipids at the membrane plays an important role in the early assembly step of the 
HTLV-1 virus. 
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We briefly note that it is important to choose a suitable scan location within the 
cell. If the protein of interest is excluded from certain cellular compartments, then the 
presence of such a compartment along the scan trajectory will lead to a dip in the 
intensity profile, provided the compartment is comparable in size to the PSF. We use a 
brightfield image of the cell to find a position that avoids large structures such as the 
nucleus and the surrounding endomembrane system. We further perform at least two 
successive z-scans at each scan location, because movement of vesicles or other 
compartments between two successive scans introduces changes in the intensity profile. 
We only accept data where the intensity profile remains unchanged between scans. While 
these methods have proven sufficient for studying protein binding to the plasma 
membrane, a more sophisticated approach will be needed for proteins that interact with 
internal membranes to account for their complex spatial distribution inside the cell. 
FPD analysis of the z-scan intensity profile separates membrane-bound and 
cytoplasmic protein components in terms of intensity. To translate these intensities into 
absolute concentrations requires an additional conversion factor from an independent 
experiment. In this work, we used the brightness of monomeric EGFP (determine from an 
independent control experiment) as our conversion factor to identify concentrations. 
However, even in the absence of a conversion factor, it is still possible to quantitatively 
compare intensity-based binding curves because the concentration and intensity are 
linearly related. This point is illustrated by the competition experiments depicted in 
Figures. 6.4, 6.5, and 6.6. 
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The heterogeneity of the cytoplasm introduces uncertainty in brightness 
experiments and therefore in the determination of protein concentration, an issue that has 
been studied early on (1). We have found that the uncertainty of brightness measurements 
in cells is ~10% (76), which implies a ~10% uncertainty in determining the 
concentration. Similarly, we also observed a brightness uncertainty of ~10% at the 
plasma membrane (51). Our current study generated membrane binding curves through 
single point z-scan measurements taken over a sample of cells. However, the scatter in 
the data points of the measured binding curves appears much larger than the 
measurement uncertainty. This spread of intensities at the membrane for a given 
cytoplasmic concentration might reflect cell to cell variations or be caused by spatial 
heterogeneity at the cell membrane. To address this issue we plan to expand the z-scan 
technique by combining it with x-y scans to explore small regions of the plasma 
membrane. This approach should allow us to investigate the origin of the scatter in the 
binding curve and potentially expand the reach of the technique to study binding of 
proteins with a non-uniform spatial distribution at the plasma membrane. While these 
developments will strengthen the technique, the results obtained from simple z-scans are 
already impressive. Single point z-scans have proven to be sufficient for quantitative 
analysis of the binding and competition experiments shown here. 
In summary, z-scan FPD offers a new method for characterizing binding curves of 
peripheral membrane proteins within their native environment. The technique not only 
offers a way to test the binding results from ex situ studies within a cellular system, but 
also promises to reveal novel features. For example, competition assays can be performed 
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to identify specific lipid-protein binding partners. We anticipate that the ability to 
quantitatively monitor membrane binding in situ should prove useful for functional 
studies of membrane-binding proteins. 
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7.  Summary 
Quantitative analysis of protein-protein interactions at the plasma membrane is 
important for addressing fundamental biological and physical questions of cellular 
systems. In addition, information about protein-protein interactions is a prerequisite for 
developing a molecular-level picture of disease models. While FFS brightness analysis 
offers a way to determine the oligomeric state of a protein within a live cell environment, 
traditional FFS analysis breaks down when different compartments and their boundaries, 
such as the plasma membrane, are present in the observation volume.  
In this thesis we addressed this challenge by developing z-scan FFS to 
simultaneous determine brightness at the membrane and in the cytoplasm. The technique 
requires only four inputs to connect the experimental raw brightness to the underlying 
physical brightness of each fluorescent layer of the sample: (1) a well characterize PSF, 
(2) a geometric model for the cell layers, (3) the z-scan fluorescence intensity profile, and 
(4) point FFS measurements taken at the top and bottom plasma membrane and in the 
cytoplasm. We demonstrated the feasibility of the technique by using H-Ras-EGFP as a 
model system and showed that in U2OS cells it exists as monomer both in cytoplasm and 
at the plasma membrane.  
A byproduct of z-scan FFS is the z-scan intensity profile. We realized that 
deconvolution of the intensity profile into the cytoplasmic and membrane-associated 
components provides an excellent opportunity for quantitative membrane binding of 
proteins in a living cell. The deconvolution, which we refer to as z-scan FPD analysis, 
requires an accurate PSF model together with a geometric model of the cell layers. The 
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intensities recovered by FDP analysis can be translated into concentrations through use of 
an independently determined conversion factor, like the brightness of EGFP. 
We experimentally validated z-FPD and characterized both the resolvability and 
stability of z-scan fitting and applied the technique in two distinct ways. First, we made 
time-resolved measurements of the reversible association of peripheral membrane 
proteins to the plasma membrane, quantified the translocation of the protein, and 
measured protein-specific cell height changes. Second, we generated membrane binding 
curves by performing FPD analysis over a population of cells. By fitting the membrane 
binding curves, we determined the number of binding sites and the dissociation 
coefficient of the protein. Finally, we combined the dual-color work from chapter 3 with 
z-scan FPD analysis to examine the protein-lipid interactions of selected protein domains 
and demonstrated that competition binding experiments can be used to identify specific 
lipid-protein interactions in living cells.  
We applied z-scan FFS and z-scan FPD to provide insight into the early assembly 
steps of the HTLV-1 retrovirus. We focused on the matrix (MA) domain of HTLV-1 Gag 
because it is the primary driver of Gag association with the plasma membrane’s inner 
leaflet. Figure 7.1 summarizes our results. HTLV-1 MA-EGFP binds to the plasma 
membrane with a lower affinity than we initially predicted based on earlier work, which 
demonstrated association of MA and full length Gag with the plasma membrane at very 
low intensities (108). We resolved this inconsistency by examining the limiting value of 
the membrane intensity fraction, which suggested that an abundant number of 
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Figure 7.1 Summary of HTLV-1 MA-EGFP results. 
HTLV-1 MA-EGFP binds to the plasma membrane as a monomer with an affinity of 
K~250 nM and undergoes a monomer to dimer transition at the membrane with a 
dissociation coefficient of ~300 µm
–2
.   
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binding sites compensates for a lower binding affinity. The z-scan brightness data 
showed that HTLV-1 MA-EGFP is monomeric in the cytoplasm and undergoes a 
monomer to dimer transition at the plasma membrane. Competition studies further 
showed that PS lipids are an important target for the MA domain of HTLV-1 Gag. These 
results provide the foundation for future z-scan studies on the full-length Gag protein.  
Z-scan FFS and z-scan FPD appear to be very promising techniques with many 
potential applications. At this point there are at least three future developments that 
would significantly broaden the range of applications: (1) apply the z-scan techniques to 
internal membranes, (2) perform dual-color z-scan studies to probe hetero-species 
interactions, and (3) combine z-scanning with x-y imaging. We already applied z-scan 
FFS to an internal membrane in collaboration with researchers in the department of 
Molecular, Cellular, Developmental Biology and Genetics. More specifically we 
completed preliminary feasibility studies (see Appendix F) and have taken z-scan 
brightness data on Torsin-1A (TA) within the perinuclear space (see Appendix G).  
Dual-color z-scans were only used in a rudimentary way within this thesis and 
dual-color brightness measurements were never performed. In future work, dual-color z-
scan FFS in combination with TIFCA analysis could have an important role in 
quantifying protein interactions at the plasma membrane where many intracellular 
signaling and trafficking processes are accompanied by hetero-species interactions. While 
the z-scan theory put forth within the thesis will be the platform of the technique, the 
cotransfection modeling work within chapter 3 will also be important. The cotransfection 
model allows us to predict the average and distribution of the protein expression ratios for 
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different pDNA mixing ratios, which will be useful for choosing expression ratios that 
maximize the presence of hetero-protein complexes. 
Finally, the combination of x-y scanning with z-scanning will allow us to probe 
spatial heterogeneities at the plasma membrane, while retaining the geometric and 
intensity information from the z-scan analysis. While the single point measurement per 
cell was sufficient for quantitative analysis of the binding curve (chapter 6), we observed 
significant scatter in the measured data points. This result might reflect the presence of 
significant spatial heterogeneity of membrane binding at the plasma membrane. A 
combined x-y and z-scan technique should be able to address this open question. 
In conclusion, this work describes a pair of z-scan fluorescence techniques that 
characterize proteins at the cytoplasm / plasma membrane interface of living cells. Our 
experimental results are testimony to the unique strength of our approach. The techniques 
described in this thesis add new powerful tools to our arsenal for studying and 
quantifying the behavior of proteins that interact with the plasma membrane. 
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Appendix A:  
HRas-EGFP and HRas-EGFP2 at the membrane 
 
In this thesis, we applied z-scan FFS to characterize the brightness of both the 
membrane-bound and cytoplasmic populations of HRas-EGFP. Our data showed HRas-
EGFP to be monomeric at both the upper and lower plasma membrane and also in the 
cytoplasm of U2OS cells, thus making HRas-EGFP an ideal monomeric calibration 
protein.  
To study higher-order oligomeric proteins at the plasma membrane, it is 
advantageous to have a membrane-bound dimer calibration protein. We cloned such a 
tandem dimeric protein by adding a second EGFP sequence to our HRas-EGFP plasmid 
and performed z-scan FFS to measure its brightness at the membrane and cytoplasm. 
Further we constructed a monomer-to-dimer plot which shows that the membrane 
brightness of HRas-EGFP2 is twice that of HRas-EGFP (Figure A1).    
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Figure A.1 Membrane brightness calibration standard 
 
Normalized raw brightness of HRas-EGFP (solid circles) and of HRas-EGFP2 (shaded 
circles) (A) Raw measured brightness at the membrane (B) True underlying membrane 
layer brightness.   
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Appendix B:  
Binding Curve for PH-PLCδ-EGFP at Low Intensities 
The presence of miniGAP-mCh led to a decrease in the binding curve for PH-
PLC-EGFP. We plot the same data with a reduced scale so the behavior at low 
intensities can be more clearly visualized. The marked decrease in the amplitude of the 
binding curve seen in Figure B.1 implies that miniGAP and PH-PLC compete for the 
same binding sites at the membrane. 
 
Figure B.1 Close-up view of the low cytoplasmic intensity region of Figure 5.4A. 
  
Binding curve for PH-PCLδ-EGFP (open circles) and fit (solid line) are shown together 
with the competitive binding curve for PH-PCLδ-EGFP coexpressed with miniGAP-mCh 
(solid stars) and fit (dotted line).  
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Appendix C: miniGAP-EGFP Membrane Binding Curve 
 
Gap43 is a peripheral membrane protein shown to interact with PI(4,5)P2 lipids as 
a result of palmitolyation at Cys-3 and Cys-4 (154, 155). MiniGAP-EGFP is a truncated 
membrane binding version of Gap43 (the first 10 amino acids) with an EGFP label. We 
measured U2OS cells transiently transfected with miniGap-EGFP and determined the 
experimental membrane-binding curve (Figure C.1, open triangles). A fit (shaded line) to 
the Langmuir-isotherm binding model identified a saturation concentration 
2
0
6710 980 μm

   and a dissociation coefficient 1280 320K   nM. The saturation 
concentration matches with the saturation concentration observed for EGFP-PLCδ-PH 
(6200±1300 molecules/µm
2
), another PI(4,5)P2 binding protein. 
 
 
 
 
Figure C.1 miniGAP-EGFP membrane binding curve 
 
Fluorescence membrane binding curve of miniGAP-EGFP in U2OS cells (open 
triangles). The fit (shaded line) to Eq. 6.6 recovers 
0
550 80F   kcps and 
80 20
k
F   kcps. 
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Appendix D: Oligomeric State of Myo1C-EGFP 
We used Myo1C, a member of the myosin I superfamily, as a model system for 
fitting membrane-binding curves in chapter 6. We also performed z-scan FFS to 
determine the oligomeric state of Myo1C at the plasma membrane. The z-scan analysis 
determined that Myo1C-EGFP was monomeric at the plasma membrane over the 
concentration range studied (Figure D.1).  
 
 
Figure D.1 Normalized membrane layer brightness of Myo1C-EGFP 
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Appendix E: Lipid Specificity of Myo1C-EGFP  
Myo1C is known to associate with plasma membrane lipids (PI(4,5)P2 and PS) 
through electrostatic interactions involving the tail domain (161, 162). Studies have 
confirmed the binding of Myo1C to PI(4,5)P2 and PS lipids in an in-vitro model 
membrane environment (163, 164). We decided to apply our dual-color z-scan FPD 
competition technique to study the lipid-specific binding of Myo1C within a live cell 
environment. We first coexpressed Myo1C-EGFP with miniGAP-mCh to probe the 
binding to PI(4,5)P2. In Figure E.1 A, the presence of miniGAP-mCh led to a decrease in 
the Myo1C-EGFP binding curve (solid diamonds) as compared to the binding data (open 
triangles) taken for Myo1C-EGFP alone. This observation suggests that PI(4,5)P2 is a 
potential lipid target for Myo1C-EGFP. We next coexpressed Myo1C-EGFP with Lact-
C2-mCh to probe PS binding. The presence of Lact-C2-mCh led to a decrease in the 
binding curve of Myo1C-EGFP (Figure E.2 B, solid squares) as compared to Myo1C-
EGFP alone (open triangles). This result indicates that PS lipids are also an important 
binding target of Myo1C-EGFP.  
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Figure E.1 Membrane binding and lipid specificity of Myo1C-EGFP  
 
Fluorescence membrane binding for Myo1C-EGFP (open triangles) in U2OS cells. (A) 
The competitive binding for Myo1C-EGFP coexpressed with miniGAP-mCh (solid 
diamonds) shows a decrease as compared to Myo1C-EGFP alone. (B) The competitive 
binding for Myo1C-EGFP coexpressed with LactC2-mCh (solid squares) shows a 
decrease as compared to Myo1C-EGFP alone.  
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Appendix F. SS-EGFP and SS-EGFP2 in the Nuclear Envelope 
 
 
The development of z-scan FFS broadened the capability of brightness analysis to 
include proteins distributed across stratified layers, such as the cytoplasm and the plasma 
membrane. In this work we collaborated with Dr. G.W. Gant Luxton and his graduate 
student Cosmo Sanders to further extend z-scan FFS to study proteins that reside on or 
within the nuclear envelope.  
We test the feasibility of this extension to internal membranes with a new EGFP 
calibration complex. Our collaborators in Genetics Cell Biology and Development placed 
a 20 amino acid ER signal sequence (SS) in front of EGFP. We denote this complex as 
SS-GFP. The complex is translated into the lumen of the endoplasmic reticulum (ER) 
with the signal sequence cleaved, resulting in an EGFP protein free to diffuse within the 
ER and nuclear envelope. The brightness of SS-EGFP is determined by performing z-
scan FFS measurements where corrections are applied for both the thin layer geometry 
and coexcitation of adjacent layers.  Additionally, our collaborators cloned and we tested 
a tandem dimeric EGFP protein (SS-EGPF2) to establish a model for calibrating 
brightness and stoichiometry.  
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Figure F.1 Z-scan brightness analysis of SS-EGFP and SS-EGFP2.  
 
SS-EGFP brightness b  (solid diamonds) and SS-EGFP2 b (solid triangles) in the nuclear 
envelope. 
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Appendix G. torsinA-EGFP and torsinAΔNTD- EGFP in the 
Nuclear Envelope 
 
We furthered our collaborative research efforts with the Luxton Lab and studied 
the oligomerization of torsin-1A (torsinA, TA) within the nuclear envelope. TA is a 
protein of interest because a glutamic acid deletion (ΔE) from TA causes the neurological 
movement disorder DYT1 dystonia, a specific type of dystonia that is frequently found in 
children. TorsinA is a membrane-associated AAA+ ATPase that resides within the 
nuclear envelope (NE) where it is required for proper NE structure and nuclear-
cytoskeletal coupling through an undefined molecular mechanism. As a starting point of 
our investigation into the behavior of TA we used z-scan FFS to probe its oligomeric 
state within the NE of living cells. 
Through z-scan FFS brightness measurements we determined that TA 
oligomerizes to form dimeric to trimeric assembly states within the NE. We further tested 
the oligomerization of a TA mutant that does not associate with the membrane (TA-
ΔNTD). This TA mutant forms higher order oligomers on average, which suggests that 
TA’s ability to associate with membranes negatively regulates homo-oligomerization.   
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Figure G.1 Z-scan brightness analysis of EGFP-TA-WT and EGFP-TA-ΔNTD. 
 
EGFP-TA-WT brightness b  (asterisks) and EGFP-TA-ΔNTD b (solid diamonds) in the 
nuclear envelope. 
 
 
 
